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3 
1. OVERVIEW 
In March 2012 the population of earth surpassed seven billion and it is currently estimated that around 
7.2 billion people live on earth,
1
 meaning that at the beginning of the 21st century the world has more 
inhabitants than ever before. This huge growth in population, which started with the agricultural and 
industrial revolution,
2
 was (and is) further promoted by technological and scientific achievements like 
for example improvements in sanitation and medicine.
3
 Not only does the world population constantly 
grow, but more and more developing and emerging countries demand rightfully access to western 
standard technology, which results in an increased concern about climate change, environmentalism and 
limited resources. From these facts result the major challenges for the 21st century scientist: To establish 
technologies for cheap, clean and sustainable energy sources, to reduce the amount of precious raw 
materials being wasted, to find ways to satisfy the increasing demand of foodstuff and to create new 
methods and drugs to face problems like increasing antibiotic resistance and rising cancer rates, as well 
as finding vaccines and cures for diseases like malaria and HIV/AIDS. 
Applied to chemistry this means a huge variety of new materials and drugs must be developed, as well 
as new ways to synthesize these compounds. These processes must be environmentally beneficial, 
sustainable, cost-efficient and of course energy and resource saving. Therefore chemical reactions not 
only need to be selective but also high yielding and atom economical to avoid large amounts of materials 
being wasted. Moreover unnecessary interconversions of functional groups and protection/deprotection 
steps should be kept at a minimum. Since many of these required materials are organic compounds like 
pesticides
4
 and drugs,
5
 as well as semiconductors
6
 or organic frameworks,
7
 chemists in this field are in 
great demand.  
To achieve these goals there are several different approaches like cascade and multi-component reaction 
(MCR) to reduce the overall number of steps and purification procedures necessary.
8
 But also 
technologies like high-throughput screenings/reactions
9
 gain more and more importance since they 
make it possible to screen a big set of different reaction conditions in a very short time using rather small 
amounts of chemicals, thus making it possible to optimize reaction conditions and catalysts for desired 
                                                     
1 Population Division of the Department of Economic and Social Affairs of the United Nations Secretariat, World Population 
Prospects. The 2012 Revision.  
2 G. Caselli, G. Wunsch, J. Vallin, Demography: Analysis and Synthesis, A Treatise in Population, Elsevier, Oxford, UK, 2005. 
3 B. Robinson, Victorian Medicine - From Fluke to Theory, BBC, February 1, 2002, retrieved from http://www.bbc.co.uk on 
February 5th, 2014. 
4 Sittig's Handbook of Pesticides and Agricultural Chemicals (Eds.: S. A. Greene, R. P. Pohanish), William Andrew Publishing, 
Norwich, 2005. 
5 M. Negwer, H.-G. Scharnow, Organic-Chemical Drugs and Their Synonyms, 8th Edition, Wiley-VCH, Weinheim, 2001. 
6 D. Yan, H. Wang, B. Du, Introduction to Organic Semiconductor Heterojunction, John Wiley&Sons, Singapore, 2010. 
7 a) J. L.C. Rowsell, O. M. Yaghi, Microporous Mesoporous Mater. 2004, 73, 3; b) X. Feng, X. Ding, D. Jiang, Chem. Soc. 
Rev. 2012, 41, 6010; c) S.-Y. Ding, W. Wang, Chem. Soc. Rev. 2013, 42, 548; d) H. Furukawa, K. E. Cordova, M. O’Keeffe, 
O. M. Yaghi, Science, 2013, 341, 974. 
8 a) K. C. Nicolaou, T. Montagnona, S. A. Snydera, Chem. Commun. 2003, 551; b) D. E. Fogg, E. N. dos Santos, Coord. Chem. 
Rev. 2004, 248, 2365; c) K. C. Nicolaou, Jason S. Chen, Chem. Soc. Rev. 2009, 38, 2993; d) M. S. Singh, S. Chowdhury, 
RSC Adv. 2012, 2, 4547; e) H. Pellissier, Chem. Rev. 2013, 113, 442; f) S. Brauch, S. S. van Berkela, B. Westermann, Chem. 
Soc. Rev., 2013, 42, 4948; g) C. M. R. Volla, I. Atodiresei, M. Rueping, Chem. Rev. 2013, 113, DOI: 10.1021/cr400215u. 
9 a) A. Hagemeyer, P. Strasser, A. F. Volpe Jr., High-Throughput Screening in Chemical Catalysis: Technologies, Strategies 
and Application (Eds. A. Hagemeyer, P. Strasser, A. F. Volpe Jr,) Wiley-VCH, Weinheim, 2004; b) C. Jäkel, R. Paciello, 
Chem. Rev. 2006, 106, 2912; c) D. Farrusseng, Surf. Sci. Rep. 2008, 63, 487. 
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compounds fast and efficient.
10
 Moreover, it is possible to synthesize a large plethora of different 
compounds in a rapid and automated way and test them for new applications.
11
  
 
Figure 1: Selected relevant organic molecules. 
 
Organometallic reagents play a special role in organic synthesis since they have a broad scope of 
developed methods for transformations of chemical structures, mainly due to the variety of metals which 
can be used.
12
 Furthermore, organometallics have proven to be crucial synthetic tools in MCR as 
catalysts and/or as reagents (Scheme 1),
13
 and moreover transition metal catalysts play a key role in 
high-throughput experimentation.
14
 Therefore, organometal-chemists are under pressure to improve the 
existing methodologies for synthesizing and transforming organometallic compounds, as well as 
developing new types of reagents and new ways to react these. 
                                                     
10 a) M. S. Congreve, C. Jamieson, Drug Discovery Today 2002, 7, 139; b) J. F. Traverse, M. L. Snapper, Drug Discovery 
Today 2002, 1002; c) J. G. de Vries, A. H. M. de Vries, Eur. J. Org. Chem. 2003, 799; d) R. J. Hendershot, C. M. Snively, 
J. Lauterbach, Chem.‒Eur. J. 2005, 11, 806. 
11 a) S. Ma, R. Subramanian, J. Mass Spectrom. 2006, 41, 1121; b) D. C. Webster, Macromol. Chem. Phys. 2008, 209, 237; c) 
O. Sharma, A. Kotnala, B. Shrivastva, R. K Singla, Pharmacologyonline Newsletter 2011, 2, 134. 
12 a) E. Negishi, Organometallics in Organic Synthesis, Wiley, New York, 1980; b) Handbook of Functionalized 
Organometallics (Ed.: P. Knochel), Wiley-VCH, Weinheim, 2005. 
13 a) D. M. D’Souza, T. J. J. Müller, Chem. Soc. Rev. 2007, 36, 1095; b) Y. Yoshida, K. Murakami, H. Yorimitsu, K. Oshima, 
J. Am. Chem. Soc., 2010, 132, 8878; c) M. G. Kamau, L. S. Harikrishnan, H. J. Finlay, J. X. Qiao, J. Jiang, M. A. Poss, M. 
E. Salvati, R. R. Wexler, R. M. Lawrence, Tetrahedron 2012, 68, 2696; d) E. Le Gall, Eric Léonel, Chem.‒Eur. J. 2013, 19, 
5238; e) L. Zhang, L. Sonaglia, J. Stacey, M. Lautens, Org. Lett. 2013, 2128; f) T. Wakamatsu, K. Nagao, H. Ohmiya, M. 
Sawamura, Angew. Chem. Int. Ed. 2013, 52; g) J. Tsoung, J. Panteleev, M. Tesch, M. Lautens, Org. Lett. 2014, 16, 110; h) 
D.-Chao Wang, H.-Y. Niu, M.-S. Xie, G.-R. Qu, H.-X. Wang, H.-M. Guo, Org. Lett. 2014, 16, 262.  
14 H. Zhang, V. Marin, M. W. M. Fijten, U. S. Schubert, J. Polym. Sci., Part A: Polym. Chem. 2004, 42, 1876; J. Le Nôtre, R. 
Touzani, O. Lavastre, C. Bruneau, P. H. Dixneuf, Adv. Synth. Catal. 2005, 347, 783; J. Zhang, C. Stanciu, B. Wang, M. M. 
Hussain, C.-S. Da, P. J. Carroll, S. D. Dreher, P. J. Walsh, J. Am. Chem. Soc. 2011, 133, 20552; J. Zhang, A. Bellomo, A. 
D. Creamer, S. D. Dreher, P. J. Walsh, , J. Am. Chem. Soc. 2012, 134, 13765; For a review see: S. Monfette, J. M. Blacquiere, 
D. E. Fogg, Organometallics 2011, 30, 36. 
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Scheme 1: Three-Component Domino Heck−Negishi Coupling Reaction for the Functionalization of Purines. 
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2. PREPARATION OF ORGANOMETALLIC REAGENTS 
The first organometallic compound ever synthesized
15
 is considered to be “Cadet's fuming liquid”, a 
mixture of cacodyl (Me2As)2 and cacodyl oxide ((Me2As)2O), prepared by the French pharmacist-
chemist Louis-Claude Cadet de Gassicourt in 1760.
16
 And although the synthesis of yet another 
organometallic species, Zeise’s Salt (potassium trichloro(ethene)platinate(II)), was published in 1827,
17
 
the first “successful” reagent of this class was certainly diethylzinc, first reported by Frankland in 
1849,
18
 which is industrially used until today. However, the final breakthrough for organometallic 
chemistry was eventually made by the introduction of organomagnesium reagents 50 years later by 
François Auguste Victor Grignard.
19
 Over the course of the 20th century organometallic reagents gained 
more and more importance and since the millennium alone three Nobel-Prizes were given to contributors 
in the field of organometallic chemistry.
20
 One of the major reasons for the success story of this 
compound class is the broad latitude of different reagents with a huge variety of transformations 
possible. This is partly due to the nature of the carbon-metal bond being more reactive, the more 
electropositive the specific metal is, causing the bond to become more ionic and less covalent. Thus, 
organolithium, -sodium or -potassium reagents possess a very nucleophilic carbon atom and exhibit an 
excellent reactivity towards many electrophiles. However, this comes at the expense of a very limited 
functional group tolerance.
21
 At the other end of the spectrum are organoboron or –indium reagents with 
a very covalent carbon-metal bond which is stable towards most functionalities and even tolerates air 
and water.
22
 Yet, since these reagents are relatively inert, they require either an appropriate catalyst or 
harsh reaction conditions in order to react with most electrophiles.
12
 A maybe even more important role 
play transition metals. The presence of valence electrons in the d-orbitals significantly differentiates the 
reactivity of the carbon-transition-metal bond from the carbon-main-group-metal bond. Since the d-
orbitals of the transition metals can interact with the bonding to the carbon as well as with other reagents, 
they allow particular, very selective transformations that would be impossible with main group metals. 
For this reason they are broadly used as catalysts in organic synthesis. One example for the use of 
organometallic reagents and catalysts on a large scale is the synthesis of the endothelin antagonist CI-
1034 (1)
23
 by Pfizer. Using a palladium catalyzed Suzuki–Miyaura cross-coupling
24
 of the triflate 2 with 
                                                     
15 C. Eschenbroich, Organometallchemie, Wiley-VCH, Weinheim, 2008. 
16 a) J.J. Berzelius. Jahresber. 1839, 18, 487; b) J. H. Burns, J. Waser, J. Am. Chem. Soc. 1957, 79, 859; c) D. Seyferth, 
Organometallics 2001, 20, 1488. 
17 a) W. C. Zeise, Poggendorff’s Ann. Phys. 1827, 9, 632; b) W. C. Zeise, Poggendorff’s Ann. Phys. 1831, 21, 497; c) W. C. 
Zeise, Poggendorff’s Ann. Phys. 1837, 40, 234. 
18 a) E. Frankland, Ann. Chem. 1849, 71, 171; b) E. Frankland, Ann. Chem. 1849, 71, 213. 
19 V. Grignard, Compt. Rend. Acad. Sc. Paris 1900, 130, 1322. 
20 2001: Knowles, Noyori, Sharpless; 2005: Chauvin, Grubbs, Schrock; 2010: Heck, Negishi, Suzuki. 
21 J. Clayden, Organolithiums: Selectivity for Synthesis (Ed. J. E. Baldwin), Pergamon Press, Oxford, 2002. 
22 a) Boronic Acids: Preparation and Applications in Organic Synthesis, Medicine and Materials (Ed. D. G. Hall), Wiley-
VCH, Weinheim, 2011; b) Z.-L. Shen, S.-Y. Wang, Y.-K. Chok, Y.-H. Xu, T.-P. Loh, Chem. Rev. 2013, 113, 271. 
23 S. Motte, K. McEntee, R. Naeije, Pharmacol. Ther. 2006, 110, 386. 
24 a) N. Miyaura, K. Yamada, A. Suzuki, Tetrahedron Lett. 1979, 20, 3437; b) N. Miyaura, A. Suzuki, J. Chem. Soc., Chem. 
Commun., 1979, 866. 
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the arylboronic acid 3 the precursor 4 was prepared on an 80 kg scale in 95% yield and after an ester 
saponification the desired CI-1034 (1) was obtained in 78% (Scheme 2).
25
  
 
Scheme 2: Large scale synthesis of CI-1034 (1) by a Suzuki cross-coupling. 
 
2.1 Oxidative Insertion 
Oxidative insertion of elemental metal into a carbon-halogen bond is by far the oldest method of 
preparing organometallic reagents. It was first reported by Frankland, who reacted zinc metal with alkyl 
halides, thus creating the first organozinc compound.
18
 Later the first organoaluminum reagent was 
prepared in a similar way from aluminum and methyl iodide by Hallwachs and Schaferik.
26
 The final 
breakthrough was made by Grignard, who generated the first organomagnesium reagents also via 
insertion of elemental magnesium into a carbon halide bond.
19
 
One of the major drawbacks of the first magnesium insertions are the rather harsh reaction conditions, 
(normally refluxing of the solvent is required), which limit the functional groups that can be tolerated. 
Another problem is the fact that those reactions normally have an induction period followed by heat 
evolution since the insertion can be very exothermic, which is especially problematic for large scale 
syntheses. The first successful approach to overcome these obstacles was made by Rieke: By reducing 
anhydrous metal chlorides with an alkali metal such as lithium, sodium or potassium in THF it is possible 
to generate highly reactive metal powders. This method enables the preparation of Grignard reagents at 
low temperatures, thus increasing the functional group tolerance. Moreover, is also a feasible way to 
transform relatively unreactive organohalides, for instance fluorides, into the corresponding magnesium 
species (Scheme 3).
27
 
                                                     
25 T. E. Jacks, D. T. Belmont, C. A. Briggs, N. M. Horne, G. D. Kanter, G. L. Karrick, J. J. Krikke, R. J. McCabe, J. G. 
Mustakis, T. N. Nanninga, G. S. Risedorph, R. E. Seamans, R. Skeean, D. D. Winkle, T. M. Zennie, Org. Process Res. Dev. 
2004, 8, 201. 
26 W. Hallwachs, A. Schaferik, Ann. Chem. 1859, 109, 206. 
27 a) R. D. Rieke, L.-C. Chao, Syn. React. Inorg. Metal-Org. Chem. 1974, 4, 101; b) R. D. Rieke, Acc. Chem. Res. 1977, 10, 
301; c) R. D. Rieke,, Science 1989, 246, 1260; d) L. Zhu, R. M. Wehmeyer, R. D. Rieke, J. Org. Chem. 1991, 56, 1445; R. 
D. Rieke, M. V. Hanson, Tetrahedron, 1997, 53, 1925; f) R. D. Rieke, Aldrichim. Acta 2000, 33, 52; g) J. Lee, R. Velarde-
Ortiz, A. Guijarro, J. R.Wurst, R. D. Rieke, J. Org. Chem. 2000, 65, 5428. 
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Scheme 3: Preparation and reaction of functionalized Grignard reagents using Rieke magnesium. 
 
This method not only works for magnesium, but is also viablefor the insertion of zinc metal into a 
carbon-halide bond. The so called Rieke zinc is prepared by the reduction of zinc chloride with lithium 
naphtalenide and reacts readily under mild conditions with a variety of functionalized alkyl- and aryl 
halides.27d By adding 2 equivalents of potassium iodide it was even possible to perform an insertion into 
the carbon-chlorine bond of the alkyl ester 5 to generate the organozinc compound 6 that underwent a 
copper mediated acylation
28
 to give the desired product 7 in high yield (Scheme 4).  
 
Scheme 4: Preparation and reaction of functionalized zinc reagents using Rieke zinc. 
 
A major drawback of this method is however, that the Rieke metals always have to be freshly prepared 
and the functional group tolerance of the magnesium reagents are still limited and require low 
temperatures. In recent years Knochel and coworkers developed a method to generate magnesium and 
zinc organometallics from commercially available metal turnings or powders. They found, that the 
addition of lithium chlorides promotes the insertion reaction dramatically, making it possible to prepare 
a variety of functionalized organozinc and -magnesium reagents in a simple straightforward manner.
29
 
Several studies show that the LiCl facilitates the metal insertion by lowering the energy of the transition 
state
30
 and, as ESI-measurements imply, the generated metal compounds are existent as ate-species of 
the general formula RMetXCl-Li+ (R = alkyl or aryl; Met = Mg, Zn, X = Cl, Br, I).
31
 LiCl also increases 
the solubility of the formed metal reagents.
32
 It is believed, that the LiCl thus “cleans up” the metal 
surface by solubilizing the already generated organometallics and therefore regenerating active metal 
                                                     
28 a) P. Knochel, M. C. P. Yeh, S. C. Berk, J. Talbert, J. Org. Chem. 1988, 53, 2390; b) P. Knochel, M. C. P. Yeh, S. C. Berk, 
J. Talbert,. Tetrahedron Lett. 1988, 29, 2395; c) M. C. P. Yeh, P. Knochel, W. M. Bulter, S. C. Berk, Tetrahedron Lett. 
1988, 29, 6693. 
29 Zn reagents: a) A. Krasovskiy, V. Malakhov, A. Gavryushin, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 6040; b) N. 
Boudet, S. Sase, P. Sinha, C.-Y. Liu, A. Krasovskiy, P. Knochel, J. Am. Chem. Soc. 2007, 129, 12358; c) A. Metzger, M. 
A. Schade, P. Knochel, Org. Lett. 2008, 10, 1107; Mg reagents: d) F. M. Piller, P. Appukkuttan, A. Gavryushin, M. Helm, 
P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 6802 
30 C.-Y. Liu, X. Wang, T. Furuyama, S. Yasuike, A. Muranaka, K. Morokuma, M. Uchiyama, Chem. Eur. J. 2010, 16, 1780. 
31 a) K. Koszinowski, P. Böhrer, Organometallics 2009, 28, 771; b) J. E. Fleckenstein, K. Koszinowski, Organometallics 2011, 
30, 5018. 
32 A. Krasovskiy, B. F. Straub, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 159. 
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surface.31a Using this methods various aryl- and heteroarylhalides can be transformed into the 
corresponding magnesium or zinc species. For instance the electron rich arylchloride 8 was converted 
into the magnesium species 9 at ambient temperature, which then could be reacted with 
dimethylcarbamoyl chloride to give the amide 10 in 81% yield (Scheme 5)
33
 Using zinc insertion also 
very sensitive functionalities such as aldehydes or esters can be tolerated and the generated organozinc 
reagents can undergo a variety of reactions with different electrophiles (Scheme 5).29a 
 
Scheme 5: Selected examples for LiCl promoted Mg and Zn insertion. 
 
Nevertheless, in some cases the zinc insertion is still very slow and the generated zinc reagents are inert 
towards many electrophiles. This problem can be overcome by performing a LiCl promoted Mg 
insertion in the presence of ZnCl2. The magnesium reagent is formed fast and is then instantly 
transmetalated to zinc creating MgXCl (X = Cl, Br, I) complexed organozinc species of the general 
formula RZnCl·MgXCl·LiCl. These Mg salt containing zinc compounds react readily with aldehydes, 
ketones and CO2, whereas reagents free of MgXCl do not react at all or only in moderate yields.
34
  
 
2.2 Halogen-Metal Exchange Reactions 
A different approach for the synthesis of organometallics is the halogen metal exchange which normally 
starts from an aryl bromide or iodide and an alkyl-metal reagent. In the course of the reaction the more 
stable organometallic species is formed, thus making it a convenient method for the formation of C(sp2)-
metal bonds.
35
 The halogen-magnesium exchange was pioneered by Prévost in 1931, who used EtMgBr 
for the generation of allylic magnesium reagents.
36
 Another version, developed by Wittig and Gillman 
in the same decade, uses lithium compounds like nBuLi, tBuLi or PhLi.
37
 However halogen-lithium 
exchange reactions always require very low temperatures and carefully controlled reaction conditions, 
                                                     
33 C. Dunst, P. Knochel, Synlett 2011, 14, 2064. 
34 A. Metzger, S. Bernhardt, G. Manolikakes, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 4665 
35 D. Hauk, S. Lang, A. Murso, Org. Process Res. Dev. 2006, 10, 733. 
36 C. Prévost, Bull. Soc. Chim. Fr. 1931, 49, 1372. 
37 a) G. Wittig, U. Poeckels, H. Dröge, Chem. Ber. 1938, 71, 1903; b) H. Gilman, W. Langham, A. L. Jacoby, J. Am. Chem. 
Soc. 1939, 61, 106; c) W. F. Bailey, J. J. Patricia, J. Organomet. Chem. 1988, 352, 1. 
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since alkyllithium reagents are prone to undergo side reactions especially when N-heterocycles are 
involved.
38
 Another version of the halogen magnesium exchange was eventually made by Knochel and 
coworkers, who prepared arylmagnesium reagents by treating aryl iodides with iPrMgBr or iPr2Mg and 
in the case of very electron poor aromatics with PhMgCl.
39
 This method was further improved by 
developing the LiCl complexed reagent iPrMgCl·LiCl (11), the so called “turbo-Grignard”, that shows 
an extremely high exchange reactivity towards aryl iodides and bromides.
40
 This behavior might be due 
to the formation of the magnesiate species iPrMgCl2-Li+ and furthermore the LiCl also increases the 
solubility of the Grignard reagent. Due to this enhanced reactivity aryl-, heteraoaryl and vinyl-
magnesium reagents can be prepared at low temperatures, making it possible to tolerate sensitive 
functionalities such as a nitrile or even an ester (Scheme 6).
41
 
 
Scheme 6: Hal/Mg exchange using iPrMgCl·LiCl. 
 
Also zinc reagents can be prepared directly via exchange reactions. For instance iPr2Zn in the presence 
of Li(acac) (acac = acetylacetonate) can perform iodine-zinc exchange on various iodinated aromatic 
and heteroaromatics.
42
 By using the dianion-type zincate tBu4ZnLi2 (12), Uchiyama and coworkers 
managed to find an exchange protocol that can be applied in the presence of unprotected alcohols 
(Scheme 7).
43
 The magnesium zincate 13, developed by Knochel et al., can even be used to perform a 
chlorine zinc exchange in the presence of catalytic amounts of Fe(acac)3 or Co(acac)2.
44
  
                                                     
38 P. Pierrat, P. Gros, Y. Fort, Synlett 2004, 2319. 
39  a) L. Boymond, M. Rottländer, G. Cahiez, P. Knochel, Angew. Chem. Int. Ed. 1998, 37, 1701; b) I. Sapountzis, P. Knochel, 
Angew. Chem. Int. Ed. 2002, 41, 1610. 
40 A. Krasovskiy, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 3333. 
41 H. Ren, A. Krasovskiy, P. Knochel, Org. Lett. 2004, 6, 4215; H. Ren, P. Knochel, Chem. Commun. 2006, 726;  
42 F. F. Kneisel, M. Dochnahl, P. Knochel, Angew. Chem. Int. Ed. 2004, 43, 1017. 
43 M. Uchiyama, T. Furuyama, M. Kobayashi, Y. Matsumoto, K. Tanaka, J. Am. Chem. Soc. 2006, 128, 8404. 
44 L. Melzig, C. R. Diène, C. J. Rohbogner, P. Knochel, Org. Lett. 2011, 13, 3174. 
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Scheme 7: Hal/Zn exchange using lithium or magnesium zincates. 
 
2.3 Metalation 
As described above the metal insertion as well as the halogen-metal exchange require a halogen 
precursor, usually iodine or bromine. This is a serious drawback since halogenated substrates can be 
expensive, especially iodides, or might not be accessible at all. Therefore, generating a carbon-metal 
bond from a C-H bond is a feasible route for the preparation of organometallics. The first attempt on 
metalation of aromatics were made by Gilman and Wittig who used organolithium compounds like 
nBuLi or PhLi for the directed ortho-metalation (DoM) next to a methoxy moiety as directing metalation 
group (DMG).
45
 The DMG normally contains a heteroatom with a free electron pair that can coordinate 
to the lithium reagent and thus the deprotonation occurs in ortho-position to this group. Later non-
nucleophilic, sterically hindered lithium bases such as lithium diisopropylamide (LDA) or TMPLi (TMP 
= 2,2,6,6-tetramethylpiperidyl)
46
 were established and the directed ortho-litiation was especially 
promoted by the work of Snieckus and coworkers, who introduced carbamates, amides, and a variety of 
ethers as convenient DMGs.
47
 There is also a modification of the DoM where not the carbon next to the 
DMG is metalated, but a “remote” C-H bond in the molecule is activated. This variation, the directed 
remote metalation (DreM), is particularly useful in the metalation of biarylic substrates (Scheme 8).
48
  
 
Scheme 8: Example for a directed remote metalation (DreM). 
                                                     
45 a) H. Gilman, R. L. Bebb, J. Am. Chem. Soc. 1939, 61, 109; b) G. Wittig, G. Fuhrmann, Ber. Dtsch. Chem. Ges. 1940, 73, 
1197. 
46 a) V. Snieckus, Chem. Rev. 1990, 90, 879; b) M. Schlosser, Angew. Chem. Int. Ed. 2005, 44, 376. 
47 a) V. Snieckus, Pure & Appl. Chem. 1990, 62, 2047; b) T. K. Macklin, J. Panteleev, V. Snieckus, Angew. Chem. Int. Ed. 
2008, 47, 2097. 
48 a) M. Alessi, A. L. Larkin, K. A. Ogilvie, L. A. Green, S. Lai, S. Lopez,. V. Snieckus, J. Org. Chem. 2007, 72, 1588; for a 
review see: b) D. Tilly, J. Magolan, J. Mortier, Chem.‒Eur. J. 2012, 18, 3804, and references cited therein. 
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However, the major drawback of the directed lithiation is however, the high reactivity of the bases used 
and also the generated metal species, which can lead to numerous side reactions like, for instance 
Chichibabin addition.
49
 This high reactivity also limits the number of functional groups that are tolerated 
and in addition, most lithiations require low temperatures (-78 to -100 °C). Therefore, the use of 
magnesium amide bases is generally preferred when dealing with more sensitive functionalities. 
Historically, the first magnesium amides were prepared by Meunier at the beginning of the 20th century 
by mixing the recently discovered Grignard reagents with various amines.
 50
 Over 40 years later Hauser 
and coworkers established bases of the type R2NMgBr for the condensation of esters, referred to from 
that time on as Hauser bases.
51
 However, the first application for a directed ortho magnesiation was 
made by Eaton et al., who used the sterically demanding amides TMPMgBr and TMP2Mg for the 
metalation of aromatic carboxamides and esters (Scheme 9).
52
 Further improvement was made by 
Mulzer by applying TMPMgCl for the magnesiation of pyridinecarboxamides and carbamates (Scheme 
9).
53
 Although, these magnesium amide bases are superior to the lithium derivatives regarding functional 
group tolerance their general utilization is hampered by low solubility due to aggregation, and the need 
of large excesses of both base and electrophile.
53
  
 
Scheme 9: Early examples of magnesiation by TMP-magnesium amides. 
 
Knochel and coworkers found, that similar to the turbo-Grignard reagents the solubility and reactivity 
of these TMP-magnesium amides could be significantly enhanced by using stoichiometric amounts of 
LiCl, thus creating the so called turbo-Hauser bases with the general formula R2NMgCl·LiCl.
54
 
Especially the sterically hindered TMPMgCl·LiCl (14), obtained by mixing turbo-Grignard 11 with 
TMPH, proved to be an excellent reagent to deprotonate a large variety of functionalized aromatic 
compounds and heterocycles.
55
 Studies by the Mulvey group imply that the LiCl causes a deaggregation 
of the magnesium amide, thus TMPMgCl·LiCl (14) crystallizes as a monomer (Scheme 10), whereas 
                                                     
49 A. E. Chichibabin, O. A. Zeide, J. Russ. Phys. Chem. 1914, 46, 1216. 
50 L. Meunier, C. R. Hebd. Seances Acad. Sci. 1903, 136, 758. 
51 a) C. R. Hauser, H. G. Walker, J. Am. Chem. Soc. 1947, 69, 295; b) C. R. Hauser, F. C. Frostick, J. Am. Chem. Soc. 1949, 
71, 1350. 
52 P. E. Eaton, C. H. Lee, Y. Xiong, J. Am. Chem. Soc. 1989, 111, 8016. 
53 W. Schlecker, A. Huth, E. Ottow, J. Mulzer, J. Org. Chem. 1995, 60, 8414. 
54 A. Krasovskiy, V. Krasovskaya, P. Knochel, Angew. Chem. Int. Ed. 2006, 45, 2958. 
55 For a review see: B. Haag, M. Mosrin, H. Ila, V. Malakhov, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9794. 
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TMPMgCl forms a dimer. Although the structure in solution may be different from the crystal, it is 
reasonable to assume that 14 reacts as a monomeric species.
56
  
 
Scheme 10: Synthesis and crystal structure of TMPMgCl·LiCl (14) 
 
The excellent kinetic basicity and high solubility of 14 makes it possible to magnesiate various substrates 
such as isoquinoline (15), benzothiophene (16) and even the sensitive disubstituted furan 17 under very 
mild reaction conditions and using only 1.1 equiv. of base. The generated magnesium species can react 
with various electrophiles in very good to excellent yields (Scheme 11).
54
 
 
Scheme 11: Deprotonation of various heterocycles with TMPMgCl·LiCl (14) and subsequent reactions with 
electrophiles. 
 
By mixing TMPLi with TMPMgCl·LiCl (14) the LiCl activated TMP2Mg·2LiCl (18)
 57
 can be prepared, 
which has an enhanced kinetic basicity compared to 14 and can therefore be used for the deprotonation 
of moderately activated substrates in the cases were 14 is not reactive enough (Scheme 12).
58
  
                                                     
56 P. García-Álvarez, D. V. Graham, E. Hevia, A. R. Kennedy, J. Klett, R. E. Mulvey, C. T. O'Hara, S. Weatherstone, Angew. 
Chem. Int. Ed. 2008, 47, 8079. 
57 a) G. C. Clososki, C. J. Rohbogner, P. Knochel, Angew. Chem. Int. Ed. 2007, 46, 7681; b) C. J. Rohbogner, A. J. Wagner, 
G. C. Clososki, P. Knochel, Org. Synth. 2009, 86, 374. 
58 C. J. Rohbogner, G. C. Clososki, P. Knochel, Angew. Chem. Int. Ed. 2008, 47, 1503; F. M. Piller, T. Bresser, M. K. R. 
Fischer, P. Knochel, J. Org. Chem. 2010, 75, 7365; T. Bresser, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 1914;  
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Scheme 12: Magnesiation of various aromatic and non-aromatic substrates by TMP2Mg·2LiCl (18). 
 
Although these magnesium amide bases have an excellent reactivity and can be applied in the presence 
of nitriles, esters, and aryl ketones, there are still some very sensitive functionalities such as nitro- or 
aldehyde groups as well as electron poor heterocycles that are not compatible with magnesium reagents. 
For such substrates the zinc derivatives of 14 and 18 have been established. By transmetalating 
TMPMgCl·LiCl (14) or TMPLi with ZnCl2 the very mild zinc amides TMP2Zn·2MgCl2·2LiCl (19)
 59
 
and TMPZnCl·LiCl (20),
60
 respectively, can be readily prepared. These bases can be used for the mild 
zincation of a variety of sensitive substrates (Scheme 13 and Scheme 14) 
 
Scheme 13: Zincation of various sensitive heterocycles using TMP2Zn·2MgCl2·2LiCl (19). 
 
 
Scheme 14: Zincation of various functionalized aromatics using TMPZnCl·LiCl (20). 
 
                                                     
59 a) S. H. Wunderlich, P. Knochel, Angew. Chem., Int. Ed. 2007, 46, 7685, b) S. H. Wunderlich, P. Knochel, Org. Lett. 2008, 
10, 4705; c) M. Mosrin, P. Knochel, Chem.‒Eur. J. 2009, 15, 1468; d) M. Kienle, C. Dunst, P. Knochel, Org. Lett. 2009, 
11, 5158; e) A. Unsinn, P. Knochel, Chem. Commun. 2012, 48, 2680. 
60 a) M. Mosrin, P. Knochel, Org. Lett. 2009, 11, 1837; b) M. Mosrin, G. Monzon, T. Bresser, P. Knochel, Chem. Commun. 
2009, 5615, c) T. Bresser, M. Mosrin, G. Monzon, P. Knochel, J. Org. Chem. 2010, 75, 4686; d) T. Bresser, P. Knochel, 
Angew. Chem., Int. Ed. 2011, 50, 1914. 
A. Introduction 
 
 
15 
Over the course of the last decades a broad variety of mixed Li/metal amide bases have been developed 
with Fe, Mn, La, Zr, Cd and Cu.
55
 
Kessar discovered that the lithiation of pyridine and related heterocycles can be assisted by pre-mixing 
pyridine with the Lewis acid (LA) BF3·OEt2 before the addition of an appropriate lithium base.
61
 
Recently Knochel and coworkers found that this protocol can also be expanded to magnesium or zinc 
amide bases, thus generating much milder reaction conditions. This metalation procedure does not only 
accelerate or facilitate the metalation, but in some cases the regioselectivity of the deprotonation can be 
orthogonal to the one achieved without the use of BF3·OEt2 (Scheme 15).
62
  
 
Scheme 15: Switchable, regioselective metalation of N-heterocycles with TMP-bases in the presence or absence 
of BF3·OEt2 
 
It was also found, that the Lewis base TMPMgCl·LiCl (14) is compatible with the Lewis acid BF3·OEt2 
at low temperatures. It is believed that the two compounds form the Lewis pair TMPMgCl·BF3 (21), 
which is still able to deprotonate various N-heterocycles. This led to the assumption that the Lewis base 
TMPMgCl·LiCl (14) and the Lewis acid BF3·OEt2 form a so called frustrated Lewis pair (FLP),
 63
 where 
the BF3·OEt2 can still act as a Lewis acid and 14 is able to perform the deprotonation, instead of 
irreversibly forming an acid base adduct that possesses no metalation potential anymore. Therefore it is 
possible to perform the metalation of 4-phenylpyridine (22) by first activating it with BF3·OEt2 and then 
adding the base 14 to give, after a Negishi cross-coupling,
64
 the product 23 in very good yield. Also pre-
                                                     
61 a) S. V. Kessar, P. Singh, K. N. Singh, M. Dutt, J. Chem. Soc. Chem. Commun. 1991, 570; b) S. V. Kessar, P. Singh, R. 
Vohra, N. P. Kaur, K. N. Singh, J. Chem. Soc. Chem. Commun 1991, 568; c) S. V. Kessar, R. Vohra, N. P. Kaur, Tetrahedron 
Lett. 1991, 32, 3221; d) S. V. Kessar, P. Singh, K. N. Singh, V. K. Kuul, G. Kumar, Tetrahedron Lett. 1995, 36, 8481; for a 
review see: e) S. V. Kessar, P. Singh, Chem. Rev. 1997, 97, 721. 
62 a) M. Jaric, B. A. Haag, A. Unsinn, K. Karaghiosoff, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 5451; b) L. Klier, T. 
Bresser, T. A. Nigst, K. Karaghiosoff, P. Knochel, J. Am. Chem. Soc. 2012, 134, 13584. 
63 a) G. C. Welch, L. Cabrera, P. A. Chase, E. Hollink; J. D. Masuda, P. Wei, D.W. Stephan, Dalton Trans. 2007, 3407; b) J. 
D. Masuda, P. Wei, D. W. Stephan, Dalton Trans. 2007, 3407; c) J. S. J. McCahill, G. C. Welch, D.W. Stephan, Angew. 
Chem. Int. Ed. 2007, 46, 4968; d) T. A. Rokob, A. Hamza, A. Stirling, T. Soós, I. Pápai, Angew. Chem. Int. Ed. 2008, 47, 
2435; e) D.W. Stephan, Dalton Trans. 2009, 3129; f) S. Grimme, H. Kruse, L. Goerigk, G. Erker, Angew. Chem. Int. Ed. 
2010, 49, 1402; for a reaview see: f) D.W. Stephan, G. Erker, Angew. Chem. Int. Ed. 2010, 49, 46. 
64 a) E. Negishi, L. F. Valente, M. Kobayashi, J. Am. Chem. Soc. 1980, 102, 3298; b) E. Negishi, Acc. Chem. Res. 1982, 15, 
340. 
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mixing the base 14 with BF3·OEt2 at -40 °C to form the Lewis pair 21 followed by addition of the 
pyridine 22 leads, after cross-coupling, to the same product 23 in slightly reduced yield (Scheme 16).
62
 
 
Scheme 16: BF3-mediated deprotonation of 4-phenylpyridine (22). 
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3. OBJECTIVES  
The goal of the first project was to expand the metalation of TMPZnCl·LiCl (20) to the zincation of the 
benzylic position of various methylated pyridines and quinolines and the subsequent Negishi cross-
coupling with various aryl bromides (Scheme 17). So far, palladium-catalyzed arylations of picolines 
via C–H activation
65
 have no generality. This might be due to the formation of palladium complexes 
that are reluctant to undergo reductive elimination.  
 
Scheme 17: Benzylic zincation of picolines with TMPZnCl·LiCl (20) followed by Negishi cross-coupling. 
 
Another aim was to investigate the metalation of pyridines and other N-heterocyles with TMPMgCl·BF3 
(21). It is known that when the metalation occurs at the carbon atom adjacent to the nitrogen atom, the 
resulting species are pyridyl trifluoroborates. In general, the reactivity of pyridyl trifluoroborates 
towards aldehydes is quite low and a successful addition usually requires a rhodium, nickel or palladium 
catalyst.
66
 Our goal was to develop a transition metal free addition of these borates to aldehydes (Scheme 
18).  
 
Scheme 18: Transition metal free addition of pyridyl trifluoroborates to aldehydes. 
 
We also wanted to investigate the structure of the metal intermediate generated by treating 3-substituted 
pyridine derivatives with 21. In those cases, the metalation occurs in position 4 of the pyridine scaffold. 
So far, the structure of the 4-metalated pyridines has not been studied. Therefore, it is not known if they 
are also pyridyl trifluoroborates (structure A, Scheme 19) or if they are pyridyl magnesium compounds 
(structures B or C). This would raise the question if the BF3 coordinates to the pyridyl nitrogen (structure 
B) or to the Grignard reagent (structure C) or if it located somewhere else. 
 
Scheme 19: Possible structure of N-heterocycles metalated by TMPMgCl·BF3 (21). 
                                                     
65 a) S. Murai, Activation of Unreactive Bonds and Organic Synthesis, Springer-Verlag, Berlin Heidelberg, 1999; b) D. Kalyani, 
N. R. Deprez, L. V. Desai, M. S. Sanford, J. Am. Chem. Soc. 2005, 127, 7330; c); d) A. R. Dick, M. S. Sanford, Tetrahedron 
2006, 62, 2439; d) M. Schlosser, F. Mongin, Chem. Soc. Rev. 2007, 36, 1161; e) D. Alberico, M. E. Scott, M. Lautens, 
Chem. Rev. 2007, 107, 174; f) For a special issue on Selective Functionalization of C-H Bonds: Chem. Rev. 2010, 110, 575. 
66 a) M. Pucheault, S. Darses and J.-P. Genet, Chem. Commun., 2005, 4714; b) F. Sakurai, K. Kondo and T. Aoyama, Chem. 
Pharm. Bull., 2009, 57, 511; c) M. Kuriyama, R, Shimazawa, T. Enomoto and R. Shirai, J. Org. Chem., 2008, 73, 6939. 
3. Objectives 
 
 
18 
 
Furthermore, we wanted to expand the regioselective metalations of pyrimidines, pyrazines and other 
N-heterocycles by using frustrated Lewis pairs of BF3·OEt2 and hindered magnesium and zinc amide 
bases. We also investigated, if a switch in regioselectivity was observered in the presence or absence of 
the Lewis acid (Scheme 20). 
 
Scheme 20: Switchable regioselectivity in the presence or absence of BF3·OEt2. 
 
Recently our group has established solid salt stabilized organozinc reagents, by transmetalation of 
organomagnesium reagents, obtained by either Hal/Mg exchange or Mg insertion, with Zn(OPiv)2·2LiCl 
(24a). These compounds are obtained as easy-to-handle solids that prove to be stable against air 
exposure for a certain time.
67
 Another route for the preparation of solid organozinc pivalates is the 
magnesiation of aryls and heteroaryls by TMPMgCl·LiCl (14) followed by transmetalation with 
Zn(OPiv)2 (24b).
68
 However, for preparing organozinc reagents bearing very sensitive functional 
groups, such as an aldehyde or a nitro group, those routes are not suitable. Therefore we wanted to 
prepare a zinc base that would directly generate the desired organozinc pivalate without having an 
unstable magnesium intermediate and check their reactivity towards various electrophiles (Scheme 21).  
 
Scheme 21: Preparation of organozinc pivalates by directed zincation followed by reaction with various 
electrophiles. 
 
Since these organozinc pivalates are complex mixtures of three different metals (Li, Mg and Zn) and 
three different anionic ligands (Cl-, OPiv- and Ar-) they make for highly complex chemistry. Therefore, 
studies were performed to elucidate the multicomponent compositions and structures of the organozinc 
pivalate “cocktail”.  
 
                                                     
67 S. Bernhardt, G. Manolikakes, T. Kunz, P. Knochel, Angew. Chem. Int. Ed. 2011, 50, 9205. 
68 C. I. Stathakis, S. Bernhardt, V. Quint, P. Knochel, Angew. Chem. Int. Ed. 2012, 51, 9428. 
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1. BENZYLIC ZINC REAGENTS OF PYRIDINES AND QUINOLINES FOR CROSS-
COUPLINGS WITH ARYL BROMIDES 
1.1. Introduction 
The functionalization of pyridines and related heterocycles is very important because of their biological 
properties and relevance to material science.
69
 The benzylic arylation of pyridines is, in particular, a 
challenging synthetic problem. Palladium-catalyzed arylations of 2-picoline involving direct C–H 
activation 
65
 have no generality, and only few examples have been reported. Thus, azaarenes bearing 
electron-withdrawing groups (EWG) may be arylated at 100 °C with a Pd catalyst.
70
 Several alternative 
procedures involving the fragmentation of a 2-(2-pyridyl)ethanol,
71
 the arylation of N-oxides,
72
 and N-
iminopyridinium ylides
73
 have been described. These methods, although displaying generality, require 
modified N-heterocyclic precursors. In addition, whereas 2-picoline (25a) can be functionalized in this 
way, the arylation of 4-picoline (26a) has not been described. The difficulty in forming a new carbon–
carbon bond with metalated 2-picoline (27, or 4-picoline) may be due to the nature of the palladium 
complexes
74
 28a-c resulting from the reaction with ArPdX (Scheme 22).We anticipate that all of these 
possible structures of type 28 are reluctant to undergo a reductive elimination because of the chelation 
of the heterocyclic nitrogen with the Pd-center. Hartwig and co-workers have already shown that 
                                                     
69 a) M. A. Yurovskaya, A. V. Karchava, Chem. Heterocycl. Compd. 1994, 30, 1331; b) P. N. W. Baxter, J.-M. Lehn, J. Fischer, 
M.-T. Youinou, Angew. Chem. Int. Ed. 1994, 33, 2284; c) K. C. Nicolaou, R. Scarpelli, B. Bollbuck, B. Werschkun, M. M. 
A. Pereira, M. Wartmann, K.-H. Altmann, D. Zaharevitz, R. Gussio, P. Giannakakou, Chem. Biol. 2000, 7, 593; d) J.-M. 
Lehn, Science 2002, 295, 2400; e) B. Oliva, K. Miller, N. Caggiano, A. J. O´Neill, G. D. Cuny, M. Z. Hoemann, J. R. 
Hauske, I. Chopra, Antimicrob. Agents Chemother. 2003, 47, 458; f) A. Bouillon, A. S. Voisin, A. Robic, J.-C. Lancelot, V. 
Collot, S. Rault, J. Org. Chem. 2003, 68, 10178; g) E. M. Nolan, J. Jaworski, K.-I. Okamoto, Y. Hayashi, M. Sheng, S. J. 
Lippard, J. Am. Chem. Soc. 2005, 127, 16812; h) T. Laird, Org. Process Res. Dev. 2006, 10, 851; i) A. Hayashi, M. Arai, 
M. Fujita, M. Kobayashi, Biol. Pharm. Bull. 2009, 32, 1261; j) X. Chen, K. M. Engle, D.-H. Wang, J. Q. Yu, Angew. Chem. 
Int. Ed. 2009, 48, 5094; k) J. Quiroga, J. Trilleras, B. Insuasty, R. Abonia, M. Nogueras, A. Marchal, J. Cobo, Tetrahedron 
Lett. 2010, 51, 1107. 
70 P. M. Burton, J. A. Morris, Org. Lett. 2010, 12, 5359. 
71 a) T. Niwa, H. Yorimitsu, K. Oshima, Angew. Chem. Int. Ed. 2007, 46, 2643; b) T. Niwa, H. Yorimitsu, K. Oshima, Org. 
Lett. 2007, 9, 2373. 
72 a) L.-C. Campeau, D. J. Schipper, K. Fagnou, J. Am. Chem. Soc. 2008, 130, 3266; b) D. J. Schipper, L.-C. Campeau, K. 
Fagnou, Tetrahedron 2009, 65, 3155. 
73 J. J. Mousseau, A. Larivée, A. B. Charette, Org. Lett. 2008, 10, 1641. 
74 For structures of palladium picolyl derivatives, see: a) M. Onishi, K. Hiraki, K. Maeda, T. Itoh, J. Organomet. Chem. 1980, 
188, 245; b) K. Isobe, Y. Nakamura, S. Kawaguchi, Bull. Chem. Soc. Jpn. 1989, 62, 1802; c) B. Qian, S. Guo, J. Shao, Q. 
Zhu, L. Yang, C. Xia, H. Huang, J. Am. Chem. Soc. 2010, 132, 3650. 
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palladium-catalyzed aminations are accelerated by a LA (BEt3).
75
 Nolan and co-workers have also 
reported that reductive elimination of Pd complexes are accelerated by AlCl3.
76
  
 
Scheme 22: Lewis-acid (LA) promoted benzylic cross-coupling 
 
It was envisioned that the presence of an appropriate LA complexing the nitrogen atom of the 
heterocycle may lead to a new Pd-intermediate such as 29, which would then undergo fast reductive 
elimination leading to the desired cross-coupling product 30. Similar behavior may be expected for the 
arylation of 4-picoline (26a). The beneficial effect of Lewis acids in the additions of 2-picoline (25a) to 
imines and enones has already been demonstrated.
77
 The kinetically highly active LiCl-solubilized 
TMP-base: TMPZnCl·LiCl (20) displays a high chemoselectivity in various directed zincations of 
arenes and heterocycles.
60
 Besides, 20 proved to be an excellent base for the preparation of nitrile and 
ester enolates.
78,79 We have also demonstrated that 20 is compatible with additional strong Lewis acids 
(MgCl2, BF3·OEt2) and forms frustrated Lewis pairs.62a,63 Herein, we report that Lewis acids such as 
ZnCl2, MgCl2, BF3·OEt2, and Sc(OTf)3 in combination with TMPZnCl·LiCl efficiently promote the 
Negishi cross-coupling
64
 of various methyl-substituted N-heterocycles. 
 
1.2. Preparation and Cross-Coupling of Benzylic Pyridyl Zinc Reagents 
First the zincation of 2-methylpyridine (25a) with TMPZnCl·LiCl (20, 2.0 equiv.) was performed to 
give the zincated picoline 31a after 1 h at room temperature. It was possible to perform a cross-coupling 
                                                     
75 Q. Shen, J. F. Hartwig, J. Am. Chem. Soc. 2007, 129, 7734. 
76 J. Huang, C. M. Haar, S. P. Nolan, Organometallics 1999, 18, 297. 
77 a) B. Qian, S. Guo, C. Xia, H. Huang, Adv. Synth. Catal. 2010, 352, 3195; b) M. Rueping, N. Tolstoluzhsky, Org. Lett. 2011, 
13, 1095, c) H. Komai, T. Yoshino, S. Matsunaga, M. Kanai, Org. Lett. 2011, 13, 1706. 
78 a) M. L. Hlavinka, J. R. Hagadorn, Tetrahedron Lett. 2006, 47, 5049; b) M. L. Hlavinka, J. R. Hagadorn, Organometallics 
2007, 26, 4105. 
79 S. Duez, S. Bernhardt, J. Heppekausen, F. F. Fleming, P. Knochel, Org. Lett. 2011, 13, 1690. 
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with 5-bromoindole (32a, 0.8 equiv.) using 2 mol% Pd(OAc)2 and 4 mol% SPhos
80
 (50 °C, 7 h) which 
afforded the desired pyridine 30a in 86% yield (Scheme 23). Such cross-coupling reactions could be 
extended to various substituted aryl bromides (32b-d) leading to products 30b-d in 66 to 95% yield 
(Table 1, entries 1-3). Also, pyridines bearing a substituent at the benzylic position such as 25b-c were 
readily metalated using TMPZnCl·LiCl (20) under the similar conditions and provided, after cross-
coupling with 4-bromoanisole (32b), the desired products (30e-f) in excellent yields (92 to 99%, entries 
4-5).  
 
Scheme 23: Palladium-catalyzed direct cross-coupling of 2-picoline (25a) and 4-picoline (26a). 
 
Also the zincation of 26a with 20 (1.5 equiv.) proceeded readily within 1 h at 25 °C and after a 
palladium-catalyzed cross-coupling of the generated zinc reagent 31b with the bromide 32e the desired 
product 33a was obtained in 95% yield (Scheme 23). This is remarkable, since to our knowledge, no 
arylation of 4-picoline (26a) in the bezylic postion has previously been reported in the literature. Various 
other aryl bromides (32b, 32f-i) reacted under similar conditions and furnished the 4-substituted 
pyridines 33b-f in 70 to 98% yield (Table 1, entries 6–10). 2-Chloro-4-methylpyridine (26b) reacted 
similarly and produced, after cross-coupling with the bromides 32f and 32a, the arylated products 33g 
and 33h in 69% yield (Table 1, entries 11 and 12). Finally, the substitiuted 4-picoline 33b could be 
further metalated and cross-coupling with 4-bromoanisole (32b) furnished the desired product (33i) in 
high yield (entry 13). These smooth cross-couplings may be explained by the the fact that the generated 
ZnCl2 acts as a Lewis acid. Interestingly, the use of TMPZnCl·MgCl2·2LiCl (19)
59
 led to even faster 
cross-couplings (at least six times faster). However, the yield was significantly diminished by increased 
amounts of diarylation
81
 making the general use of this base unattractive.  
 
 
 
                                                     
80 a) S. D. Walker, T. E. Barder, J. R. Martinelli, S. L. Buchwald, Angew. Chem. Int. Ed. 2004, 43, 1871; b) T. E. Barder, S. D. 
Walker, J. R. Martinelli, S. L. Buchwald, J. Am. Chem. Soc. 2005, 127, 4685; c) R. A. Altman, S. L. Buchwald, Nat. Protoc. 
2007, 2, 3115; d) R. Martin, S. L. Buchwald, Acc. Chem. Res. 2008, 41, 1461. 
81 The palladium-catalyzed arylation of 2-picoline (25a) with 3-chlorobromobenzene (32d) proceeds in 1 h in the presence of 
TMPZnCl·MgCl2·LiCl (19) instead of in 6 h in the presence of TMPZnCl·LiCl (20) but led to less product 30d (61%) owing 
to the formation of 17% of diarylated product. 
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Table 1: Direct benzylic cross-coupling of 2- and 4-picoline derivatives. 
Entry Picoline[a] Electrophile Product Yield[b] [%] 
1 
 
25a (3) 
 
32b: R = OMe 
 
30b: R = OMe 95 
2 25a (6) 32c: R = F 30c: R = F 78 
3 25a (6) 
 
32d 
 
30d 66 
4 
 
25b (20) 32b 
 
30e 99 
5 
 
25c[d] (20) 32b 
 
30f 92 
6 
 
26a (1) 32b 
 
33b: R = OMe 98[c] 
7 26a (1) 
 
32f 
 
33c 82 
8 26a (1) 
 
32g: R = NMe2 
 
33d: R = NMe2 70 
9 26a (1) 32h: R = OH 33e: R = OH 84[c] 
10 26a (1) 32i: R = OPiv 33f: R = OPiv 81[c] 
11 
 
26b (1) 32f 
 
33g 69[e] 
12 26b (1) 32a 
 
33h 69 
13 
 
33b (3) 32b 
 
33i 93 
[a] Reaction time (h) for the arylation in brackets. [b] Yield of isolated, analytically pure 
product. [c] Pd(O2CCF3)2 was used instead of Pd(OAc)2. [d] TBDMS=tert-butyldimethylsilyl. 
[e] 2 mol% Pd(OAc)2, 4 mol% PCy3 were used 
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A further hint showing the importance of Lewis acids for the tentative Pd intermediate of type 29 
(Scheme 22) is found in the cross-coupling reaction of picolines (25a or 26a) with electron deficient 
aryl bromides. Substrates like 4-bromobenzonitrile (32j) and ethyl 4-bromobenzoate (32k) gave 
disappointing results in the presence of either ZnCl2 or MgCl2 as Lewis acids. Therefore, other 
alternative Lewis acids
82
 such as ScCl3, Sc(OTf)3,
83
 Yb(OTf)3,
84
 and Y(OTf)3
82
 were screened. It was 
found, that the direct cross-coupling of zincated 2-picoline (31a) with 4-bromobenzonitrile (32j) 
proceeded readily in the presence of 10 mol% Sc(OTf)3 and afforded the coupling product 30g in 87% 
yield (Scheme 24). Without the Lewis acid, no product was obtained (even after additional ligands for 
the Pd catalyst were screened). Similarly, the cross-coupling of the metalated 4-picoline (31b) with the 
ester 32k proceeded only in 41% yield in the absence of Sc(OTf)3, but the yield of the desired product 
33j could be increased to 78% after addition of 10 mol% Sc(OTf)3 (Scheme 24).  
 
Scheme 24: Sc(OTf)3 catalyzed cross-coupling of 2-picoline (25a) and 4-picoline (26a) with electron-
withdrawing substituted aryl bromides (32j-k). 
 
The effect of Sc(OTf)3 may best be explained by an acceleration of the reductive elimination step in the 
cross-coupling as a result of the complexation of Sc(OTf)3 to the heterocyclic nitrogen (see 34a,b, 
Scheme 24). It is anticipated that electron-withdrawing substituents lead to Pd-intermediates of type 28 
(Scheme 22) which are especially reluctant to undergo reductive elimination. We found the effect of a 
strong Lewis acid to be crucial in these cases. For instance the cross-couplings of picolines 25a and 26a 
with various electron-deficient aryl bromides (32j–l) are dramatically improved by the presence of 
10 mol% Sc(OTf)3 and the cross-coupling products 30h and 33k–l are obtained in 75–85% yield. In the 
absence of Sc(OTf)3, the yields of the cross-coupling are between 0 and 51% (Table 2, entries 1–3) 
                                                     
82 a) S. Kobayashi, Lanthanides: Chemistry and Use in Organic Synthesis, Springer, Berlin, 1999; b) M. Shibasaki, S. 
Matsunaga, N. Kumagai, Acid Catalysis in Modern Organic Synthesis, Vol. 2, Wiley-VCH, Weinheim, 2008, 635. 
83 a) S. Kobayashi, I. Hachiya, M. Araki, H. Ishitani, Tetrahedron Lett. 1993, 34, 3755; b) S. Kobayashi, Lewis Acids in Organic 
Synthesis, Vol. 2, Wiley-VCH, Weinheim, 2000, 883; c) C. Ogawa, Y. Gu, M. Boudou, S. Kobayashi, Acid Catalysis in 
Modern Organic Synthesis, Vol. 2, Wiley-VCH,Weinheim, 2008, 589. 
84 a) S. Kobayashi, Transition Metals for Organic Synthesis, Vol. 1, Wiley, Weinheim, 1998, 285; b) S. Kobayashi, M. Sugiura, 
H. Kitagawa, W. L. Lam, Chem. Rev. 2002, 102, 2227. 
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Table 2: Effect of Sc(OTf)3 on the benzylic cross-coupling of 2- (25a) and 4-picoline 
(26a) with electron-deficient electrophiles 
Entry Picoline Electrophile[a] Product Yield[b] [%] 
1 
 
25a (3) 
 
32k 
 
30h 85 (31) 
2 
 
26a (1) 
 
32j 
 
33k 75 (0)  
3 
 
26a (1) 
 
32l 
 
33l 78 (51) 
[a] Cross-coupling conditions: 50 °C, 1 h. [b] Yield of isolated, analytically pure product, in 
parenthesis: isolated yield of reaction performed without Sc(OTf)3. 
 
1.3. Preparation and Cross-Coupling of Benzylic Quinolyl Zinc Reagents 
The metalation and cross-coupling protocol could also be expanded to 2- and 4-methylquinoline (35a,b) 
and 1-methylisoquinoline (15c). For all three compounds the zincation, using TMPZnCl·LiCl (20, 
1.5 equiv.), proceeded readily at room temperature within 15 to 60 min and also cross-coupling reactions 
worked well with an appropriate catalyst system. Therefore, 35a was zincated and could be cross-
coupled with 4-bromoanisole (32b) in the presence of 2 mol% Pd(OAc)2 and 4 mol% SPhos to yield the 
arylated quinoline derivative 36a in 94% (Scheme 25). The cross-coupling could be performed using 
various aryl bromides (32g-h,j,l,m) and gave the desired 4-substituted quinolines 36b-f in very good to 
excellent yields (Table 3, entries 1-5). In case of Negishi cross-couplings with aryl bromides bearing an 
acidic proton (32h,m), the use of Pd(O2CCF3)2 introduced by Oshima and Yorimitsu
71
 was advantageous 
and ensured high yields and fast cross-couplings (entries 4 and 5).  
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Scheme 25: Benzylic cross-coupling of quinoline derivatives (35a-c) with different aryl bromides. 
 
Also the isoquinoline 35c could be cross-coupled with the bromide 32f using the Pd(OAc)2/SPhos 
system and furnished the functionalized derivative 36g in 86% yield (Scheme 25). For the arylation of 
2-methylquinoline (35b), the XantPhos
85
 ligand proved to be best, since the formation of double 
arylation by products could be avoided. Thus, the arylation of 35b with the dimethoxysubstituted 
bromide 32n using 2 mol% Pd(OAc)2 and 2 mol% XantPhos provided the desired arylated quinoline 
36h in 97% yield. Similar to the 4-methylquinoline (35a) the cross-coupling of 35b could be performed 
with various different arylbromides (32f,o-r) to provide the 2-substituted quinolines 36i-m in 68 to 96% 
yield (Table 3, entries 6-10). 
 
                                                     
85 P.W. N. M. van Leeuwen, P. C. J. Kamer, J. N. H. Reek, P. Dierkes, Chem. Rev. 2000, 100, 2741. 
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Table 3: Benzylic cross-couplings of quinoline derivatives with various aryl bromides. 
Entry Quinoline Electrophile[a] Product Yield[b] [%] 
1 
 
35a  
 
32g: R = NMe2 (1) 
 
36b: R = NMe2 93 
2 35a 32j: R = CN (1) 36c: R = CN 66 
3 35a 32h: R = OH (2) 36d: R = OH 76[c] 
4 35a 32m: R = NH2 (2) 36e: R = NH2 74[c] 
5 35a 
 
32l (1) 
 
36f 72 
6 
 
35b 
 
32f: R = Me (1) 
 
36i: R = Me 96  
7 35b 32o: R = F (1) 36j: R = F 95 
8 35b 
 
32p (1) 
 
36k 86 
9 35b 
 
32q (1) 
 
36l  78 
10 35b 
 
32r (1) 
 
36m  68 
[a] Cross-coupling conditions: 50 °C, reaction time in brackets. [b] Yield of isolated, analytically pure 
product. [c] 2.0 equiv. of TMPZnCl·LiCl, 2 mol% Pd(O2CCF3)2 and 4 mol% SPhos were used. 
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2. METALATING N-HETEROCYCLES USING THE FRUSTRATED LEWIS PAIR 
TMPMGCL·BF3 FOLLOWED BY ADDITION TO AROMATIC ALDEHYDES AND 
ACTIVATED KETONES 
2.1. Introduction 
The metalation of pyridines is an important reaction since it is a convenient way of functionalization.
47a,86 
The preparation of polyfunctional pyridines can be achieved by ring metalation,
65d 87 radical 
functionalization
88
 or C-H activation.
89
 Recently Knochel and coworkers showed, that the combination 
of the hindered base TMPMgCl·LiCl (14) in the presence of BF3·OEt2 allows the regioselective 
metalation of various electron-poor N-heterocycles. It was found that the base 14 is compatible with the 
strong Lewis acid BF3·OEt2 at temperatures below -20 °C.62a This frustrated Lewis pair 21, tentatively 
written as TMPMgCl·BF3 (21), resulting from TMPMgCl·LiCl (14) and BF3·OEt2 allowed a smooth 
activation of pyridine and related heterocycles and could readily be applied in a straightforward one-pot 
synthesis of the haplophyllum alkaloid dubamine (37, Scheme 26).
90
 
 
Scheme 26: One-pot synthesis of dubamine (37). 
 
Amino substituted alcaloids could be functionalized using similar reaction conditions.
91
 Remarkably the 
activation with BF3·OEt2 happens without interference of the amino substituents and no competitive 
complexation of the BF3 group was observed. Thus, nicotine (38) was metallated and further allylated 
at the 6 position of the pyridine moiety (Scheme 27). Quinine (39) was also magnesiated, after in situ 
protection of the alcohol group with MeLi, at the 3 position of the quinoline scaffold and could be 
reacted with various electrophiles. 
                                                     
86 a) G. Bentabed-Ababsa, S. C. S. Ely, S. Hesse, E. Nassar, F. Chevallier, T. T. Nguyen, A. Derdour, F. Mongin, J. Org. Chem. 
2010, 75, 839; b) F. Mongin, G. Quéguiner, Tetrahedron, 2001, 57, 4059. 
87 a) D. L. Comins, D. H. LaMunyon, Tetrahedron Lett. 1988, 29, 773; b) A. Turck, N. Plé, F. Mongin, G. Quéguiner, 
Tetrahedron 2001, 57, 4489; c) G. Karig, J. A. Spencer, T. Gallagher, Org. Lett. 2001, 3, 835; d) M. Schlosser, Angew. 
Chem., Int. Ed. 2005, 44, 376; e) R. E. Mulvey, F. Mongin, M. Uchiyama, Y. Kondo, Angew. Chem., Int. Ed. 2007, 46, 
3802; f) P.C. Gros, Y. Fort, Eur. J. Org. Chem. 2009, 4199; g) H. K. Khartabil, P. C. Gros, Y. Fort, M. F. Ruiz-López, J. 
Am. Chem. Soc. 2010, 132, 2410. 
88 a) F. Minisci, F. Fontana, E. J. Vismara, Heterocycl. Chem. 1990, 27, 79; b) D. C. Harrowven, B. J. Sutton, Prog. Heterocycl. 
Chem. 2004, 16, 27; c) I. B. Seiple, S. Su, R. A. Rodriguez, R. Gianatassio, Y. Fujiwara, A. L. Sobel, P. S. Baran, J. Am. 
Chem. Soc. 2010, 132, 13194; d) J. A. Joule, K. Mills, Heterocyclic Chemistry, Vol. 5, Wiley-Blackwell, Chichester, 2010. 
89 a) X. Chen, K. M. Engle, D.-H. Wang, J-Q. Yu, Angew. Chem., Int. Ed. 2009, 48, 5094; b) T. W. Lyons, M. S. Sanford, 
Chem. Rev. 2010, 110, 1147; c) B. Li, Z-H. Wu, Y-F. Gu, C.-L. Sun, B-Q. Wang, Z.-J. Shi, Angew. Chem., Int. Ed. 2011, 
50, 1109; d) H. Prokopcová, S. D. Bergman, K. Aelvoet, V. Smout, W. Herrebout, B. Van der Veken, L. Meerpoel, B. U. 
W. Maes, Chem.‒Eur. J. 2010, 16, 13063. 
90 C. M. Melendez Gomez, V. V. Kouznetsov, M. A. Sortino, S. L. Alvarez, S. A. Zacchino, Bioorg. Med. Chem. 2008, 16, 
7908. 
91 M. Jaric, B. A. Haag, S. M. Manolikakes, Paul Knochel, Org. Lett. 2011, 13, 2306. 
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Scheme 27: Functionalization of nicotine (38) and quinine (39) using TMPMgCl·LiCl (14) and BF3·OEt2. 
 
2.2. Addition to Aromatic Aldehydes and Activated Ketones 
The organometallic reagent produced by the treatment of pyridine (40a) with the Lewis pair 21 is the 
pyridyl trifluoroborate 41a, as shown by a 2J19F-13C coupling between C2 of 41a and the fluorine atoms 
(Table 4, Scheme).62 In general, the reactivity of pyridyl trifluoroborates towards aldehydes is quite low 
and a successful addition usually requires a rhodium, nickel or palladium catalyst.
66
 However, we have 
found that magnesium 2-pyridyl trifluoroborates such as 41a reacted readily with various aldehydes and 
activated ketones providing the pyridyl alcohols of type 42. Thus, the reaction of pyridine (40a) with 
the Lewis pair 21 (1.1 equiv.), prepared by mixing TMPMgCl·LiCl (14, 1.1 equiv.) with BF3·OEt2 
(1.1 equiv.) at -40 °C for 10 min, gave after further 15 min at -40 °C the trifluoroborate 41a which 
reacted with 4-cyanobenzaldehyde (43a, 0.8 equiv., -40 to 25 °C, 2 h) leading to the desired pyridyl 
alcohol 42a in 73% yield (Table 4, entry 1). Similarly, the substituted benzaldehydes 43b-d reacted in 
the same way (-40 to 25 °C, 2-4 h) providing the alcohols 42b-d in 66-68% yield (entries 2-4). 
Interestingly, the pyridyl intermediate 41a also added smoothly to the ketone PhCOCF3 (43e) affording 
the tertiary alcohol 42e in 72% yield (Table 1, entry 5).
92
 The metalation of quinoline (40b) with the 
Lewis pair 21 (1.1 equiv.) proceeded readily under similar conditions (-40 °C, 40 min). The resulting 
trifluoroborate 41b added smoothly to 4-bromobenzaldehyde (43c) and the trifluoromethyl ketone (43f) 
providing the quinolyl alcohols 42f-g in 65% yield (entries 6-7). 
 
                                                     
92 The use of aliphatic aldehydes leads only to decomposition and no product could be isolated. 
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Table 4: Addition of 2-pyridyl trifluoroborates to aromatic aldehydes or activated 
ketones. 
 
Entry Substrate 
Carbonyl 
Compound 
Product Yield[a] [%] 
1 40a  
 
43a: R = CN 
 
42a: R = CN 73 
2 40a 43b: R = Cl 42b: R = Cl 68 
3 40a 43c: R = Br 42c: R = Br 67 
4 40a 
 
43d 
 
42d 66 
5 40a 
 
43e 
 
42e 72 
6 40b  43c 
 
42f 65 
7 40b 
 
43f 
 
42g 65 
[a] Yield of isolated, analytically pure product.  
 
 
Scheme 28: Metalation of monosubstituted pyrazines followed by trapping with aromatic aldehydes. 
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The 2-pyrazine 44a could also be metalated using 1.1 equivialents of TMPMgCl·BF3 (21, -40 °C, 
10 min). The deprotonation occurred next to the thiomethyl group and after the addition to the 
substituted benzaldehydes 43b,c,g the expected carbinols 45a-c were obtained in 63-67% yield (Scheme 
28). The silylsubstituted pyrazine 44b was also readily metalated using 21 (-40 °C, 15 min), this time 
however, the deprotonation took place opposite to the bulky SiMe2Ph group. It can be assumed that due 
to the steric hinderance of the silyl group the base coordinates to the less hindered nitrogen atom of the 
pyrazine ring and then abstracts the less hindered proton in position 5.
93
 Therefore, after addition to 4-
bromobenzaldehyde (43c), the 2,5-disubstituted pyrazine derivative 45d is obtained in 67% yield. 
Then, we examined various 3-substituted pyridines (46a-d) and found that their treatment with 
TMPMgCl·BF3 (21) at -40 °C or -78 °C afforded metalated species of type 47 which reacted readily 
with several aromatic aldehydes (Table 5). Thus, the treatment of ethyl nicotinate (46a) with 21 
(1.1 equiv., -40 °C, 30 min) provided after the addition to 4-bromobenzaldehyde (43c) or benzaldehyde 
(43h, 0.8 equiv. -40 °C to 25 °C, 4 h), respectively, and cyclization the lactones 48a-b in 62-72% yield 
(entries 1 and 2). It was also possible to react the intermediate 47a with the ketone 43e to yield the 
lactone 48c in 65% (entry 3). Similarly, the 3-fluoro and 3-chloro substituted pyridines 46b and 46c 
were readily metalated in position 4 by TMPMgCl·BF3 (21, 1.1 equiv.) at -78 °C within 10 min. After 
quenching 47b with the aldehyde 43c the carbinol 48d could be isolated in 81% (entry 4). Quenching 
the metalated species of 46c with either 4-chloro- or 4-bromobenzaldehyde (43b,c) furnished the 
alcohols 48e and 48f in 71% yield each (entries 5 and 6). Finally, diethyl nicotinamide (46d) was 
metalated under the same conditions providing after addition to 3,4-dichlorobenzaldehyde (43d) the 
desired product 48g in 81% yield (entry 7).  
 
 
                                                     
93 K. Groll, S. M. Manolikakes, X. mollat du Jourdin, M. Jaric, A. Bredihhin, K. Karaghiosoff, T. Carell, P. Knochel, Angew. 
Chem. Int. Ed. 2013, 52, 6776.  
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Table 5: Metalation of 3-substituted pyridines followed by trapping with aromatic 
aldehydes. 
 
Entry Substrate Carbonyl 
Compound 
Product Yield[a] [%] 
1 
 
46a 
 
43c  
 
48a: Ar = p-C6H4Br 72 
2 46a 
 
43h 
 
48b 62 
3 46a 
 
43e 
 
48c 65 
4 
 
46b 43c 
 
48d: Ar = p-C6H4Br 81 
5 
 
46c 
 
43b 
 
48e: Ar = p-C6H4Cl 71 
6 46c 43c 
 
48f: Ar = p-C6H4Br 71 
7 
 
46d 
 
43d 
 
48g: Ar = 3,4-C6H3Cl 81 
[a] Yield of isolated, analytically pure product.  
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2.3. Unraveling the Structures of the Intermediates 
As studies have already shown, the intermediates of type 41 are indeed pyridyl trifluoroborates that 
display a noticeable 2J19F-13C coupling of 14.7 Hz between C2 of 41 and the fluorine atoms.62a,
94
 This is 
also reasonable since the C-B bond is thermodynamically favoured over the C-Mg bond, due to the 
higher electronegativity of the boron atom. However, the nature of the 4-metalated pyridines of type 47 
could not be so easily evaluated. This is also due to the fact, that the intermediates 47b-d are only stable 
for a limited time at -78 °C, which makes NMR-studies extremely difficult. Luckily, the intermediate 
47a proved to be stable at -60 °C over a longer period of time, so that extensive 1H-, 11B-, 13C- and 19F-
NMR experiments could be performed. Contrary to the 2-metalated species of type 41 where a 2J19F-13C 
between C2 and the fluorine atoms was observed in the 13C-NMR spectrum, such couplings could not 
be found for the 4-metalated species 47a, clearly indicating, that the transmetalation from Mg to B does 
not occur in position 4 of the pyridine scaffold, thus excluding the formation of an arylic trifluoroborate 
of structure 47aa (Figure 2). Also, no 3J19F-13C coupling between C2 or C6 and fluorine could be 
observed, suggesting that no, or only a very weak, complexation of BF3 at the pyridyl nitrogen occurs 
(see complex 47ab).
95
 This would implicate that the structure of the intermediates of type 47 is a 
pyridylmagnesium derivative like 47ac. However, this leaves the question open to where the BF3 group 
is located, if not on the pyridyl nitrogen. 
 
Figure 2: Possible structure of N-heterocycles metalated by TMPMgCl·BF3 (21) and BF3 complexes. 
 
Therefore, several control experiments were performed: First, 46a was treated with BF3·OEt2 
(1.1 equiv., 0 °C, 15 min) in THF-d8 resulting in the pyridinium complex 49 (Scheme 29), where the 
complexation of BF3 with the pyridine nitrogen resulted in a distinct shift and splitting of the C2 and C6 
in the 13C-NMR spectrum (3J19F-13C = 2.2 Hz).
95
 In another control experiment the TMPH-BF3 complex 
(50, Figure 2) was prepared by reacting TMPH with BF3·OEt2 (1.1 equiv., 0 °C, 15 min) in THF-d8. The 
complexation of the BF3 through the nitrogen was again confirmed via NMR-spectroscopy.
95
 When 
evaluating the 13C-NMR spectra of 47a complex 50 is not observed and therefore is not formed during 
the metalation process, thus the BF3 group must be located somewhere else. The BF3 could also be 
coordinated to the carbonyl of the ethyl nicotinate (47a). To evaluate this possibility the pyridinium 
complex 49 was treated with second equivalent of BF3·OEt2 to see if the signal of the carbonyl group 
would show any significant shift in the 13C-NMR spectrum implying the formation of a complex 
tentatively depicted as 51a (Scheme 29). No such shift was observed, but instead a low field shift of the 
THF-d8 signal in the 13C-NMR from 66.7 to 69.4 ppm and 24.4 to 25.5 ppm, respectively, clearly 
                                                     
94 M. Jeganmohan, P. Knochel, Angew. Chem. Int. Ed. 2010, 49, 8520. 
95 See: C. Experimental Section and D. Appendix 
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indicated a coordination of the BF3 to the THF-d8.
95
 The same effect was observed when ethyl benzoate 
(52) was treated in the same way, which means that the structures 51a-b were not formed, since the THF 
is the stronger ligand. However, in the 13C-NMR spectrum of 47a no solvent signal shift was observed, 
meaning there must be a stronger complexing ligand present in the reaction mixture. 
 
Scheme 29: Reaction of ethyl nicotinate (46a) and ethyl benzoate (52) with BF3·OEt2. 
 
The experiments described above clearly show, that in the case of 47a the BF3 coordinates neither to 
TMPH nor to THF. It is also reasonable to conclude that the BF3 does not coordinate to the ester group 
of the metalated ethyl nicotinate (47a). Unfortunately, the 13C-NMR signals of the metalated species 
47a are broad (Δ1/2 ca. 5 Hz) and do not show any evidence for a splitting due to 3J19F-13C coupling, which 
is in the region of ca. 2 Hz and therefore probably not visible. Thus it can only be assumed that there 
might be a weak coordination of BF3 to the pyridine nitrogen atom as depicted in structure 47ab (since 
the BF3 group does not seem to be located anywhere else), however there is no direct evidence for this 
fact. 
Another remarkable result is the fact, that a C-B bond is formed only when the metalation takes place 
next to the nitrogen but not when the 4 position of the pyridine ring is deprotonated. The question arises 
if the transmetalation from Mg to B is generally hindered and in the case of pyridine (40a) and quinoline 
(40b) a direct boronation occurs, whereas in the case of the C4 metalation, a magnesiation takes place 
(Scheme 30). Another possibility would be that in both cases the first step is a magnesiation and the 
transmetalation is generally hindered at low temperatures and that the pyridyl nitrogen coordinates to 
the BF3 group (as the studies described above suggest). In the case of the pyridine (40a) this would bring 
the boron atom in direct vicinity to the C-Mg bond (see structure 53), thus making an intramolecular 
transmetalation possible, while in the intermediate 47ab the boron and the magnesium atom are simply 
too far away from each other to make a transmetalation possible. 
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Scheme 30: Possible metalation pathways for position 2 and 4 of the pyridine scaffold. 
 
To elucidate the reaction pathway the 2-, 3- and 4-magnesiated pyridine derivatives 54a-c were 
generated separately via halogen magnesium exchange using iPrMgCl·LiCl (11, 1.1 equiv., 0 to 25 °C, 
2-5 h), starting from 2- or 3-bromo- or 4-iodopyridine (55a-c), respectively (Scheme 31). The reagents 
54a-c were examined using 1H- and 13C-NMR spectroscopy before the reaction mixtures were cooled 
to -40 °C and 1.1 equiv. of BF3·OEt2 were added. The resulting mixtures were investigated via 1H- and 
13C-, 11B- and 19F-NMR spectroscopy. 
 
Scheme 31: Reactions of pyridyl magnesium reagents with BF3·OEt2. 
 
The magnesium species 54a-c, in the absence of BF3·OEt2, proved to be mixtures of two or more 
reagents, which is not surprising since organomagnesium reagents are known to undergo Schlenk 
equilibria in THF.
96
 Interestingly, when BF3·OEt2 was added to the reagent 54a there only one metalated 
species could be observed in the 13C-NMR, namely the same species 41a which was also obtained by 
metalating pyridine (40a) with the base TMPMgCl·BF3 (21), showing the same 2J19F-13C coupling of 
14.5 Hz between C2 and the fluorine atoms.
95
 When the magnesium was located in position 3 or 4 of 
                                                     
96 W. Schlenk, W. Schlenk jun., Chem. Ber. 1929, 62, 920.  
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the pyridine residue however, no carbon fluorine coupling could be observed and also the Schlenk 
equilibria did not change significantly. 
These results indicate that for the pyridine metalation, the magnesiation/transmetalation pathway is 
definitely possible, although the direct boronation pathway cannot be completely excluded. As for the 
4-substituted magnesium reagents of type 47 , 54b and 54c a transmetalation to boron does not occur.  
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3. REGIOSELECTIVE METALATIONS OF PYRIMIDINES BY USING FRUSTRATED LEWIS 
PAIRS OF BF3·OET2 AND HINDERED MAGNESIUM AND ZINC AMIDE BASES 
3.1. Introduction 
The functionalization of pyrimidines is of great importance, since this class of heterocycles is 
represented in numerous natural products, pharmaceuticals, and agrochemicals.
97
 They also have various 
applications in materials science and polymer chemistry.
98
 As described in A2.3 the directed metalation 
and further functionalization of electron-deficient N-heterocycles can be realized with different 
sterically hindered metal amides. So far, the C-H activation of diazines has been accomplished by ate 
bases
99
 and Li amides.
100
 However, due to the low stability of the generated lithiated intermediates, low 
temperatures and carefully designed reaction conditions are required. Moreover, some of these 
metalations provide the desired products only in low yields or furnish mixtures of different regioisomers 
(Scheme 32).
101
 
 
Scheme 32: Metalation of a pyrimidine derivative with TMPLi. 
 
The previously discussed LiCl-solubilized TMP metal bases give access to several metalated 
diazines
60a,102and purines.
103
 As already mentioned in A2.3 and B2 it was also found that various N-
heterocycles can be activated by strong Lewis acids like BF3·OEt2, which proved to be compatible with 
the metallic amide bases. Thus, the reactivity of the sterically hindered TMP base is not quenched by 
BF3·OEt2, but on the contrary, a synergetic effect is observed (dual activation). This effect allows a 
regioselective metalation of various non-activated substituted pyridines and derivatives,62a,91 which is 
not possible without the use of this Lewis pair combination.  
. 
                                                     
97 T. Eicher, S. Hauptmann, A. Speicher, The Chemistry of Heterocycles, 2nd ed., Wiley-VCH, Weinheim, 2003, Chap. 6. 
98 a) K.-T. Wong, T. S. Hung, Y. Lin, C.-C. Wu, G.-H. Lee, S.-M. Peng, C. H. Chou, Y. O. Su, Org. Lett. 2002, 4, 513; b) N. 
Hebbar, C. Foil-Petit, Y. Ramondenc, G. Plé, N. Plé, Tetrahedron 2011, 67, 2287. 
99 a) Y. Kondo, H. Shilai, M. Uchiyama, T. Sakamoto, J. Am. Chem. Soc. 1999, 121, 3539; b)W. Clegg, S. H. Dale, A. M. 
Drummond, E. Hevia, G.W. Honeyman, R. E. Mulvey, J. Am. Chem. Soc. 2006, 128, 7434; c) W. Clegg, S. H. Dale, R. W. 
Harrington, E. Hevia,G.W. Honeyman, R. E. Mulvey, Angew. Chem. Int. Ed. 2006, 45, 2374; d) A. Seggio, F. Chevallier, 
M. Vaultier, F. Mongin, J. Org. Chem. 2007, 72, 6602; e) J.-M. L’Helgoual’ch, G. Bentabed-Ababsa, F. Chevallier, M. 
Yonehara, M. Uchiyama, A. Derdour, F. Mongin, Chem. Commun. 2008, 5375. 
100 For reviews see: a) A. Turck, N. Plé, F. Mongin, G. Quéguiner, Tetrahedron 2001, 57, 4489; b) F. Chevallier, F. Mongin, 
Chem. Soc. Rev. 2008, 37, 595. 
101 N. PIé A. Turck, P. Martin, S. Barbey, G. Quéguiner, Tetrahedron Lett. 1993, 34, 1605 
102 a) M. Mosrin, P. Knochel, Org. Lett. 2008, 10, 2497; b) M. Mosrin, N. Boudet, P. Knochel, Org. Biomol. Chem. 2008, 6, 
3237; c) A. Unsinn, M. J. Ford, P. Knochel, Org. Lett. 2013, 15, 1128. 
103 S. Zimdars, X. M. du Jourdin, F. Crestey, T. Carrell, P. Knochel, Org. Lett. 2011, 13, 792. 
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3.2. Effect of Different TMP-Metal Bases and BF3·OEt2 on the Metalation of 
Pyrimidines 
We found that the use of BF3·OEt2 allowed the orthogonal metalation of the pyrimidine scaffold. 
Treating 4,6-dimethoxypyrimidine (55a) with TMPMgCl·LiCl (14, 1.1 equiv., 0 °C, 40 min) provided 
a regioselective magnesiation at position 5 (Scheme 33). After iodolysis, the expected iodide 56a was 
isolated in 85% yield. In contrast, the reaction of the pyrimidine 55a with BF3·OEt2 (1.1 equiv.; 0 °C, 
15 min) followed by the addition of TMPZnCl·LiCl (20, 1.5 equiv., -20 °C, 1 h) led to a quantitative 
metalation at position 2. After a copper-mediated allylation with 3-bromocyclohexene (57a), the desired 
2-functionalized pyrimidine 56b was isolated in 92% yield (Scheme 33). This behavior might be 
explained by an increased acidity at position 2 owing to the complexation of BF3 with the pyrimidine 
ring allowing a complete switch of regioselectivity. In the absence of BF3·OEt2 no zincation of 55a was 
observed at -20 °C (under 5% conversion).
104
 However, the use of 2.0 equiv of TMPZnCl·LiCl (20) at 
25 °C for 30 min affords an unselective metalation (1:1) and only 25% conversion. The combination of 
BF3·OEt2 with TMPMgCl·LiCl (14, 1.1 equiv.) mostly led to decomposition of 55a at low temperature 
and only 20% of the 2-metalated pyrimidine derivative was detected by GC-analysis. The zincated 
intermediate of 55a also underwent a smooth palladium catalyzed Negishi cross-coupling
64
 with 4-
iodoanisole (57b) affording the 2-arylated pyrimidine 56c in 89% yield (Table 6, entry 1) 
Scheme 33: Reactivity of 4,6-dimethoxypyrimidine (55a) towards metalation in the presence or absence of 
BF3·OEt2. 
 
4-Butoxypyrimidine (55b) could also be selectively metalated in position 2 by pre-treating it with 
BF3·OEt2 (1.1 equiv.; 0 °C, 15 min) and using TMPZnCl·LiCl (20, 1.5 equiv., -20 °C, 1 h). After 
iodolysis the disubstituted pyrimine 56d was obtained in 86% yield (Scheme 34). In the absence of 
BF3·OEt2 the zincation also occured regioselective at position 2, however the conversion was low, even 
when an excess of base was used and the reaction time was extended to 48 h. Thus, after iodolysis, the 
compound 56d was only isolated in 40% yield. Treating 55b with TMPMgCl·LiCl (14) in the presence 
or absence of BF3·OEt2 only led to decomposition of the starting material. 
                                                     
104 The conversion was determined by GC-analysis. 
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Scheme 34: Metalation of 4-butoxypyrimidine (55b) in the presence or absence of BF3·OEt2. 
Table 6: Regioselective zincation of pyrimidine derivatives 55 in position 2. 
 
Entry Substrate Electrophile Product Yield[a] [%] 
1 
 
55a 
 
57b 
 
56c 89[b] 
2 
 
55b 
 
57c 
 
56e 66[b] 
3 
 
55c 
 
57b 
 
56f 70[b] 
4 55c 
 
57d 
 
56g 69[b] 
5 55c 
 
57a 
 
56h 71[c] 
6 
 
55d I2 
 
56i  92 
7 
 
55e I2 
 
56j  82 
8 
 
55f I2 
 
56k  77 
9 55f 
 
57d 
 
56l  67[b] 
[a] Yield of isolated, analytically pure product. [b] 3 mol% of Pd(dba)2 and 6 mol% of TFP were 
used. [c] Obtained by Cu-mediated allylation.  
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The zincated pyrimidine 55b could also be cross-coupled with 1-iodo-3-(trifluoromethyl)benzene (57c) 
to yield the desired biaryl 56e in 66% (Table 6, entry 2). This regioselectivite metalation is quite general 
and independent of the substitution pattern, as also the pyrimidines 55c-f are all selectively zincated in 
position 2. After allylation, iodolysis or Pd-catalyzed cross-coupling the expected 2-functionalized 
pyrimidines 56f-l are obtained in 67-92% yield (entries 3-9). 
It was also possible to perform a regioselectivity switch at the condensed thienopyrimidines 58a-b 
(Scheme 35). Thus, the treatment of 58a (R = NMe2) with TMPZnCl·LiCl (20) led to a smooth 
deprotonation of the most acidic proton of 58a (i.e. position 6) giving after Negishi cross-coupling with 
57d the 6-arylated product 59a in 83% yield. Alternatively, addition of BF3·OEt2 to 58a-b followed by 
TMPZnCl·LiCl (20) leads to a regioselective zincation at position 2 (>10:1) of the pyrimidine ring. Pd-
catalyzed cross-coupling or a Cu-mediated allylation furnishes the 2-functionalized thienopyrimidines 
60a-b in 70-77% yield. 
 
Scheme 35: Switchable, regioselective metalation of the thienopyrimidines 58a and 58b. 
 
3.3. NMR-Studies of BF3-Activated Pyrimidine 55d 
To gain some structural information of the BF3-activated and zincated pyrimidines we decided to 
investigate the metalation of the pyrimidine 55d via NMR-spectroscopy. Therefore the pyrimidine 55d 
was treated with 1.1 equiv. of BF3·OEt2 in deuterated THF and the resulting aduct 61 was subjected to 
1H-, 11B-, 13C- and 19F-NMR spectroscopy (Scheme 36). The coordination of the BF3 group to the 
pyrimidyl nitrogen atom could easily be verified in the 13C-NMR spectrum, where the C2 and the C6 
carbon atoms show a distinct coupling to the fluorine atoms (3J19F-13C = 2.8 and 2.0 Hz). 
 
Scheme 36: BF3-activation and zincation of pyrimidine 55d. 
 
The base 20 was added and the formed zincated species 62 was investigated via NMR spectroscopy. 
The metalated reagent definitely proved to be a zinc species, since there was no detectable interaction 
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between the pyrimidine moiety and the BF3 group, which clearly indicates that there is no 
transmetalation from zinc to boron, although the C-B would be thermodynamically favored being 
slightly more covalent.
105
 Moreover, the zinc species 62 proved to be nonsymmetrical, i.e the hydrogen 
and carbon atoms at position 4 and 6 exhibit different chemical shifts. This indicates that some ligand 
coordinates to the zinc reagent making it unsymmetrical. The nature of this ligand could not be 
completely clarified, but a BF3 coordination could be excluded, since no evidence for this was visible in 
the NMR spectra. Remarkably, what could be detected were small amounts of the TMPH-BF3 adduct 
50 (see B2.3), however this does not seem to be the major BF3 species.  
 
  
                                                     
105 Electronegativity (according to the Pauling-scale): Zn: 1.65; B: 2.04; C: 2.55 from L. Pauling, The Nature of the Chemical 
Bond and the Structure of molecules and Crystals: An Introduction to Modern Structural Chemistry, 3rd ed., Cornell 
University Press, New York, 1960, Chapter 3. 
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4. TMPZNOPIV·LICL: A NEW BASE FOR THE PREPARATION OF AIR-STABLE SOLID 
ZINC PIVALATES OF SENSITIVE AROMATICS AND HETEROAROMATICS 
4.1. Introduction 
Organozinc reagents hold a special position among organometallics due to their compatibility with a 
wide range of sensitive functional groups.
12b,106
 In addition, they are valuable synthetic tools in C-C 
bond formation reactions, via transition-metal catalyzed transformations.
28a,64,107
 However, a major 
drawback is their instability when exposed to air and the pyrophoric properties of some of the smaller 
alkylic derivatives. Knochel and coworkers recently described the preparation of aryl- and heteroaryl-
zinc pivalates which are easy-to-handle solids with exceptional stability when exposed to air.67,68 These 
zinc reagents have been prepared via, either Mg insertion in the presence of Zn(OPiv)2·2LiCl (24a, 
Scheme 37)
67
 or directed metalation using TMPMgCl·LiCl (14) and subsequent transmetalation to zinc 
(Scheme 38).
68
  
 
Scheme 37: Preparation of solid functionalized zinc pivalates from via Mg insertion. [a] Complexed 
Mg(OPiv)Cl and LiCl are omitted for clarity 
 
When the transmetalation of the magnesiated species was performed using the LiCl-free Zn(OPiv)2 
(24b) instead of 24a this stability towards air is further improved, since LiCl is known to be highly 
hygroscopic. 
 
Scheme 38: Preparation of aryl zinc pivalate by metalation with 14 followed by transmetalation with 24a or 24b 
 
However, none of the methods above can be applied efficiently when sensitive functionalities, such as 
an aldehyde, a nitro group or other electron-withdrawing groups, are present. To overcome this 
limitation, we envisioned the use of a milder zinc amide base, as these are known to provide zinc 
                                                     
106 a) P. Knochel, J. Almena, P. Jones, Tetrahedron 1998, 54, 8275; b) A. Boudier, L. O. Bromm, M. Lotz, P. Knochel, Angew. 
Chem., Int. Ed. 2000, 39, 4115. 
107 P. Knochel, R. D. Singer, Chem. Rev. 1993, 93, 2117.  
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reagents which are compatible with most functionalities. The zinc base would have to contain the 
stabilizing pivalate salt since a transmetalation cannot be performed. 
 
4.2. Preparation of Air-Stable Solid Zinc Pivalates using TMPZnOPiv·LiCl 
We were able to prepare a new mild zinc amide base TMPZnOPiv·Mg(OPiv)Cl·LiCl (63)
108
 which was 
compatible with functionalities like nitro groups, aldehydes or sensitive heteroaromatic rings. In 
addition, we showed that the new base 63 provided fast and efficient access, after removal of the solvent, 
to solid zinc pivalates, which exhibit significant tolerance towards hydrolysis or oxidation after air-
exposure. TMPZnOPiv·LiCl (63) is prepared by addition of solid Zn(OPiv)2 (1.05 equiv., 0 °C) to a 
solution of TMPMgCl·LiCl (14, 1.23 M in THF) and subsequent dilution with dry THF until a clear 
solution arises (final concentration: 0.85 – 0.99 M, Scheme 39). 
 
Scheme 39: Preparation of the new zinc amide base TMPZnOPiv·LiCl (63) from TMPMgCl·LiCl (14).  
 
 
Scheme 40: Preparation of aromatic zinc pivalates 65a-c using TMPZnOPiv·LiCl (63). [a] OPiv = 
Cl·Mg(OPiv)2·LiCl see also B5. [b] MWI was used. 
 
The new zinc amide base 63 was tested for the metalation of a broad range of aromatic and 
heteroaromatic substrates bearing sensitive functionalities and of heteroaromatics prone to 
fragmentation. In most cases, the metalation proceeded with excellent regio- and chemo-selectivity, in 
short reaction times (< 2 h), using 1.1 to 2.0 equiv. of the base at 25 °C or by mild heating to 50 °C. 
After removal of the solvent under high vacuum (0.1 mbar, 3 h), the zinc reagents were obtained as fine 
powders.
109
 In this way, the aromatic compounds 64a-c could be readily transformend into the 
                                                     
108 For the detailed structure of the generated zinc reagnets see B5 
109 Typical titration via iodolysis was not possible for most of the solid zinc pivalates due to their deep red or brown color. In 
these cases the content of active zinc species was determined by GC-analysis and calculation of the iodinated compound 
derived by iodolysis of a certain amount of zinc pivalate, based on a calibration curve using an external standard. See C. 
Experimental Section. 
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corresponding zinc pivalates 65a-c in 76 to 91% yield (Scheme 40). Remarkably, the base 63 could also 
be used under very harsh conditions. Thus the trichlorobenzene 65c was metalated using microwave 
irradiation (MWI) at 160 °C to give the desired zinc pivalate in good yield. 
The zincation of heteraromatic substrates proved to be quite general and could be performed under mild 
conditions and the solid zinc reagents were obtained in good yields (Scheme 41). Thus, the diazines 
66a-d were zincated by 63 (1.1 equiv.) at 25 °C or, using MWI, at 90 °C within 0.5 – 3 h to give the 
heteroaromatic zinc reagents 67a-d in 72-76% yield. Also the sensitive ethyl 5-nitrofuran-2-carboxylate 
(66e) could be metalated using 2.0 equiv. of TMPZnCl·LiCl (63) at -10 °C within 1 h to yield the 
zincated furan 67e in 77% yield. The zincation also worked at ambient temperature on the aldehydes 
66f and 66g, as well as on 6-nitrobenzothiazole (66h) and caffeine (66i). Coumarin (66j) was 
deprotonated using MWI at 80 °C for 1 h to give the zincated product 67j in 82% yield. Finally, also 
chromone (66k) could be regioselectively metalated with TMPZnOPiv·LiCl (63), exclusively at the 
beta-position to the carbonyl group (-30 °C, 1 h), after preactivation with BF3·OEt2.62b 
 
Scheme 41: Preparation of heteroaromatic zinc pivalates 67a-k using TMPZnOPiv·LiCl (63). [a] OPiv = 
Cl·Mg(OPiv)2·LiCl see also B5. [b] MWI was used [c] 2.0 equiv. of 63 were used. 
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4.3. Reactions of Air-Stable Solid Zinc Pivalates 
The reactivity of the thus obtained zinc reagents was then studied in various reactions with electrophiles, 
such as Negishi cross-coupling, copper mediated allylation
110
 or acylation reactions.
28a,111 While cross-
couplings and copper catalyzed allylation reactions proceeded readily (vide infra), copper mediated 
acylation reactions proved to be problematic. Thus, the reactions with various acyl chlorides did only 
work in certain cases (Scheme 42 and Scheme 43), depending on the zinc reagent and/or the acyl 
chloride, and seemed not to be general. We assumed that the acyl chlorides might form a mixed 
anhydride with the pivalate anion PivO- which is significantly less reactive than the acyl chloride itself 
and therefore in some cases no or only very slow conversion to the desired products was observed. This 
obstacle could be overcome by the addition of an excess of TMSCl (6.0 equiv.). We assume that by 
addition of TMSCl the free PivO- is trapped in the form of the silylester PivOTMS which does not 
undergo the mixed anhydride formation anymore.  
Thus, in the presence of TMSCl (6.0 equiv.) and stoichiometric amounts of CuCN·2LiCl the pyridazine 
67d reacted readily with benzoylchloride (68a) and 2-furoyl chloride (68b) to the desired ketones 69a 
and 69b in 96 and 87% yield, respectively (Scheme 42). The allylation reaction of 67d with 3-
bromocyclohex-1-ene (57a, 1.2 equiv.) in the presence of catalytic amounts of CuCN·2LiCl gave the 
allylated product 69c in 90% yield. Finally, iodolysis of 67d gave the trihalogenated diazine 67d in 92% 
yield. 
 
Scheme 42: Reactions of functionalized organozinc reagent 67d with various electrophiles. [a] In the absence of 
TMSCl only trace amounts of 69a were observed. 
 
                                                     
110 a) F. Dübner, P. Knochel, Angew. Chem. Int. Ed. 1999, 38, 379; b) F. Dübner, P. Knochel Tetrahedron, 2000, 41, 9233; c) 
H. Malda, A. W. van Zijl, L. A. Arnold, B. L. Feringa, Org. Lett., 2001, 3, 1169; d) C. A. Falciola, A. Alexakis, Eur. J. Org. 
Chem. 2008, 3765; e) K. Geurts, S. P. Fletcher, A. W. van Zijl, A. J. Minnaard, B. L. Feringa, Pure Appl. Chem., 2008, 5, 
1025; f) E. Erdik, M. Koçoğlu, J. Organomet. Chem. 2009, 694, 1890. 
111 a) E. Nakamura, I. Kuwajima, J. Am. Chem. Soc. 1982, 106, 3368; b) P. Knochel, S. A. Rao, J. Am. Chem. Soc. 1990, 112, 
6146. 
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Remarkably, the zincated pyrimidine 67a underwent the acylation reaction with 2-furoyl chloride (68b) 
also in the absence of TMSCl to give the ketone 70a in 96% yield (Scheme 43). Also a Negishi cross-
coupling with 4-iodothioanisole (68c) could be performed using Pd(dba)2 (3 mol%) and TFP (6 mol%) 
(dba = dibenzylideneacetone, TFP = Tri(2-furyl)phosphine)
112
 to yield the biaryl 70b in 91%. A copper 
catalyzed allylation reaction with allylbromide (68d) furnished the desired product 70c in 88% yield. 
 
Scheme 43: Reactivity of 67a towards various electrophiles. 
 
The reactivity of the aromatic zinc pivalates 65a-c towards various electrophiles proved to be excellent 
(Table 7). Therefore, it was possible to perform a Pd-catalyzed cross-coupling of 65a with 1-iodo-3,5-
dimethylbenzene (68e) as well as a copper mediated acylation with benzoylchloride (68a) and a 
iodolysis to give the products 71a-c in 59 to 98% yields (entries 1-3). Also 65b could be readily acylated 
in the presence of an excess of TMSCl and stoichiometric amounts of CuCN·2LiCl yielding after 
reaction with the perfluorated acyl chloride 68f or cyclobutoylchloride (68g) the desired ketones 71d-e 
in 95% each (entries 4-5). Iodolyis of 65b gave the tetrasubstituted benzene 71f in 91% (entry 6). The 
trichlorobenze derivative 65c could also be acylated with cyclobutoylchloride (68g) or allylated using 
2-methyl-allylbromide (68h) and the desired functionalized aromatics 71g-h wre obtained in excellent 
yields (entries 7-8) 
 
                                                     
112 a) V. Farina, B. Krishnan, J. Am. Chem. Soc. 1991, 113, 9585; b) I. Klement, M. Rottlander, C. E. Tucker, T. N. Majid, P. 
Knochel, P. Venegas, G. Cahiez, G. Tetrahedron 1996, 52, 7201. 
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Table 7: Reactions of aromatic organozinc pivalates 65a-c with various 
electrophiles. 
Entry Substrate Electrophile Product 
Yield[a] 
[%] 
1 
 
65a 
 
68e 
 
71a 98[b] 
2 65a 
 
68a 
 
71b 59[c] 
3 65a I2 
 
71c 98 
4 
 
65b 
 
68f 
 
71d 95[c] 
5 65b 
 
68g 
 
71e 95[c] 
6 65b I2 
 
71f 91 
7 
 
65c 
 
68g 
 
71g 95 
8 
 
65c 
 
68h 
 
71h 94 
[a] Isolated yield of analytically pure product. [b] Obtained by cross-coupling in the presence 
of Pd(dba)2 (3 mol%) and TFP (6 mol%). [c] 1.1 equiv. CuCN·2LiCl and 6.0 equiv. TMSCl 
were used. [d] 10 mol% CuCN·2LiCl were used. 
 
Also, the heteroaromatic zinc reagents 67b-c,e-k proved to be excellent nucleophiles in various 
reactions. Thus, the zincated pyrimidine 67b underwent a smooth Pd-catalyzed cross-coupling with 4-
iodothioanisol (68c) and a copper catalyzed allylation reaction with 3-bromocyclohexene (57a) to 
furnish the desired full functionalized pyrimidines 72a and 72b in 81 and 89%, respectively (Table 8, 
entries 1-2). The zincated chloropyrazine 67c could also be allylated using 57a or iodinated to give the 
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disubstituted derivative 72c and 72d in excellent yields (entries 3-4). The furan derivative 67e and the 
indole 67f both could be cross-coupled with 3-iodobenzonitrile (68i) and ethyl 4-iodobenzoate (57d), 
respectively, and the biaryls 72e and 72g were obtained in 66 to 91% (entries 5 and 7). CuCN·2LiCl-
catalyzed allylation of the furan 67e and the aldehydes 67f and 67g with 3-bromocyclohexene (57a) 
furnished the desired alkenes 72f,h,i in70-98% yield (entries 6, 8 and 9). Iodolysis of the benzothiophene 
67g provided the disubstituted product 72j in 89% (entry 10). A Pd-catalyzed cross coupling of the 
benzothiazole 67h with the E-alkenyl iodide 68j
113
 furnished the product 72k in 95% yield and with 
complete retention of the double-bond configuration (entry 11). Addition of 2-bromomethylpropene 
(68h) to 67h, in the presence of 10 mol% CuCN·2LiCl, led to the allylated derivative 72l in 88% yield 
(entry 12). The copper mediated acylation in the presence of an excess of TMSCl of the zincated caffeine 
(67i) with 3,4-difluorobenzoyl chloride (68k) afforded the ketone 72m in 73% (entry 13) and after 
copper catalyzed allylation allylation of 67i with 2-bromomethylpropene (68h) the alkene 72n was 
obtained in 94% yield (entry 14).The zincated coumarin 67j was cross-coupled with the iodide 57c 
allylated with allylbromide (68d) and iodinated and the desired 3-substituted coumarin derivatives 72o-
q were isolated in 92 to 98% yield (entries 15-17). Finally, cross-coupling of the chromone 67k with 
the iodide 68l and acylation with cyclohexanoyl chloride (68m) furnished the biaryl 72r and the ketone 
72s in 70 and 78% yield, respectively (entries 18-19). 
Table 8: Reactions of heterocyclic zinc pivalates of with various electrophiles. 
Entry Substrate Electrophile Product 
Yield[a] 
[%] 
1 
 
67b 
 
68c 
 
72a 81[b] 
2 67b 
 
57a 
 
72b 89[c] 
3 
 
67c 57a 
 
72c 91[c] 
4 67c I2 
 
72d 93 
5 
 
67e 
 
68i 
 
72e 66[b] 
                                                     
113 Alkenyl iodide 68j was prepared in 87% yield according to the procedure described in: V. R. Krishnamurthy, A. Dougherty, 
C. A. Haller, E. L. Chaikof, J. Org. Chem. 2011, 76, 5543. 
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Table 8 continued. 
Entry 
Substrate Electrophile Product 
Yield[a] 
[%] 
6 
67e 
 
57a 
 
72f 70[c] 
7  
67f 
 
57d 
 
72g 91[b] 
8 
67f 
 
57a 
 
72h 98[c] 
9  
67g 57a 
 
72i 95[c] 
10 
67g I2 
 
72j 89 
11  
67h 
 
68j (> 99% E) 
 
72k (> 99% E) 95[b] 
12 
67h 
 
68h 
 
72l 88[c] 
13  
67i 
 
68k 
 
72m 73[d] 
14 
67i 
 
68h 
 
72n 94[c] 
15 
 
67j 
 
57c 
 
72o 96[b] 
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Table 8 continued. 
Entry Substrate Electrophile Product 
Yield[a] 
[%] 
16 67j 
 
68d 
 
72p 98[c] 
17 67j I2 
 
72q 92 
18 
 
67k 
 
68l 
 
72r 78[b] 
19 67k 
 
68m 
 
72s 70[d] 
[a] Yield of isolated, analytically pure product. [b] Obtained by cross-coupling in the presence 
of Pd(dba)2 (3 mol%) and TFP (6 mol%). [c] 10 mol% CuCN·2LiCl were used [d] 1.1 equiv. 
CuCN·2LiCl and 6.0 equiv. TMSCl were used. 
 
4.4.  Air-Stability of the Solid Zinc Pivalates 
The vast majority of the organozinc pivalates tested exhibited exceptional air-stability. For instance, 
after 4 h air exposure the aromatic zinc pivalates 65a and 65b still showed 97 and 86%, respectively, of 
their initial activity (Table 9, entry 1-2).109 Also the heterocyclic reagents 67a,b,d-j,k were tested for 
their stability towards air exposure (entries 3-11). Most of the heteroaromatic zinc pivalates showed an 
activity loss of less than five percent after being exposed for 4 h to air (entries 3, 5-8). Moreover, the 
zinc reagents 67f,h.j,k even showed some remaining activity after 24 h of air exposure (42-52% of 
initial activity, entries 7, 9-11). When leaving the pyrimidine derivatives 67a,b in air for 24 h even 69 
and 72%, respectively, of the original concentrations of active zinc species were obtained (entries 3-4). 
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Table 9: Stability studies of organozinc reagents towards air. 
 Time in 
air [h] 
0 1 2 4 24 
Entry 
Zinc 
reagent 
Percentage of the active aryl- or 
heteroarylzinc species109 
1 65a 100 100 98 97 -[a] 
2 65b 100 95 92 86 -[a] 
3 67a 100 99 97 95 69 
4 67b 100 100 97 94 72 
5 67d 100 99 97 95 -[a] 
6 67e 100 97 96 95 -[a] 
7 67f 100 99 98 96 48 
8 67g 100 99 98 95 -[a] 
9 67h 100 100 96 94 52 
10 67j 100 93 91 88 51 
11 67k 100 98 95 90 42 
[a] After 24 h the organozinc compound had become a sticky/oily 
substance which could not be weighted properly and was therefore 
not titrated again. 
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5. STRUCTURAL INSIGHTS ON ORGANOZINC PIVALATE REAGENTS 
5.1. Introduction 
As already described in A2, salt additives can activate but also deactivate organometallic 
compounds.
34,114
 Metal halides like LiCl and MgCl2 can enhance the reactivity of organometallic 
compounds within their THF solutions as examplified in TMP2Zn·2MgCl2·2LiCl (19). And as described 
in B4 the magnesium-zinc pivalate systems “RZnOPiv·Mg(OPiv)X·nLiCl (R = aryl, heteroaryl or 
benzyl; X = Cl, Br or I) show a high stability towards attack by air and moisture, especially when isolated 
as solids (Table 9).67,68 Rapid decomposition is the normal outcome when such organometallic 
compounds are exposed to these antagonists since Met-C bonds are generally thermodynamically 
unstable with respect to the Met-O bonds that form as a result, making inert atmosphere protocols 
mandatory. While synthetic applications of these salt-stabilized organo zinc compounds in a variety of 
C-C bond formation reactions have been demonstrated (vide supra) their multicomponent 
heterotrimetallic-heterotrianionic compositions make for highly complicated chemistry. To begin 
unravelling this complexity the goal was to elucidate the structures and roles of the compounds 
generated in these challenging pivalate mixtures. 
 
5.2. Elucidating the Structure and Role of the Existing Compounds 115 
The first question that was pursued was what the exact nature of the organozinc pivalates, formed by 
transmetalation of the RMgX species with Zn(OPiv)2·nLiCl (24), was. Usually, the formed reagents are 
represented by the general formula RZnOPiv·Mg(OPiv)Cl·nLiCl (vide supra) implying the formation 
of a mixed Mg salt and two distinct pivalate anions (Equation 1). This transmetalation was tested by 
investigating the arylester reagent EtO2C(p-C6H4)MgCl·LiCl (73) and zinc pivalate (24b) in THF 
solution by NMR spectroscopy.  
 
Surprisingly, 1H-NMR and COSY spectra of this mixture revealed only one pivalate signal and two 
distinct sets of aryl signals, in contrast to the two pivalate and one set of aryl signals expected from the 
transmetalation.
116
 1H-DOSY-NMR
117
 experiments implied the presence of two major species of which 
one could be identified as ethyl benzoate, presumably from partial hydrolysis of the zinc reagent due to 
                                                     
114 a) M. Hatano, S. Suzuki, K. Ishihara, J. Am. Chem. Soc. 2006, 128, 9998; b) M. Hatano, K. Ishihara in Acid Catalysis in 
Modern Organic Synthesis Vol. 1, (Eds.: H. Yamamoto, K. Ishihara), Wiley-VCH, Weinheim, 2008, pp. 175 c) L. Jin, C. 
Liu, J. Liu, F. Hu, Y. Lan, A. S. Batsanov, J. A. K. Howard, T. D. Marder, A. Lei, J. Am. Chem. Soc. 2009, 131, 16656; d) 
M. Hatano, O. Ito, S. Suzuki, K. Ishihara, Chem. Commun. 2010, 46, 2674; e) M. Hatano, S. Suzuki, K. Ishihara, Synlett, 
2010, 321; f) E. Hevia, R. E. Mulvey, Angew. Chem. Int. Ed. 2011, 50, 6448. 
115 The NMR experiments and X-ray crystal-structures described in this chapter have been performed by the Mulvey/Hevia 
group at the University of Strathclyde, Glasgow; for more detailed information check: A. Hernán-Gómez, E. Herd, E. Hevia, 
A. R. Kennedy, P. Knochel, K. Koszinowski, S. M. Manolikakes, R. E. Mulvey, C. Schnegelsberg, Angew. Chem. Int. Ed. 
2014, 53, DOI: 10.1002/anie.201309841. 
116 See D Appendix 1 
117 For DOSY reviews, see: a) D. Li, I. Keresztes, R. Hopson, P. Williard, Acc. Chem. Res. 2009, 42, 270; b) A. Macchioni, G. 
Ciancaleoni, C. Zuccaccia, D. Zuccaccia, Chem. Soc. Rev. 2008, 37, 479; c) B. Antalek, Concepts Magn. Reson. Part A 
2007, 30, 219. 
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prolonged storage of the sample prior to the NMR studies. Supporting this assumption was the 
crystallization of a mixed cluster that can be formalized as [{Mg(OPiv)2}5{Mg(OH)2}(MgO)∙4THF]
115
 
from the THF solution. Apart from the OH- and O2- incorporation the 1:2 stoichiometry of Mg/OPiv is 
the most telling feature, since from Equation 1 a Mg/OPiv ratio of 1:1 would be expected. These results 
indicate two things: The Mg pivalate produced in the reaction could act as a moisture/oxygen scavenger 
and the transmetalation process seems to go beyond the monopivalate Mg(OPiv)Cl to the bispivalate 
Mg(OPiv)2 (74). To investigate these assumptions attempts were made to prepare Mg(OPiv)2 (74) by an 
alternative method by deprotonating pivalic acid with Bu2Mg (Equation 2).  
 
X-ray crystallography however showed, that the product was not the desired product 74 but the O2- 
contaminated product 74’. It turned out that the O2- contamination came from the commercially 
purchased Bu2Mg. The desired Mg(OPiv)2 (74) was eventually prepared by using self-prepared 
Mg(CH2SiMe3)2 under strict anhydrous and oxygen free conditions. This result suggests that Mg(OPiv)2 
(74) could be functioning as a decontaminating agent mopping up any OH− or related ions by trapping 
them in clusters, thus protecting the zinc organometallic species. 
Then the transmetalation was monitored at the less sensitive p-tolyl derivative (Scheme 44). For 
comparison the spectra of the separately prepared compounds Me(p-C6H4)MgCl·LiCl (75) and Me(p-
C6H4)ZnCl·LiCl (76a) were also recorded. Most informatively 13C NMR spectra revealed well separated 
Cipso resonances for 75 (165.8 ppm) and 76a (153.0 ppm) (Figure 4).  
 
Scheme 44: Transmetalation of p-tolylMgCl with Zn(OPiv)2 an in the presence of LiCl. 
 
Most striking is the fact that the mixture of Me(p-C6H4)MgCl (75) and Zn(OPiv)2·nLiCl (n = 1 or 2) 
shows only aromatic resonances matching those of Me(p-C6H4)ZnCl·LiCl (76a) and none 
corresponding to the magnesium species 75. Also, the 1H-DOSY-NMR spectrum of the reaction mixture 
revealed that the aromatic resonances and pivalate resonance belong to distinct molecules.
116
 
 
Figure 3: Molecular structure of [(THF)2Li2(µ-Cl)2(µ-OPiv)2Zn] (24c). Ellipsoids set at 50% probability; 
hydrogen atoms omitted for clarity.
115
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Figure 4: From bottom to top: 13C-NMR spectrum of a) Me(p-C6H4)MgCl·LiCl (75), b) Me(p-C6H4)ZnCl·LiCl 
(76a), c) Zn(OPiv)2·LiCl (24c) and Me(p-C6H4)MgCl (75), and d) Zn(OPiv)2·2LiCl (24a) and Me(p-C6H4)MgCl 
in THF-d8 at 25 °C. 
 
These observations indicate strongly that there is indeed a complete transmetalation of Zn(OPiv)2 (24b) 
to Mg(OPiv)2 (74) with Zn receiving the aryl and the Cl ligands. This assumption was further reinforced 
by the trapping of this Zn heteroleptic complex as its TMEDA solvate, (TMEDA)ZnMe(p-C6H4)Cl, by 
adding TMEDA to the original reaction mixture of Me(p-C6H4)ZnCl·LiCl (76a) and Mg(OPiv)2 (74).
115
 
Next the solubilizing effect of LiCl on the Zn(OPiv)2 (24b) was investigated. The salt 24b alone barely 
dissolves in THF, however when one equivalent of LiCl is added a clear solution forms within ca. 
15 min. Crystals deposited from this solution turned out to be [(THF)2Li2(µ-Cl)2(µ-OPiv)2Zn] (24c, 
Figure 3). It can be assumed, that the enhanced solubility can be led back to the formation of this 
complex since the LiCl completes the coordination of the Lewis basic OPiv moiety and the Lewis acidic 
Zn atom. 
 
5.3. Reactivity of Different Salts Containing p-Tolylzinc Reagents 
Next, we checked whether in addition to its stabilizing role Mg(OPiv)2 (74) had any appreciable effect 
on the Negishi cross-coupling capability of the Me(p-C6H4)ZnX (X = Cl·LiCl, Cl·MgCl2·LiCl, 
OPiv·LiOPiv, or Cl·Mg(OPiv)2·LiCl) reagents. For this purpose we prepared (p-C6H4Me)MgCl·LiCl 
(75) via Mg insertion from 4-chlorotoluene and (p-C6H4Me)Li (77) from 4-iodotoluene via I/Li 
exchange (Scheme 45). These reagents were then each transmetalated using either ZnCl2 or Zn(OPiv)2 
providing the zinc reagents 76a-d (Scheme 45). 
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These organozinc compounds were then compared with respect to their reactivity in a cross-coupling 
reaction using ethyl 4-iodobenzoate (78) as electrophile and Pd(dba)2 (3 mol%) and TFP (6 mol%) as 
catalyst system. As shown in Table 10 all cross-coupling reactions proceeded very fast at ambient 
temperature giving the biphenyl 79 in comparable yields of 89-94%. 
 
Scheme 45: Preparation of (p-C6H4Me)ZnX with X = Cl·LiCl (76a), OPiv·LiOPiv (76b), Cl·MgCl2·LiCl (76c), 
Cl·Mg(OPiv)2·LiCl (76d). 
 
Table 10: Reactivity of zinc reagents 76a-d towards cross-coupling with ethyl 
4-iodobenzoate (78). 
 
Entry X Reaction conditions 
Isolated yield 
of 79 [%] 
1 Cl·LiCl (76a) 25 °C, 30 min 94 
2 OPiv·LiOPiv (76b). 25 °C, 30 min 93 
3 Cl·MgCl2·LiCl (76c) 25 °C, 30 min 91 
4 Cl·Mg(OPiv)2·LiCl (76d) 25 °C, 30 min 89 
 
Since the reaction with ethyl 4-iodobenzoate showed no significant difference neither in reaction time 
nor in product yield, the reactivity was further studied with a less reactive electrophile such as 4-
bromoanisole (80) to see if longer reaction times and higher temperatures lead to any significant 
differences in the reaction outcome. Also, the influence of the more polar solvent EtOAc was 
investigated and the effect of air on the cross-coupling capability. The cross-couplings with 80 
(0.8 equiv.) in the presence of 3 mol% Pd(OAc)2 and 6 mol% of DavePhos
118
 in THF under argon gave 
the biphenyl 81 in 82 to 86% yield (Table 11, entries 1, 5, 9 and 13). Then the cross-couplings were 
performed in air in non-dried glassware but in dry THF. For the pivalate-free reactions the yield dropped 
slightly from 86 to 81% for reagent 76a and from 85 to 77% for reagent 76c, respectively (entries 2 and 
                                                     
118 D. W. Old, J. P. Wolfe, S. L. Buchwald, J. Am. Chem. Soc. 1998, 120, 9722. 
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10). For the pivalate-containing reagents 76b and 76d however, the yield increased from 82 to 88% for 
both reagents (entries 6 and 14). When the cross-couplings were carried out in EtOAc and under argon 
the yields for the magnesium salt containing reagents 76c and 76d increased to 91% and to 85%, 
respectively (entries 11 and 15). However, the yield dropped slightly for both reagents when the 
reactions were performed in air in non-dried glassware (entries 12 and 16). Remarkably, when no 
magnesium salt was present, the cross-coupling in EtOAc did not work at all no matter if it was 
performed under argon or open to air (entries 3, 4, 7 and 8). GC-samples quenched with iodine showed 
that the metal species 76a and 76b did not decompose when the reaction was performed under argon, 
and the amount of electrophile did also not decrease significantly. Longer reaction time and a higher 
catalyst loading did not lead to any improvements. However, for the reactions carried out in air a slow 
decomposition of the metal species could be observed. 
Table 11: Reactivity of zinc reagents 76a-d towards cross-coupling with ethyl 4-bromoanisole (80). 
 
Entry X Solvent 
Reaction 
Conditions 
Isolated yield of 81 
[%] 
1 Cl·LiCl (76a) THF under Argon 86 
2 Cl·LiCl (76a) THF in air 81 
3 Cl·LiCl (76a) EtOAc[a] under Argon only traces of 81[b,c] 
4 Cl·LiCl (76a) EtOAc[a] in air only traces of 81[b,c] 
5 OPiv·LiOPiv (76b) THF under Argon 82 
6 OPiv·LiOPiv (76b) THF in air 88 
7 OPiv·LiOPiv (76b) EtOAc[a] under Argon only traces of 81[b,c] 
8 OPiv·LiOPiv (76b) EtOAc[a] in air only traces of 81[b,c] 
9 Cl·MgCl2·LiCl (76c) THF under Argon 85 
10 Cl·MgCl2·LiCl (76c) THF in air 77 
11 Cl·MgCl2·LiCl (76c) EtOAc[a] under Argon 91 
12 Cl·MgCl2·LiCl (76c) EtOAc[a] in air 78 
13 Cl·Mg(OPiv)2·LiCl (76d) THF under Argon 82 
14 Cl·Mg(OPiv)2·LiCl (76d) THF in air 88 
15 Cl·Mg(OPiv)2·LiCl (76d) EtOAc[a] under Argon 85 
16 Cl·Mg(OPiv)2·LiCl (76d) EtOAc[a] in air 81 
[a] EtOAc was purchased from Fluka as analytical grade reagent (99.9%) which was stored open to air and used 
without further drying. [b] GC-analysis of hydrolyzed/iodolyzed reaction aliquots was performed, no product was 
isolated. [c] The reaction was also performed with 6 mol% Pd(OAc)2 and 12 mol% DavePhos and the reaction time 
was elongated to 24 h. 
 
We also briefly examined the cross-coupling of Me(p-C6H4)ZnCl·MgCl2·LiCl (76c) with the even less 
reactive electrophile 4-chloroanisole (82). However, we were unable to find a catalyst system where 
more than trace amounts of the desired product 81 could be observed using GC-analysis. In all cases the 
undesired side product 81’ was the major product (Table 12). 
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Table 12: Reactivity of zinc reagent 76c towards cross-coupling with ethyl 4-chloroanisole 
(82). 
 
Entry Pd/Ligand Reaction Time Results[a] 
1 
Pd(OAc)2 (3 mol%) 
SPhos (6 mol%) 
45 h 
only trace amounts of 81 
ca. 25% of 81’ 
2 
Pd(OAc)2 (3 mol%) 
DavePhos (6 mol%) 
45 h 
ca. 15% of 81 
ca. 20% of 81’ 
3 
Pd(OAc)2 (3 mol%) 
XPhos (6 mol%) 
45 h 
only trace amounts of 81 
ca. 30% of 81’ 
4 PEPPSITM-IPr  45 h no reaction 
[a] via GC-analysis of hydrolyzed reaction aliquots. 
 
Next, the air stability of the zinc reagents 83a-c, containing different amounts of LiCl was briefly 
investigated (Scheme 46). Therefore, Mg insertion reactions were performed on 1-bromo-3-
(trifluoromethyl)benzene (84) in the presence of Zn(OPiv)2·2LiCl (24a),67 Zn(OPiv)2 (24b) and 
1.2 equivalents of LiCl or Zn(OPiv)2 (24b) in the absence of LiCl. While the yield of the two LiCl 
containing reagents 83a and 83b was comparable, the Mg insertion in the absence of LiCl was very 
sluggish and did not go to full conversion due to the bad solubility of the reactants and 83c could only 
be obtained as an inhomogeneous suspension.  
 
Scheme 46: Comparison of air stability of the organozinc species 83a-c. 
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Remarkably, the stability towards air exposure increases drastically by reducing the amount of LiCl 
from two to one equivalents. Thus, when the reagent 84a was exposed to air for one hour no active 
metalating species could be detected while the zinc reagent 84b still exhibited 79% of its initial activity 
and after 2 h in air 59% of the original concentration was preserved. These results clearly indicate, that 
on the one hand the presence of LiCl is necessary for the solubility and reactivity of the organozinc 
pivalates, but that on the other hand the hygroscopic nature of LiCl diminishes the stability of the 
generated zinc reagents and therefore the amount should be kept at a minimum. 
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6. SUMMARY 
6.1. Benzylic Zinc Reagents of Pyridines and Quinolines for Cross-Couplings 
with Aryl Bromides 
The very mild zinc base TMPZnCl·LiCl was successfully used for the regioselective benzylic metalation 
of a variety of methyl substituted pyridines and quinolines at ambient temperature. The resulting zinc 
reagents underwent smooth Negishi cross-coupling reactions with a plethora of electron rich aryl 
bromides using Pd(OAc)2 or Pd(O2CCF3)2 and an appropriate Phos-type ligand in good to excellent 
yields (Scheme 47).  
 
Scheme 47: Negishi cross-coupling of benzyilic pyridyl zinc reagents with electron rich aryl bromides. 
 
The cross-coupling reaction with electron poor aryl bromides proved to be difficult due to a hampered 
reductive elimination step of the intermediate palladium complex. This problem was overcome by the 
addition of catalytic amounts of Sc(OTf)3, since this Lewis acid can complex to the pyridyl nitrogen and 
thus promote the reductive elimination. In the presence of Sc(OTf)3 the cross-coupling of benzylic zinc 
reagents with electron poor aryl bromides proceeded readily to the desired products (Scheme 48). 
 
Scheme 48: Sc(OTf)3-promoted cross-coupling of benzyilic pyridyl zinc reagents with electron poor aryl 
bromides. 
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6.2. Metalating N-Heterocycles using the Frustrated Lewis Pair TMPMgCl·BF3 
Followed by Addition to Aromatic Aldehydes and Activated Ketones 
The Lewis pair TMPMgCl·BF3 has successfully been used for the deprotonation of pyridine, quinoline 
and pyrazine derivatives. The generated trifluoroborates could be added to various aromatic aldehydes 
and activated ketones in good yields without the need of a transition metal catalyst (Scheme 49). 
 
Scheme 49: Addition of N-heteroaryl trifluoroborates to aldehydes and activated ketones. 
 
Several 3-substituted pyridine derivatives were metalated by TMPMgCl·BF3 in position 4 of the 
pyridine scaffold. The metalated intermediates reacted readily with a range of benzaldehyde derivatives 
to give the desired carbinoles in very good yields (Scheme 50). 
 
Scheme 50: Metalation of 3-substituted pyridines followed by trapping with aromatic aldehydes. 
 
The structure of the metalated intermediate was investigated via 1H-, 11B-, 13C- and 19F-NMR studies. It 
turned out to be a magnesium species and not, as for the 2-metalated pyridines, a trifluoroborate, since 
there was no evidence pointing towards a C-B bond. The location of the BF3-group could not be 
completely clarified, but it is assumed that it is coordinating to the pyridyl nitrogen or to the magnesium 
(as depicted in Scheme 50). 
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6.3. Regioselective Metalations of Pyrimidines Using Frustrated Lewis Pairs of 
BF3·OEt2 and Hindered Magnesium and Zinc Amide Bases 
A range of pyrimidine derivatives could be regioselectively deprotonated at position 2 of the pyrimidine 
scaffold under mild conditions by activating the heterocycle with BF3·OEt2 prior to adding the base 
TMPZnCl·LiCl. The zincated pyrimidines underwent various cross-coupling reactions as well as 
allylation reactions (Scheme 51). 
 
Scheme 51: Regioselective zincation of pyrimidine derivatives in position 2. 
 
A switch of reagioselectivity could be performed in the presence or absence of BF3·OEt2, thus making 
it possible to deprotonate benzothiophenes in the absence of the Lewis acid in position 6. When 
BF3·OEt2 was present however, the zincation took place at the position 2 (Scheme 52). A similar effect 
could be observed at 4,6-dimethoxypyrimidine: Using TMPMgCl·LiCl in the absence of BF3·OEt2 
magnesiated the pyrimidine at position 5, whereas when BF3·OEt2 was present the base TMPZnCl·LiCl 
deprotonated the carbon at position 2 (Scheme 53).  
 
Scheme 52: Switchable, regioselective metalation of 4-(N,N-dimethylamaino)thienopyrimidine. 
 
Scheme 53: Switchable, regioselective metalation of 4,6-dimethoxypyrimidine. 
 
Moreover, the structure of the intermediates have been studied via NMR spectroscopy. The activation 
with BF3OEt2 results from a coordination of the Lewis acid to the nitrogen atom of the pyridine ring. 
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The addition of the base TMPZnCl·LiCl results in the formation of a non-symmetrical pyrimidyl zinc 
species and a TMPH-BF3 adduct (Scheme 54).  
 
Scheme 54: BF3-activation and zincation of 5-neopentylpyrimidine. 
 
6.4. TMPZnOPiv·LiCl: A New Base for the Preparation of Air-Stable Solid 
Zinc Pivalates of Sensitive Aromatics and Heteroaromatics 
By adding Zn(OPiv)2 to a solution of TMPMgCl·LiCl in THF the new base TMPZnOPiv·LiCl was 
prepared as a clear solution that proved to be stable for several month under argon (Scheme 55). This 
base proved to have a similar metalation capability as TMPZnCl·LiCl with the advantage that it allowed 
to prepare solid organozinc reagents without going through a magnesiated intermediate.  
 
Scheme 55: Preparation of the new zinc amide base TMPZnOPiv·LiCl. 
 
Using this base it was possible to transform sensitive aromatic and heteroaromatic substrates bearing a 
nitro or an aldehyde group into the corresponding solid zinc pivalates. The generated solid organozinc 
reagents exhibited an exceptional stability towards air. Thus, most of the formed zinc reagents lost less 
than five percent of their initial activity after 4 h of air exposure. Moreover, the solid organozinc reagents 
proved to be excellent nucleophiles for Negishi cross-coupling, acylation and allylation reactions 
(Scheme 56). 
 
Scheme 56: Preparation of solid organozinc pivalates and subsequent reactions with electrophiles. 
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6.5. Structural Insights into Organozinc Pivalate Reagents 
Several studies have been performed to elucidate the structure of the zinc reagents formed by 
transmetalation of a magnesium species RMgCl with Zn(OPiv)2·nLiCl (n = 1 or 2). The first thing that 
was found out is that the pivalate anions are completely transmetalated to magnesium thus generating 
RZnCl and Mg(OPiv). Therefore, when p-tolyMgCl·LiCl is treated with Zn(OPiv)2 the corresponding 
p-tolylZnCl·LiCl is formed alongside with Mg(OPiv)2 (Scheme 57). 
 
Scheme 57: Transmetalation of p-tolylMgCl·LiCl with Zn(OPiv)2. 
 
Another striking insight is the fact that Mg(OPiv)2 was easily contaminated by O2- and OH- ions thus 
generating structures of the type as [{Mg(OPiv)2}5{Mg(OH)2}(MgO)∙4THF] or 
[{Mg6(OPiv)12}(MgO)2]. This might explain the excellent air stability of the generated zinc reagents 
since the Mg(OPiv)2 could mop up OH- and O2- ions and thus capture and hold on to H2O molecules 
making them less accessible for the hydrolysis of the C-Zn bond. Also the role of the LiCl has been 
investigated. It was found that by adding LiCl the otherwise insoluble Zn(OPiv)2 could be dissolved in 
THF, whereupon crystals of the formula [(THF)2Li2(µ-Cl)2(µ-OPiv)2Zn] deposited from this solution. 
It can therefore be assumed that the LiCl enhanced solubility can be led back to the formation of this 
complex, since the LiCl completes the coordination of the Lewis basic OPiv moiety and the Lewis acidic 
Zn atom. This assumption was reinforced by the fact, that when no LiCl is present a clean 
transmetalation from MgCl to Zn(OPiv)2 is not possible due to the low solubility of the reactants. 
Another remarkable result is the fact that too much LiCl drastically diminishes the air stability of the 
organozinc pivalate. Thus, when two equivalents of LiCl are present the organozinc reagent decomposes 
completely within one hour in air, while zinc reagents with only one equivalent of LiCl still exhibit 
rather high activity, even after being exposed to air for two hours. Removing the LiCl completely is not 
possible however, since the solubility of the reactants was to low to give satisfactory yields (Scheme 
58). 
 
Scheme 58: Comparison of air stability of different organozinc species. 
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Moreover, the cross-coupling capability of different salt containing p-tolylZnX (X = Cl·LiCl, 
Cl·MgCl2·LiCl, OPiv·LiOPiv, Cl·Mg(OPiv)2·LiCl) derivatives was tested. The Negishi cross-coupling 
with 4-bromoanisole under argon atmosphere in THF gave comparable yields of the desired biaryl. 
When performing the cross-coupling in air the pivalate-free zinc reagents gave somewhat lower yields 
than the reagents containing zinc pivalate. The influence of the more polar solvent EtOAc was also 
studied. While the cross-coupling proceeded well with the magnesium salt containing zinc reagents, it 
did not work at all in the absence of magnesium salts, i.e. p-tolylZnX with X = Cl·LiCl and 
OPiv·LiOPiv.  
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1. GENERAL CONSIDERATIONS 
If not otherwise stated, all reactions have been carried out using standard Schlenk-techniques in flame-
dried glassware under nitrogen or argon. Prior to use, syringes and needles have been purged with the 
respective inert gas. 
 
1.1. Solvents 
Solvents needed for moisture sensitive reactions were dried according to the following standard 
procedures via distillation over drying agents and stored under an inert gas atmosphere: 
 
DME (1,2-dimethoxyethane) was predried over CaCl2 and distilled from Na/benzophenone ketyl under 
argon. 
DMF was refluxed over CaH2 (14 h), distilled from CaH2 and stored over 4 Å molecular sieve under an 
Ar atmosphere. 
DMPU (1,3-dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone) was predried over CaH2 (4 h) and 
distilled off. 
Et2O was predried over CaCl2 and dried with the solvent purification system SPS-400-2 from 
INNOVATIVE TECHNOLOGIES INC. 
NEP (N-ethylpyrrolidinone) was refluxed over CaH2 and distilled from CaH2. 
NMP (N-methylpyrrolidinone) was refluxed over CaH2 and distilled from CaH2. 
Pyridine was dried over KOH and distilled. 
THF (tetrahydrofuran) was continuously refluxed and freshly distilled from Na/benzophenone ketyl 
under nitrogen and stored over 4 Å molecular sieve under an Ar atmosphere.. 
Toluene was predried over CaCl2, distilled from CaH2 and stored over 4 Å molecular sieve under an Ar 
atmosphere. 
Triethylamine was dried over KOH and distilled. 
Solvents for reaction workup and for column chromatography were distilled prior to use. 
 
1.2. Reagents 
Commercially available reagents were used without further purification unless otherwise stated. Liquid 
aldehydes and acid chlorides were distilled prior to use.  
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BF3·OEt2 was distilled under Ar prior to use. 
TMPH was distilled under Ar prior to use.  
CuCN·2LiCl solution was prepared by drying CuCN (8.96 g, 100 mmol) and LiCl (8.48 g, 200 mmol) 
in a Schlenk-flask under high vacuum for 5 h at 140 °C. After cooling to 25 °C, dry THF (100 mL) was 
added and the mixture was stirred for 24 h. 
ZnCl2 solution was prepared by drying ZnCl2 (68.2 g, 500 mmol) in a Schlenk-flask under high vacuum 
for 6 h at 140 °C. After cooling to 25 °C, dry THF (500 mL) was added and the mixture was stirred until 
all salts were dissolved. 
Zn(OPiv)2 (24b): Pivalic acid (20.4 g, 22.6 mL, 200 mmol) was placed in a dry and argon-flushed 
500 mL three-necked round-bottom flask, equipped with a magnetic stirring bar, a septum and a pressure 
equalizer, and was dissolved in dry THF (120 mL). The mixture was cooled at 0 °C, and a solution of 
Et2Zn (13.0 g, 10.8 mL, 105 mmol) in dry THF (120 mL) was cannulated to it over a period of 30 min 
under vigorous stirring. Then, the ice-bath was removed and stirring continued at 25 °C for one 
additional hour at which point bubbling was ceased (a thick slurry was formed). The solvent was 
removed in vacuo and the solid residue was dried for at least 4 h longer. Zn(OPiv)2 was received in 
quantitative yield, as a puffy amorphous white solid. 
iPrMgCl·LiCl was purchased as a solution in THF from Rockwood Lithium GmbH. 
nBuLi was purchased as a solution in hexane from Rockwood Lithium GmbH. 
TMPMgCl·LiCl (14): A dry and argon flushed 250 mL flask, equipped with a magnetic stirrer and a 
septum, was charged with freshly titrated iPrMgCl·LiCl
119
 (100 mL, 1.2 M in THF, 120 mmol). 2,2,6,6-
Tetramethylpiperidine (TMPH) (19.8 g, 126 mmol, 1.05 equiv) was added dropwise at room 
temperature. The reaction mixture was stirred at 25 °C until gas evolution was completed (ca. 48 h). 
TMPZnCl·LiCl (20): A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic stirrer 
and a septum, was charged with freshly distilled 2,2,6,6-tetramethylpiperidine (10.2 mL, 60 mmol) 
dissolved in THF (60 mL). This solution was cooled to -40 °C and nBuLi (2.4 M in hexane, 25 mL, 
60 mmol) was added dropwise. After the addition was complete, the reaction mixture was allowed to 
warm up slowly to -10 °C for 1 h. ZnCl2 (1.0 M in THF, 66 mL, 66 mmol) was added dropwise and the 
resulting solution was stirred for 30 min at -10 °C and then for 30 min at 25 °C. The solvents were then 
removed under vacuum affording a yellowish solid. Freshly distilled THF was then slowly added under 
vigorous stirring until the salts were completely dissolved. The freshly prepared TMPZnCl·LiCl (20) 
solution was titrated prior to use at 0 °C with benzoic acid using 4-(phenylazo)diphenylamine as 
indicator. A concentration of 1.30 M in THF was obtained. 
TMPZnOPiv·LiCl (63): A dry and argon flushed 250 mL Schlenk-flask, equipped with a magnetic 
stirring bar, was charged with a solution of TMPMgCl·LiCl (14, 87.7 mL, 100 mmol) and cooled at 
0 °C. Then, solid Zn(OPiv)2 (28.1 g, 105 mmol, dried in vacuo at 400 °C prior to use) was added in one 
portion and the mixture was allowed to slowly warm up to 25 °C over ca. 1.5 h. Then THF (ca. 10-
                                                     
119 A. Krasovskiy, P. Knochel, Synthesis, 2006, 890. 
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20 mL) was added to give 63 as a bright yellow solution. The freshly prepared TMPZnOPiv·LiCl was 
titrated prior to use at 0 °C with benzoic acid using 4-(phenylazo)diphenylamine as indicator. A 
concentration of 0.85 to 0.99 M in THF was obtained. 
 
1.3. Analytical Data 
Gas chromatography was performed with machines of type Hewlett-Packard 6890 or 5890 series II, 
using a column of type HP 5 (Hewlett-Packard, 5% phenylmethylpolysiloxane; length: 15 m, diameter: 
0.25 mm; film thickness: 0.25 µm). The detection was accomplished by using a flame ionization 
detector. The carrier gas was nitrogen. Alkanes like dodecane or tetradecane were used as internal 
standards. 
Infrared spectra were recorded from 4000-400 cm-1 on a Perkin 281 IR spectrometer. Samples were 
measured neat (ATR, Smiths Detection DuraSample IR II Diamond ATR). The absorption bands are 
reported in wave numbers (cm
-1
). 
Mass spectra were recorded on Finnigan MAT 95Q or Finnigan MAT 90 instrument for electron impact 
ionization (EI). High resolution mass spectra (HRMS) were recorded on the same instrument.  
Melting points are uncorrected and were measured on a Büchi B.540 apparatus. 
NMR spectra were recorded on Varian Mercury 200, Bruker AC 300, WH 400, or AMX 600 
instruments. Chemical shifts are reported as δ-values in ppm relative to the solvent peak, i.e. chloroform-
d (δ 7.26 ppm for 1H NMR and δ 77.0 ppm for 13C NMR), DMSO-D6 (δ 2.50 ppm for 1H-NMR and δ 
39.5 ppm for 13C-NMR) THF-d8 (δ 1.73 and 3.58 ppm for 1H NMR and δ 25.4 and 67.6 ppm for 13C-
NMR) . For the characterization of the observed signal multiplicities the following abbreviations were 
used: s (singlet), d (doublet), t (triplet), m (multiplet), q (quartet), quint (quintet), sxt (sextet), oct (octet), 
as well as br (broad). 
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1.4. Chromatography 
Thin layer chromatography (TLC) was performed using aluminum plates coated with SiO2 (Merck 60, 
F-254). The spots were visualized by UV-light or by staining of the TLC plate with the solution below 
followed by heating if necessary: 
- Phosphormolybdic acid (5.0 g), Ce(SO4)2 (2.0 g) and conc. H2SO4 (12.0 mL) in water 
(230 mL). 
- Iodine absorbed on silica gel. 
- KMnO4 (0.3 g), K2CO3 (20 g) and KOH (0.3 g) in water (300 mL). 
Flash column chromatography was performed using SiO2 60 (0.04-0.063 mm, 230-400 mesh) from 
Merck. 
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2. BENZYLIC ZINC REAGENTS OF PYRIDINES AND QUINOLINES FOR CROSS-
COUPLINGS WITH ARYL BROMIDES 
Note: The Lewis acid screening and the Pd-salt/Ligand screening for the picoline metalation mentioned 
in B1 were performed by Andreas Steib and Dr. Stéphanie Duez. 
2.1. Typical Procedure 
Typical Procedure for the Metalation of pyridines and related N-heterocycles with 
TMPZnCl·LiCl (20) (TP1): 
In a dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar and a septum, the 
methylated N-heterocycle (1.30 mmol, 1.00 equiv.) was dissolved in dry THF (2 mL). Then, 
TMPZnCl·LiCl (20, 1.50 mL, 1.30 M in THF, 1.95 mmol) was added dropwise and the reaction mixture 
was stirred for the indicated time at the indicated temperature. The completion of the zincation was 
checked by GC-analysis of reaction aliquots quenched with a solution of I2 in dry THF. 
 
2.2. Preparation and Cross-coupling of Benzylic Pydridyl Zinc Reagents 
Synthesis of 5-(pyridine-2-ylmethyl)-1H-indole (30a):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 5-
bromoindole (32a, 196 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting 
mixture was stirred for 7 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane / ether = 3:2) furnished 5-(pyridine-2-ylmethyl)-1H-indole (30a, 180 mg, 
86%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.58 (d, J = 4.9 Hz, 1H), 8.22 (s, 1H), 7.57 (dt, J = 7.6, 1.9 Hz, 
1H), 7.57 ‒ 7.56 (m, 1H), 7.35 (d, J = 8.7 Hz, 1H), 7.21 (t, J = 3.0 Hz, 1H), 7.16 ‒ 7.09 (m, 3H), 6.53 ‒ 
6.51 (m, 1H), 4.29 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 162.1, 149.1, 136.5, 134.7, 130.8, 128.2, 124.4, 123.5, 123.1, 121.0, 
120.9, 111.1, 102.5, 44.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3114, 3097, 3028, 2852, 2361, 1739, 1592, 1474, 1344, 1218, 
1138, 1093, 998, 889, 793, 755, 736, 655. 
MS (EI, 70 eV): m/z (%) = 208 [M+] (70), 207 (100), 130 (48), 127 (18), 44 (62). 
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HRMS for C14H12N2 (208.1000): 208.0933 (M+). 
 
Synthesis of 2-(4-methoxybenzyl)pyridine (30b):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting 
mixture was stirred for 3 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane / ether = 20:3) furnished 2-(4-methoxybenzyl)pyridine (30b, 190 mg, 95%) 
as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.52 (dd, J = 5.8, 1.9 Hz, 1H), 7.54 (dt, J = 7.5, 2.0 Hz, 1H), 
7.16 (d, J = 8.8 Hz, 2H), 7.07 (d, J = 7.5 Hz, 2H), 6.83 (d, J = 8.8 Hz, 2H), 4.08 (s, 2H), 3.76 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 161.4, 158.2, 149.3, 136.5, 131.6, 130.1, 123.0, 121.1, 114.0, 55.2, 
43.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3004, 2951, 2931, 2833, 1737, 1609, 1587, 1508, 1470, 1433, 
1300, 1243, 1175, 1032, 993, 850, 841, 805, 781, 748, 725.  
MS (EI, 70 eV): m/z (%) = 199 [M+] (57), 198 (100), 184 (52), 167 (12), 156 (15), 121 (15). 
HRMS for C13H13NO (199.0997): 199.0975 (M+). 
 
Synthesis of 2-(4-fluorobenzyl)pyridine (30c):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-
bromo-4-fluorobenzene (32c, 175 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 6 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 4:1) furnished 2-(4-fluorobenzyl)pyridine (30c, 147 mg, 
78%) as a slightly yellow oil. 
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1H-NMR (300 MHz, CDCl3):  / ppm = 8.55 (dd, J = 4.6, 1.9 Hz, 1H), 7.58 (dt, J = 7.8, 2.0 Hz, 1H), 
7.22 (dd, J = 8.7, 5.6 Hz, 2H), 7.13 ‒ 7.09 (m, 2H), 6.98 (d, J = 8.7, 5.6 Hz, 2H), 4.12 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 161.5 (JCF = 253 Hz), 160.8, 149.4, 136.6, 135.2, 130.4 (JCF = 7.9 Hz), 
123.0, 121.3, 115.3 (JCF = 21 Hz), 43.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 3008, 2924, 2362, 1892, 1738, 1600, 1588, 1570, 1506, 
1472, 1434, 1298, 1098, 994, 846, 790, 748, 628. 
MS (EI, 70 eV): m/z (%) = 187 [M+] (22), 186 (100), 109 (8), 93 (10), 83 (8). 
HRMS for C12H10FN (187.0797): 187.0742 (M+). 
 
Synthesis of 2-(3-chlorobenzyl)pyridine (30d):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-
bromo-3-chlorobenzene (32d, 191 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 6 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 7:3) furnished 2-(3-chlorobenzyl)pyridine (30d, 134 mg, 
66%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.58 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.61 (dt, J = 7.4, 2.0 Hz, 
1H), 7.28 ‒ 7.12 (m, 6H), 4.14 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 160.1, 149.5, 141.5, 136.6, 134.3, 129.8, 129.2, 127.3, 126.6, 123.1, 
121.5, 44.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3061, 2924, 1737, 1668, 1588, 1568, 1471, 1428, 1303, 1077, 
994, 865, 775, 769, 694, 681. 
MS (EI, 70 eV): m/z (%) = 203 [M+] (22), 202 (100), 167 (71), 139 (4), 84 (11). 
HRMS for C12H10ClN (203.0502): 203.0471 (M+). 
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Synthesis of 2-((4-methoxyphenyl)(phenyl)methyl)pyridine (30e): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-(benzyl)pyridine 
(25b, 220 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting 
mixture was stirred for 20 h at 50 °C. The reaction mixture was then quenched with a mixture of 
saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over 
anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by 
flash-chromatography (i-hexane / ether = 7:3) furnished 2-((4-methoxyphenyl)(phenyl)methyl)pyridine 
(30e, 272 mg, 99%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.62 (ddd, J = 4.9, 1.9, 1.0 Hz, 1H), 7.62 (dt, J = 7.8, 2.0 Hz, 
1H), 7.34 ‒ 7.05 (m, 9H), 6.86 (dt, J = 8.8, 3.0 Hz, 2H), 5.67 (s, 1H), 3.80 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 163.6, 158.2, 149.5, 143.1, 136.4, 135.0, 130.3, 129.3, 128.6, 126.4, 
123.7, 121.3, 113.8, 58.6, 55.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3004, 2951, 2931, 2876 1737, 1609, 1587, 1504, 1465, 1427, 
1300, 1241, 1177, 1032, 993, 850, 841, 805, 781, 748, 725.  
MS (EI, 70 eV): m/z (%) = 275 [M+] (100), 260 (31), 243 (8), 230 (12), 197 (32), 167 (23), 153 (23). 
HRMS for C19H17NO (275.1310): 275.1305 (M+). 
 
Synthesis of 2-((tert-butyldimethylsilyl)(4-methoxyphenyl)methyl)pyridine (30f): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-(tert-
butyldimethylsilyl)pyridine (25c, 269 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the 
reaction mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), 
SPhos (16 mg, 4 mol%) and 4-bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the 
reaction mixture. The resulting mixture was stirred for 20 h at 50 °C. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate 
(3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane / ether = 95:5) furnished 2-((tert-
butyldimethylsilyl)(4-methoxyphenyl)methyl)pyridine (30f, 288 mg, 92%) as a slightly yellow oil. 
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1H-NMR (300 MHz, CDCl3):  / ppm = 8.55 (ddd, J = 4.9, 1.9, 0.9 Hz, 1H), 7.47 (dt, J = 7.6, 2.0 Hz, 
1H), 7.42 (dt, J = 8.7, 2.2 Hz, 2H), 7.16 (dt, J = 7.8, 2.1 Hz, 1H), 6.98 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 
6.80 (dt, J = 8.7, 2.2 Hz, 2H), 3.78 (s, 4H), 0.72 (s, 9H), 0.05 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 163.6, 157.4, 148.9, 135.9, 134.2, 129.9, 123.2, 120.0, 113.5, 55.2, 
45.0, 27.0, 17.8, -6.0. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2948, 2927, 2852, 1583, 1504, 1465, 1427, 1240, 1181, 1031, 
869, 857, 824, 807, 778, 692. 
MS (EI, 70 eV): m/z (%) = 313 [M+] (14), 298 (9), 256 (100), 242 (10), 225 (23), 212 (11), 198 (10), 
182 (11), 167 (13), 154 (8), 120 (3), 73 (42). 
HRMS for C19H27NOSi (313.1862): 313.1855 (M+). 
 
Synthesis of 4-(pyridin-2-ylmethyl)benzonitrile (30g):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 0.13 mmol, 0.10 equiv.) was added at 
25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromobenzonitrile (32j, 183 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(pyridin-2-ylmethyl)benzonitrile (30g, 
170 mg, 87%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.58 (ddd, J = 4.8, 1.9, 0.8 Hz, 1H), 7.65 (dt, J = 7.8, 1.8 Hz, 
1H), 7.60 (dt, J = 8.6, 2.1 Hz, 2H), 7.39 (dt, J = 8.6, 2.1 Hz, 2H), 7.21 ‒ 7.14 (m, 2H), 4.22 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 159.2, 149.6, 145.0, 136.9, 132.3, 129.8, 123.3, 121.8, 118.9, 110.4, 
44.5. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3061, 3044, 3005, 2932, 2226, 1737, 1670, 1585, 1504, 1470, 
1433, 1310, 1153, 1048, 994, 865, 809, 774, 749, 691.  
MS (EI, 70 eV): m/z (%) = 194 [M+] (23), 193 (100), 166 (4), 140 (2), 89 (3). 
HRMS (ESI) for C13H11N2 (195.0922): 195.0916 ([M+H]+). 
 
 
C. Experimental Section 
 
 
78 
Synthesis of ethyl 4-(pyridin-2-ylmethyl)benzoate (30h):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylpyridine 
(25a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 0.13 mmol, 0.10 equiv.) was added at 
25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and ethyl 4-
bromobenzoate (32k, 227 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting 
mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane / ether = 1:1) furnished ethyl 4-(pyridin-2-ylmethyl)benzoate (30h, 206 mg, 
85%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.57 (d, J = 5.1 Hz, 1H), 8.00 (d, J = 8.6 Hz, 2H), 7.61 (dt, J 
= 7.7, 1.9 Hz, 1H), 7.35 (d, J = 8.6 Hz, 2H), 7.18 ‒ 7.11 (m, 2H), 4.38 (q, J = 7.1 Hz, 2H), 4.23 (s, 2H), 
1.39 (t, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.5, 160.0, 149.5, 144.7, 136.7, 129.9, 129.1, 128.7, 123.2, 121.5, 
60.8, 44.6, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3059, 2904, 1710, 1709, 1585, 1472, 1434, 1415, 1366, 1270, 
1176, 1100, 1020, 752, 702. 
MS (EI, 70 eV): m/z (%) = 241 [M+] (32), 240 (100), 212 (26), 196 (15), 167 (41). 
HRMS (ESI) for C15H16NO2 (242.1181): 242.1175 ([M+H]+). 
 
Synthesis of 4-(benzo[d][1,3]dioxol-5-ylmethyl)pyridine (33a):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 5-
bromobenzo[1,3]dioxol (32e, 199 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
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by flash-chromatography (CH2Cl2 / MeOH = 99:1) furnished 4-(benzo[d][1,3]dioxol-5-
ylmethyl)pyridine (33a: 203 mg, 95%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.51 (d, J = 6.1 Hz, 2H), 7.11 (d, J = 6.1 Hz, 2H), 6.78 (d, J = 
8.5 Hz, 1H), 6.68 ‒ 6.65 (m, 2H), 5.95 (s, 2H), 3.89 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 149.9, 147.9, 146.3, 132.6, 124.0, 122.0, 109.4, 108.4, 101.0, 
40.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3066, 3024, 2982, 2854, 1596, 1485, 1440, 1413, 1244, 1186, 
1109, 1033, 925, 868, 814, 799, 767, 728, 713. 
MS (EI, 70 eV): m/z (%) = 213 [M+] (100), 183 (17), 154 (22), 135 (36), 127 (10), 77 (11). 
HRMS for C13H11NO2 (213.0790): 213.0784 (M+). 
 
Synthesis of 4-(4-methoxybenzyl)pyridine (33b):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(O2CCF3)2 (12 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(4-methoxybenzyl)pyridine (33b, 195 mg, 
98%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.50 (d, J = 5.5 Hz, 2H), 7.13 ‒ 7.08 (m, 4H), 6.88 (dt, J = 8.7, 
3.1 Hz, 2H), 3.98 (s, 2H), 3.81 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.4, 150.5, 149.8, 130.9, 130.0, 124.1, 114.1, 55.3, 40.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3065, 3027, 2954, 2907, 2834, 1737, 1598, 1509, 1413, 1245, 
1176, 1152, 1107, 1030, 993, 796, 759. 
MS (EI, 70 eV): m/z (%) = 199 [M+] (100), 184 (23), 168 (17), 154 (11), 121 (54). 
HRMS for C13H13NO (199.0997): 199.0977 (M+). 
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Synthesis of 4-(3-methylbenzyl)pyridine (33c):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-
bromo-3-methylbenzene (32f, 169 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1→2:3) furnished 4-(3-methylbenzyl)pyridine (33c, 
150 mg, 82%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.52 (d, J = 5.5 Hz, 2H), 7.25 ‒ 6.97 (m, 6H), 3.95 (s, 2H), 
2.35 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 149.8, 138.8, 138.4, 129.8, 128.6, 127.4, 126.0, 124.2, 41.2, 
21.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3023, 2920, 2854, 1737, 1720, 1597, 1558, 1490, 1413, 1284, 
1247, 1217, 1110, 993, 800, 778, 750, 698.  
MS (EI, 70 eV): m/z (%) = 183 [M+] (100), 168 (58), 152 (4), 141 (5), 128 (4), 115 (5), 105 (6), 91 (7). 
HRMS for C13H13N (183.1048): 183.1047 (M+). 
 
Synthesis of N,N-dimethyl-4-(pyridine-4-ylmethyl)aniline (33d):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromo-N,N-dimethylaniline (32g, 199 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. 
The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / ether = 1:1→2:3) furnished N,N-dimethyl-4-(pyridine-
4-ylmethyl)aniline (33d, 149 mg, 70%) as a slightly yellow oil. 
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1H-NMR (300 MHz, CDCl3):  / ppm = 8.49 (dd, J = 4.6, 1.5 Hz, 2H), 7.12 (d, J = 6.0 Hz, 2H), 7.06 
(dt, J = 9.3, 2.4 Hz, 2H), 6.71 (dt, J = 9.3, 2.4 Hz, 2H), 3.89 (s, 2H), 2.95 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 151.1, 149.7, 149.4, 129.7, 126.7, 124.1, 112.9, 40.7, 40.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3020, 2894, 2808, 2338, 2360, 1739, 1611, 1597, 1518, 1484, 
1445, 1420, 1410, 1346, 1230, 1170, 111, 1065, 945, 914, 827, 787, 720.  
MS (EI, 70 eV): m/z (%) = 212 [M+] (100), 195 (4), 167 (14), 134 (60), 118 (14). 
HRMS for C14H16N2 (212.1313): 212.1323 (M+). 
 
Synthesis of 4-(pyridin-4-ylmethyl)phenol (33e):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(O2CCF3)2 (12 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromo-phenol (32h, 172 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (CH2Cl2 / MeOH = 97:3) furnished 4-(pyridin-4-ylmethyl)phenol (33e, 
155 mg, 84%) as a colorless oil. 
1H-NMR (300 MHz, DMSO-d6):  / ppm = 9.24 (s, 1H), 8.43 (dd, J = 4.5, 1.6 Hz, 2H), 7.19 (dd, J = 
4.3, 1.7 Hz, 2H), 7.03 (d, J = 8.5 Hz, 2H), 6.69 (d, J = 8.5 Hz, 2H), 3.83 (s, 2H). 
13C-NMR (DMSO-d6, 75 MHz): δ = 156.2, 151.1, 149.9, 130.2, 130.0, 124.3, 115.7, 39.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2997, 2925, 2883, 2794, 2673, 2594, 2360, 2339, 1602, 1513, 
1455, 1420, 1430, 1380, 1245, 1217, 1205, 1007, 919, 845, 804. 
MS (EI, 70 eV): m/z (%) = 185 [M+] (100), 167 (8), 156 (9), 128 (7), 107 (43), 77 (14). 
HRMS for C12H11NO (185.0841): 185.0840 (M+). 
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Synthesis of 4-(pyridin-4-ylmethyl)phenyl pivalate (33f):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(O2CCF3)2 (12 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromophenyl pivalate (32i, 256 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. 
The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / ether = 2:3) furnished 4-(pyridin-4-ylmethyl)phenyl 
pivalate (33f, 218 mg, 81%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.52 (dd, J = 5.8, 1.6 Hz, 2H), 7.18 (d, J = 8.6 Hz, 2H), 7.11 
(d, J = 5.8 Hz, 2H), 7.03 (d, J = 8.6 Hz, 2H), 3.98 (s, 2H), 1.36 (s, 9H). 
13C-NMR (CDCl3, 75 MHz): δ = 177.1, 149.9, 149.8, 149.7, 135.1, 129.9, 124.1, 121.7, 40.6, 39.1, 
27.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3069, 3033, 3017, 2933, 2973, 2872, 1741, 1595, 1505, 1477, 
1411, 1277, 1294, 1112, 1030, 899, 806, 760. 
MS (EI, 70 eV): m/z (%) = 269 [M+] (26), 226 (4), 185 (100), 156 (12), 128 (10), 107 (11), 85 (8), 57 
(50). 
HRMS for C17H19NO2 (269.1416): 269.1425 (M+). 
 
Synthesis of 2-chloro-4-(3-methylbenzyl)pyridine (33g):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-chloro-4-
methylpyridine (26b, 165 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture 
was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), PCy3 (12 mg, 
4 mol%) and 1-bromo-3-methylbenzene (32f, 169 mg, 1.00 mmol, 0.80 equiv.) were added to the 
reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate 
(3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
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pressure. Purification by flash-chromatography (i-hexane / ether = 4:1) furnished 2-chloro-4-(3-
methylbenzyl)pyridine (33g, 150 mg, 69%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.26 (d, J = 5.1 Hz, 1H), 7.22 (t, J = 7.2, 1H), 7.14 (dd, J = 
1.5, 0.7 Hz, 1H), 7.08 (d, J = 7.6 Hz, 1H), 7.03 (d, J = 5.1 Hz, 1H), 6.98 ‒ 6.95 (m, 2H), 3.91 (s, 2H), 
2.33 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 153.6, 151.7, 149.5, 138.6, 137.9, 129.8, 128.8, 127.7, 126.0, 124.4, 
123.0, 40.9, 21.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3052, 2920, 2863, 1740, 1720, 1589, 1558, 1490, 1413, 1381, 
1284, 1247, 1217, 1110, 1084, 993, 800, 745, 750, 715, 698.  
MS (EI, 70 eV): m/z (%) = 217 [M+] (100), 202 (42), 182 (32), 166 (35), 152 (9), 139 (10). 
HRMS (ESI) for C13H13ClN (218.0737): 218.0732 ([M+H]+). 
 
Synthesis of 5-((2-chloropyridine-4-yl)methyl)-1H-indole (33h):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-chloro-4-
methylpyridine (26b, 165 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture 
was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 
4 mol%) and 5-bromoindole (32a, 195 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. 
The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / ether = 3:2) furnished 5-((2-chloropyridine-4-
yl)methyl)-1H-indole (33h, 167 mg, 69%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.23 (d, J = 5.3 Hz, 1H), 8.16 (s, 1H), 7.42 (s, 1H), 7.34 (dd, 
J = 8.4 Hz, 1H), 7.23 ‒ 7.14 (m, 2H), 7.06 (d, J = 5.1 Hz, 1H), 6.96 (d, J = 8.4 Hz, 1H), 6.51 ‒ 6.49 (m, 
1H), 4.04 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 155.2, 151.4, 149.1, 134.8, 129.2, 128.3, 124.8, 125.6, 123.2, 123.1, 
121.0, 111.5, 102.5, 41.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3052, 3022, 2920, 2863, 1740, 1589, 1545, 1464, 1381, 1216, 
1119, 1084, 989, 835, 785, 745, 715, 697. 
MS (EI, 70 eV): m/z (%) = 242 [M+] (100), 205 (21), 178 (10), 151 (8), 130 (79). 
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HRMS (ESI) for C14H12ClN2 (243.0689): 243.0683 ([M+H]+). 
 
Synthesis of 4-(bis(4-methoxyphenyl)methyl)pyridine (33i): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-(4-
methoxybenzyl)pyridine (33b, 259 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos 
(16 mg, 4 mol%) and 4-bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction 
mixture. The resulting mixture was stirred for 3 h at 50 °C. The reaction mixture was then quenched 
with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 
5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane / ether = 7:3) furnished 4-(bis(4-
methoxyphenyl)methyl)pyridine (33i, 283 mg, 93%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.52 (dd, J = 4.4, 1.6 Hz, 2H), 7.06 ‒ 6.99 (m, 6H), 6.89 ‒ 6.83 
(m, 4H), 5.42 (s, 1H), 3.81 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.4, 153.4, 149.8, 134.6, 130.2, 124.3, 113.9, 55.3, 54.6. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3066, 3032, 2995, 2833, 1608, 1594, 1581, 1506, 1491, 1457, 
1441, 1412, 1303, 1240, 1177, 1111, 1030, 819. 
MS (EI, 70 eV): m/z (%) = 305 [M+] (61), 274 (23), 227 (100), 212 (6), 198 (7), 169 (7), 154 (14). 
HRMS for C20H19NO2 (305.1416): 305.1411 (M+). 
 
Synthesis of ethyl 4-(pyridin-4-ylmethyl)benzoate (33j):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 0.13 mmol, 0.10 equiv.) was added at 
25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and ethyl 4-
bromobenzoate (32k, 227 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The resulting 
mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture of saturated 
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aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried over anhydrous 
MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification by flash-
chromatography (i-hexane / ether = 1:1) furnished ethyl 4-(pyridin-4-ylmethyl)benzoate (33j, 188 mg, 
78%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.49 (dd, J = 4.5, 1.7 Hz, 2H), 7.97 (dt, J = 8.4, 1.9 Hz, 2H), 
7.26 ‒ 7.05 (m, 4H), 4.35 (q, J = 7.1 Hz, 2H), 4.01 (s, 2H), 1.36 (t, J = 7.1 Hz, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 166.3, 149.7, 149.5, 143.8, 130.0, 130.0, 129.0, 124.2, 60.9, 41.2, 
14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3028, 2981, 2931, 1710, 1597, 1413, 1365, 1270, 1177, 1100, 
1020, 994, 870, 786, 754, 704.  
MS (EI, 70 eV): m/z (%) = 241 [M+] (31), 213 (32), 196 (100), 167 (43), 139 (10), 115 (8). 
HRMS (ESI) for C15H16NO2 (242.1181): 242.1173 ([M+H]+). 
 
Synthesis of 4-(pyridin-4-ylmethyl)benzonitrile of (33k):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 0.13 mmol, 0.10 equiv.) was added at 
25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 4-
bromobenzonitrile (32j, 183 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(pyridin-4-ylmethyl)benzonitrile (33k, 
146 mg, 75%) as a colorless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.53 (dd, J = 4.6, 2.0 Hz, 2H), 7.60 (dt, J = 8.3, 1.9 Hz, 2H), 
7.30 ‒ 7.23 (m, 2H), 7.12 (d, J = 6.1 Hz, 2H), 4.05 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 149.8, 148.5, 144.2, 132.5, 129.8, 124.2, 119.6, 110.9, 41.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3064, 3016, 226, 1739, 1597, 1554, 1506, 1496, 1414, 1426, 
1223, 993, 927, 865, 840, 783, 722. 
MS (EI, 70 eV): m/z (%) = 194 [M+] (100), 166 (9), 140 (9), 116 (10), 89 (7), 63 (5). 
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HRMS (ESI) for C13H10N2 (195.0922): 195.0916 ([M+H]+). 
 
Synthesis of 4-(3-(trifluoromethyl)benzyl)pyridine (33l):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylpyridine 
(26a, 121 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Sc(OTf)3 (64 mg, 0.13 mmol, 0.10 equiv.) was added at 
25 °C. After being stirred for 15 min, Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-bromo-
3-(trifluoromethyl)benzene (32l, 224 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. 
The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / ether = 2:3) furnished 4-(3-
(trifluoromethyl)benzyl)pyridine (33l, 185 mg, 78%) as a slightly yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.55 (dd, J = 6.2, 1.7 Hz, 2H), 7.55 ‒ 7.36 (m, 4H), 7.11 (d, J 
= 6.2, 2H), 4.05 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.1, 148.8, 139.8, 132.4, 131.1 (JCF = 32 Hz), 129.2, 125.7 (JCF = 
3.8 Hz), 124.1, 124.0 (JCF = 272 Hz), 123.6 (JCF = 3.8 Hz), 40.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3070, 3028, 2992, 1737, 1673, 1598, 1449, 1414, 1327, 1160, 
117, 1071, 919, 880, 791, 701, 663.  
MS (EI, 70 eV): m/z (%) = 237 [M+] (100), 218 (6), 167 (18), 159 (7), 139 (3). 
HRMS for C13H10F3N (237.0765): 237.0760 (M+). 
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2.3. Preparation and Cross-coupling of Benzylic Quinolyl Zinc Reagents 
Synthesis of 4-(4-methoxybenzyl)quinoline (36a):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromoanisole (32b, 187 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(4-methoxybenzyl)quinoline (36a, 
234 mg, 94%) as a white solid. 
M.p. (°C): 78.0-80.2 °C. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.84 (d, J = 4.5 Hz, 1H), 8.12 (d, J = 7.6 Hz, 1H), 8.07 (d, J = 
7.6 Hz, 1H), 7.73 (dt, d, J = 7.6, 1.5 Hz, 1H), 7.56 (dt, J = 7.6, 1.5 Hz, 1H), 7.17 ‒ 7.10 (m, 3H), 6.87 
(d, J = 8.7 Hz, 2H), 4.41 (s, 2H), 3.81 (s, 3H). 
13C-NMR (CDCl3, 75 MHz): δ = 158.4, 150.1, 148.1, 147.3, 130.5, 130.0, 129.9, 129.2, 127.6, 126.6, 
123.9, 121.7, 114.2, 55.3, 37.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3030, 3006, 2967, 2911, 2839, 1737, 1610, 1588, 1569, 1588, 
1509, 1449, 1461, 1443, 1525, 1298, 1246, 1170, 1103, 1030, 929, 846, 837, 758, 751, 730. 
MS (EI, 70 eV): m/z (%) = 249 [M+] (100), 234 (50), 217 (31), 204 (28), 121 (27). 
HRMS for C17H15NO (249.1154): 249.1143 (M+). 
 
Synthesis of N,N-dimethyl-4-(quinolin-4-ylmethyl)aniline (36b):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromo-N,N-dimethylaniline (32g, 199 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction 
C. Experimental Section 
 
 
88 
mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched 
with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 
5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane / ether = 1:1) furnished N,N-dimethyl-4-
(quinolin-4-ylmethyl)aniline (36b, 245 mg, 93%) as a yellow solid. 
M.p. (°C): 115.7-117.5 °C. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.82 (d, J = 4.5 Hz, 1H), 8.17 (d, J = 8.6 Hz, 1H), 8.12 (d, J = 
8.6 Hz, 1H), 7.71 (dt, J = 7.6, 1.4 Hz, 1H), 7.57 (dt, J = 7.6, 1.4 Hz, 1H), 7.17 (d, J = 4.5 Hz, 1H), 7.09 
(d, J = 8.5 Hz, 2H), 6.72 (d, J = 8.5, 2H), 4.38 (s, 2H), 2.94 (s, 6H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.0, 149.4, 148.1, 147.9, 129.8, 129.6, 129.2, 127.7, 126.5, 126.2, 
124.0, 121.6, 113.0, 40.7, 37.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2890, 2800, 2361, 2337, 1737, 1610, 1589, 1518, 1478, 1441, 
1343, 1324, 1218, 1139, 1124, 1057, 941, 931, 843, 835, 806, 767.  
MS (EI, 70 eV): m/z (%) = 262 [M+] (100), 245 (4), 217 (20), 204 (4), 189 (4), 134 (61), 118 (12). 
HRMS (ESI) for C18H19N2 (263.1548): 263.1541 ([M+H]+). 
 
Synthesis of 4-(quinolin-4-ylmethyl)benzonitrile (36c):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromobenzonitrile (32j, 183 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(quinolin-4-ylmethyl)benzonitrile (36c, 
161 mg, 66%) as a white solid.  
M.p. (°C): 148.0-149.0 °C 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.88 (d, J = 4.5 Hz, 1H), 8.19 (d, J = 7.6 Hz, 1H), 7.93 (dd, J 
= 7.6, 1.4 Hz, 1H), 7.75 (d, J = 8.4 Hz, 1H), 7.61 (d, J = 8.4 Hz, 2H), 7.56 (dd, J = 7.6, 1.4 Hz, 1H), 
7.31 (d, J = 8.4 Hz, 2H), 7.17 (d, J = 4.5 Hz, 1H), 4.52 (s, 2H). 
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13C-NMR (CDCl3, 75 MHz): δ = 150.1, 148.3, 144.9, 144.2, 132.6, 130.3, 129.7, 129.6, 127.3, 127.0, 
123.5, 122.0, 118.7, 110.8, 38.3.  
IR (Diamond-ATR, neat): ~  / cm-1 = 3061, 3001, 2361, 2335, 2225, 1737, 1590, 1508, 1424, 1395, 
1237, 933, 868, 861, 761, 748.  
MS (EI, 70 eV): m/z (%) = 244 [M+] (82), 243 (100), 229 (6), 214 (7), 190 (5). 
HRMS (ESI) for C17H13N2 (245.1079): 245.1071 ([M+H]+). 
 
Synthesis of 4-(quinolin-4-ylmethyl)phenol (36d):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(O2CCF3)2 (12 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromophenol (32h, 171 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (CH2Cl2 / MeOH, 99:→98:2) furnished 4-(quinolin-4-ylmethyl)phenol (36d, 
179 mg, 76%) as a white solid. 
M.p. (°C): 229.3-232.8 °C. 
1H-NMR (300 MHz, DMSO-d6):  / ppm = 9.24 (s, 1H), 8.80 (d, J = 4.8 Hz, 1H), 8.17 (dd, J = 8.4, 
1.4 Hz, 1H), 8.01 (dd, J = 8.4, 1.4 Hz, 1H), 7.72 (dt, J = 7.6, 1.50 Hz, 1H), 7.58 (dt, J = 7.6, 1.5 Hz, 
1H), 7.29 (d, J = 4.5 Hz, 1H), 7.06 (d, J = 8.6 Hz, 2H), 6.68 (d, J = 8.6 Hz, 2H), 4.34 (s, 2H). 
13C-NMR (75 MHz, DMSO-d6): δ = 156.2, 150.8, 148.3, 147.8, 130.2, 130.0, 129.6, 129.5, 127.4, 
126.9, 124.9, 122.1, 115.8, 36.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2928, 2670, 2339, 2360, 1737, 1591, 1508, 1440, 1376, 1268, 
1245, 1231, 1169, 1100, 841, 817, 771, 749, 724. 
MS (EI, 70 eV): m/z (%) = 235 [M+] (100), 217 (18), 204 (14), 129 (9), 107 (16). 
HRMS (ESI) for C16H14NO (236.1075): 236.1069 ([M+H]+) . 
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Synthesis of 4-(quinolin-4-ylmethyl)aniline (36e):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 2.00 mL, 2.60 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(O2CCF3)2 (12 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 4-bromoaniline (32m, 171 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 2 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (CH2Cl2 / MeOH = 99:1→98:2) furnished 4-(quinolin-4-ylmethyl)aniline 
(36e, 173 mg, 74%) as a orange solid. 
M.p. (°C): 139.3-141.2 °C. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.82 (d, J = 4.5 Hz, 1H), 8.18 (d, J = 8.2 Hz, 1H), 8.09 (d, J = 
8.2 Hz, 1H), 7.73 (dt, J = 7.6, 1.5 Hz, 1H), 7.56 (dt, J = 7.6, 1.5 Hz, 1H), 7.17 (d, J = 4.5 Hz, 1H), 7.00 
(d, J = 8.6 Hz, 2H), 6.67 (d, J = 8.6 Hz, 2H), 4.36 (s, 2H), 3.40 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 149.8, 148.2, 147.7, 145.0, 129.8, 129.7, 129.3, 128.2, 127.7, 126.6, 
123.9, 121.6, 115.4, 37.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3411, 3300, 3191, 3057, 3021, 2897, 2844, 2360, 1736, 1625, 
1590, 1568, 1513, 1507, 1444, 1307, 1277, 1234, 1171, 1141, 942, 915, 818, 812, 770, 748, 723.  
MS (EI, 70 eV): m/z (%) = 234 [M+] (100), 217 (17), 204 (7), 116 (7), 106 (41). 
HRMS (ESI) for C16H15N2 (235.1235): 235.1228 ([M+H]+). 
 
Synthesis of 4-(3-(trifluoromethyl)benzyl)quinoline (36f):  
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 4-methylquinoline 
(35a, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 30 min according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) 
and 1-bromo-3-(trifluoromethyl)benzene (32l, 224 mg, 1.00 mmol, 0.80 equiv.) were added to the 
reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then 
quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate 
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(3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane / ether = 1:1) furnished 4-(3-
(trifluoromethyl)benzyl)quinoline (36f, 207 mg, 72%) as a slightly yellow solid. 
M.p. (°C): 79.1-80.8 °C. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.86 (d, J = 4.7 Hz, 1H), 8.19 (d, J = 8.4 Hz, 1H), 8.01 (d, J = 
8.4 Hz, 1H), 7.75 (dd, J = 8.4, 1.5 Hz, 1H), 7.60 ‒ 7.33 (m, 5H), 7.15 (d, J = 4.7, 1H), 4.52 (s, 2H). 
13C-NMR (CDCl3, 75 MHz): δ = 150.2, 148.3, 145.6, 139.5, 132.2, 131.1 (JCF = 32 Hz), 130.2, 129.4, 
129.2, 127.4, 126.9, 125.6 (JCF = 3.7 Hz), 124.0 (JCF = 271 Hz), 123.6 (JCF = 3.7 Hz), 123.5, 121.8, 37.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3032, 2925, 2359, 2338, 1737, 1591, 1569, 1508, 1451, 1427, 
1327, 1317, 1205, 1159, 1119, 1073, 938, 831, 809, 747, 704. 
MS (EI, 70 eV): m/z (%) = 287 [M+] (100), 268 (7), 217 (53), 189 (8). 
HRMS (ESI) for C17H13F3N (288.1000): 288.0991 ([M+H]+). 
 
Synthesis of 1-(3-methylbenzyl)isoquinoline (36g): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 1-
methylisoquinoline (35c, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction 
mixture was then stirred at this temperature for 15 min according to TP1. Pd(OAc)2 (5 mg, 2 mol%), 
XantPhos (12 mg, 2 mol%) and 1-bromo-3-methylbenzene (32f, 169 mg, 1.00 mmol, 0.80 equiv.) were 
added to the reaction mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture 
was then quenched with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with 
ethyl acetate (3 x 5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated 
under reduced pressure. Purification by flash-chromatography (i-hexane/Et2O = 2:1) furnished 1-(3-
methylbenzyl)isoquinoline (36g, 200 mg, 86%) as a pale yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.50 (d, J = 5.9 Hz, 1H), 8.16 (d, J = 8.6 Hz, 1H), 7.80 (d, J = 
8.2 Hz, 1H), 7.60 ‒ 7.65 (m, 1H), 7.50 ‒ 7.57 (m, 2H), 7.05 ‒ 7.16 (m, 3H), 6.98 (d, J = 7.5 Hz, 1H), 
4.64 (s, 2H), 2.27 (s, 3H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 160.2, 141.8, 139.2, 138.1, 136.6, 129.9, 129.3, 128.4, 127.3, 
127.2, 127.2, 127.0, 125.9, 125.6, 119.8, 41.9, 21.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3049, 3016, 2916, 2861, 2360, 2334, 1772, 1621, 1605, 1585, 
1559, 1500, 1487, 1459, 1436, 1383, 1353, 1339, 1241, 1169, 1154, 1134, 1091, 1073, 1039, 1018, 999, 
952, 930, 880, 866, 822, 797, 776, 748, 737, 723, 693, 673. 
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MS (70 eV, EI): m/z (%): 233 (M+, 31), 232 (100), 217 (29), 116 (5), 109 (6). 
HRMS for C17H15N (233.1204): 233.1163 (M+). 
 
Synthesis of 2-(3,5-dimethoxybenzyl)quinoline (36h): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), XantPhos (12 mg, 2 mol%) and 
1-bromo-3,5-dimethoxybenzene (32n, 215 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction 
mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched a 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / Et2O = 4:1) furnished 2-(3,5-dimethoxybenzyl)-
quinoline (36h, 271 mg, 97%) as a pale beige oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.09 (d, J = 8.4 Hz, 1H), 8.01 (d, J = 8.4 Hz, 1H), 7.74 (d, J = 
7.9 Hz, 1H), 7.65 ‒ 7.72 (m, 1H), 7.45 ‒ 7.51 (m, 1H), 7.24 (d, J = 8.4 Hz, 1H), 6.47 (d, J = 2.2 Hz, 2H), 
6.33 (d, J = 2.3 Hz, 1H), 4.27 (s, 2H), 3.73 (s, 6H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 160.9, 160.9, 147.7, 141.4, 136.5, 129.4, 128.9, 127.5, 126.8, 
126.0, 121.4, 107.3, 98.5, 55.2, 45.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3057, 2998, 2935, 2835, 1592, 1564, 1504, 1458, 1425, 1345, 
1322, 1313, 1288, 1262, 1219, 1203, 1147, 1114, 1063, 1055, 1016, 992, 972, 940, 916, 820, 792, 762, 
734, 694, 679. 
MS (70 eV, EI): m/z (%): 279 [M+] (81), 278 (100), 264 (30), 249 (16), 204 (15). 
HRMS (ESI) for C18H18NO2 (280.1332): 280.1329 ([M+H+]). 
 
Synthesis of 2-(3-methylbenzyl)quinoline (36i): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), XantPhos (12 mg, 2 mol%) and 
1-bromo-3-methylbenzene (32f, 169 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. 
The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a 
C. Experimental Section 
 
 
93 
mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and 
dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. 
Purification by flash-chromatography (i-hexane / Et2O, 5:1) furnished 2-(3-methylbenzyl)quinoline 
(36i, 224 mg, 96%) as a yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.15 (d, J = 8.4 Hz, 1H), 8.05 (d, J = 8.4 Hz, 1H), 7.70 ‒ 7.82 
(m, 2H), 7.49 ‒ 7.57 (m, 1H), 7.20 ‒ 7.30 (m, 2H), 7.05 ‒ 7.18 (m, 3H), 4.36 (s, 2H), 2.35 (s, 3H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 161.3, 147.8, 139.1, 138.2, 136.4, 130.0, 129.4, 129.0, 128.5, 
127.5, 127.2, 126.7, 126.2, 125.9, 121.5, 45.5, 21.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3040, 3014, 2949, 2917, 2862, 1933, 1617, 1598, 1563, 1504, 
1488, 1458, 1424, 1374, 1309, 1219, 1170, 1140, 1114, 1090, 1039, 1015, 952, 869, 831, 799, 781, 757, 
737, 728, 692. 
MS (70 eV, EI): m/z (%): 233 [M+] (56), 232 (100), 217 (35), 116 (11), 44 (53). 
HRMS for C17H15N (233.1204): 233.1189 (M+). 
 
Synthesis of 2-(3-fluorobenzyl)quinoline (36j): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), SPhos (16 mg, 4 mol%) and 1-
bromo-3-fluorobenzene (32o, 174 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane / Et2O = 2:1) furnished 2-(3-fluorobenzyl)quinoline (36j, 225 mg, 
95%) as a yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.13 (d, J = 8.0 Hz, 1H), 8.08 (d, J = 8.6 Hz, 1H), 7.80 (d, J = 
8.0 Hz, 1H), 7.71 ‒ 7.77 (m, 1H), 7.50 ‒ 7.57 (m, 1H), 7.22 ‒ 7.33 (m, 2H), 7.12 (d, J = 7.7 Hz, 1H), 
7.02 ‒ 7.08 (m, 1H), 6.90 ‒ 6.98 (m, 1H), 4.37 (s, 2H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 162.9 (d, JCF = 246 Hz), 160.3, 147.8, 141.7 (d, JCF = 7.1 Hz), 
136.6, 130.0 (d, JCF = 8.3 Hz), 129.6, 129.0, 127.5, 126.8, 126.1, 124.8 (d, JCF = 2.9 Hz), 121.4, 116.0 
(d, JCF = 21 Hz), 113.4 (d, JCF = 21 Hz), 45.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3056, 2917, 2348, 1930, 1615, 1598, 1588, 1564, 1504, 1485, 
1447, 1425, 1373, 1311, 1265, 1245, 1219, 1137, 1114, 1074, 1015, 971, 946, 926, 916, 883, 865, 829, 
797, 781, 761, 741, 730, 683, 670. 
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MS (70 eV, EI): m/z (%): 237 [M+] (41), 236 (100), 118 (4). 101 (3). 
HRMS for C16H12FN (237.0954): 237.0931 (M+). 
 
Synthesis of 2-(4-(trifluoromethyl)benzyl)quinoline (36k): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), XantPhos (12 mg, 2 mol%) and 
1-bromo-4-(trifluoromethyl)benzene (32p, 223 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction 
mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched 
with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 
5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane/Et2O = 2:1) furnished 2-(4-
(trifluoromethyl)benzyl)quinoline (36k, 247 mg, 86%) as a pale yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.02 ‒ 8.11 (m, 2H), 7.78 (d, J = 8.0 Hz, 1H), 7.67 ‒ 7.74 (m, 
1H), 7.48 ‒ 7.58 (m, 3H), 7.42 (d, J = 8.0 Hz, 2H), 7.21 (d, J = 8.3 Hz, 1H), 4.39 (s, 2H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 160.0, 147.9, 143.3 (q, JCF = 1.4 Hz), 136.8, 129.6, 129.4, 
129.0, 128.8 (q, JCF = 32 Hz), 127.5, 126.8, 126.2, 125.5 (q, JCF = 3.7 Hz), 124.2 (q, JCF = 272 Hz), 
121.4, 45.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3057, 2358, 2340, 1925, 1738, 1617, 1598, 1564, 1504, 1426, 
1418, 1321, 1220, 1161, 1114, 1104, 1065, 1018, 953, 933, 885, 855, 816, 791, 766, 742, 710, 676. 
MS (70 eV, EI): m/z (%): 287 [M+] (45), 286 (100), 216 (10), 128 (14), 109 (17), 77 (11). 
HRMS for C17H12F3N (287.0922): 287.0903 (M+). 
 
Synthesis of 2-(2,4,5-trifluorobenzyl)quinoline (36l): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), XantPhos (12 mg, 2 mol%) and 
1-bromo-2,4,5-trifluorobenzene (32q, 211 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction 
mixture. The resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched 
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with a mixture of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 
5 mL) and dried over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced 
pressure. Purification by flash-chromatography (i-hexane / Et2O = 2:1) furnished 2-(2,4,5-
trifluorobenzyl)quinoline (36l, 213 mg, 78%) as a pale yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.15 – 8.04 (m, 2H), 7.80 (ddd, J = 8.1, 1.6, 0.6 Hz, 1H), 7.73 
(ddd, J = 8.5, 6.9, 1.5 Hz, 1H), 7.54 (ddd, J = 8.1, 6.9, 1.2 Hz, 1H), 7.32 – 7.26 (m, 1H), 7.20 – 7.08 (m, 
1H), 6.96 (ddd, J = 10.1, 9.1, 6.6 Hz, 1H), 4.32 (s, 2H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 158.8, 155.7 (ddd, JCF = 244, 9.3, 2.7 Hz), 148.8 (ddd, JCF = 
250, 15, 12 Hz), 147.9, 146.7 (ddd, JCF = 245, 13, 3.7 Hz), 136.9, 129.7, 129.0, 127.5, 126.9, 126.3, 
122.5 (ddd, JCF = 18, 5.6, 4.2 Hz), 121.1, 118.8 (ddd, JCF = 19, 5.7, 1.3 Hz), 105.3 (ddd, JCF = 29, 21, 
0.8 Hz), 37.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3059, 1737, 1631, 1619, 1598, 1565, 1516, 1504, 1422, 1365, 
1333, 1311, 1228, 1208, 1149, 1114, 1095, 1016, 954, 935, 876, 840, 819, 795, 765, 746, 738, 709, 682, 
660. 
MS (70 eV, EI): m/z (%): 273 [M+] (85), 254 (100), 233 (3), 128 (4), 101 (3), 44 (3). 
HRMS for C16H10F3N (273.0765): 273.0755 (M+). 
 
Synthesis of 2-(pyridin-2-ylmethyl)quinoline (36m): 
 
TMPZnCl·LiCl (20, 1.30 M in THF, 1.50 mL, 1.95 mmol) was added to a solution of 2-methylquinoline 
(35b, 186 mg, 1.30 mmol, 1.00 equiv.) in THF (2 mL) at 25 °C and the reaction mixture was then stirred 
at this temperature for 1 h according to TP1. Pd(OAc)2 (5 mg, 2 mol%), XantPhos (12 mg, 2 mol%) and 
2-bromopyridine (32r, 158 mg, 1.00 mmol, 0.80 equiv.) were added to the reaction mixture. The 
resulting mixture was stirred for 1 h at 50 °C. The reaction mixture was then quenched with a mixture 
of saturated aqueous NH4Cl and NH3 (10:1, 2 mL), extracted with ethyl acetate (3 x 5 mL) and dried 
over anhydrous MgSO4. After filtration, the solvent was evaporated under reduced pressure. Purification 
by flash-chromatography (i-hexane/EtOAc = 1:1) furnished 2-(pyridin-2-ylmethyl)quinoline (36m, 
150 mg, 68%) as a pale yellow oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.57 (ddd, J = 4.9, 1.8, 0.9 Hz, 1H), 8.03 – 8.13 (m, 2H), 7.77 
(dd, J = 8.0, 1.3 Hz, 1H), 7.65 – 7.73 (m, 1H), 7.59 (td, J = 7.7, 1.9 Hz, 1H), 7.45 – 7.53 (m, 1H), 7.40 
(d, J = 8.4 Hz, 1H), 7.27 – 7.34 (m, 1H), 7.13 (ddd, J = 7.5, 4.9, 1.2 Hz, 1H), 4.55 (s, 2H).  
13C-NMR (75 MHz, CDCl3):  / ppm = 159.7, 159.1, 149.3, 147.8, 136.6, 136.6, 129.5, 128.9, 127.5, 
126.9, 126.1, 123.7, 121.8, 121.6, 48.0. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3053, 3010, 1681, 1618, 1596, 1586, 1568, 1502, 1466, 1426, 
1397, 1382, 1324, 1306, 1283, 1243, 1214, 1194, 1148, 1123, 1118, 1081, 1050, 1016, 995, 972, 952, 
928, 853, 821, 785, 755, 718, 704, 700, 686. 
MS (70 eV, EI): m/z (%): 220 [M+] (36), 219 (100), 218 (11), 207 (3), 192 (5), 76 (2), 44 (24). 
HRMS for C15H12N2 (220.1000): 220.0940 (M+). 
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3. METALATING N-HETEROCYCLES USING THE FRUSTRATED LEWIS PAIR 
TMPMGCL·BF3 FOLLOWED BY ADDITION TO AROMATIC ALDEHYDES AND 
ACTIVATED KETONES 
3.1. Typical Procedure 
Typical Procedure for the metalation with “TMPMgCl·BF3·LiCl”(21) (TP2): 
A dry and argon flushed 20 mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
TMPMgCl·LiCl (1.95 mL, 2.2 mmol, 1.13 m in THF) and cooled to the indicated temperature. BF3·OEt2 
(312 mg, 2.2 mmol) was added dropwise and the resulting mixture was stirred for 10 min before the 
corresponding N-heteroarene (2.0 mmol) dissolved in dry THF (10 mL) was added. The reaction mixture 
was stirred at the given temperature for the indicated time. Complete metalation was monitored by GC-
analysis of reaction aliquots, quenched with iodine in dry THF using decane as internal standard. 
 
3.2. Addition to Aromatic Aldehydes and Activated Ketones 
Synthesis of 4-[hydroxy(pyridin-2-yl)methyl]benzonitrile (42a): 
 
According to TP2, pyridine (40a, 158 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40 °C for 15 min. 4-Cyanobenzaldehyde 
(43a, 1.6 mmol, 288 mg) was added and the mixture was slowly warmed to 25 °C. The reaction mixture 
was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with 
EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents 
were evaporated in vacuo. Purification by flash column chromatography (silica gel, pentane / EtOAc = 
3:2) furnished 42a as pale yellow oil (246 mg, 73%). 
1H-NMR (400 MHz, CDCl3): δ / ppm: 8.58 (d, J = 6.0 Hz, 1H), 7.62 ‒ 7.70 (m, 3H), 7.52 (d, J = 8.0 Hz, 
2H), 7.20 ‒ 7.26 (m, 1H), 7.18 (d, J = 6.0 Hz, 1H) 5.81 (s, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm: 159.4, 148.3, 148.0, 137.0, 132.2, 127.4, 122.8, 121.0, 118.5, 
111.4, 74.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3192, 3062, 2872, 2228, 1738, 1724, 1668, 1608, 1592, 1572, 
1502, 1472, 1436, 1406, 1312, 1196, 1114, 1056, 870, 810, 780, 750, 616. 
MS (70 eV, EI): m/z (%) = 210 [M+] (100), 192 (15), 130 (17), 108 (42), 102 (18), 80 (18), 79 (91), 51 
(20). 
HRMS (EI) for C13H10N2O (210.0793): 210.0791 (M+). 
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Synthesis of (4-chlorophenyl)(pyridin-2-yl)methanol (42b): 
 
According to TP2, pyridine (40a, 158 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40 °C for 15 min. 4-Chlorobenzaldehyde 
(43b, 1.6 mmol, 225 mg) was added and the solution was slowly warmed to 25 °C. The reaction mixture 
was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with 
EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents 
were evaporated in vacuo. Purification by flash column chromatography (silica gel, pentane / EtOAc = 
2:1) furnished 42b as pale yellow solid (239 mg, 68%). 
M. p. (°C): 96.3-97.5. 
1H-NMR (400 MHz, CDCl3): δ / ppm: 8.59 (d, J = 4.5 Hz, 1H), 7.73 (t, J = 7.7 Hz, 1H), 7.15 – 7.44 
(m, 6H), 5.95 (br, 1H), 5.84 (s, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm: 160.2, 146.8, 141.2, 138.2, 133.8, 128.8, 128.4, 122.9, 121.8, 
73.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3142, 2848, 1592, 1572, 1492, 1468, 1438, 1410, 1334, 1192, 
1114, 1090, 1056, 1018, 1002, 856, 812, 770, 748, 624. 
MS (70 eV, EI): m/z (%) =219 [M+] (100), 217 (41), 201 (47), 188 (46), 139 (40), 111 (25), 108 (40), 
79 (94). 
HRMS (EI) for C12H10ClNO (219.0451): 219.0444 (M+). 
 
Synthesis of (4-bromophenyl)(pyridin-2-yl)methanol (42c): 
 
According to TP2, pyridine (40a, 158 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40 °C for 15 min. 4-Bromobenzaldehyde 
(43c, 1.6 mmol, 296 mg) was added and the solution was slowly warmed to 25 °C. The reaction mixture 
was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with 
EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents 
were evaporated in vacuo. Purification by flash column chromatography (silica gel, pentane / EtOAc = 
2:1) furnished 42c as pale white solid (282 mg, 67%). 
M.p. (°C): 97.5-99.1. 
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1H-NMR (400 MHz, CDCl3):  / ppm = 8.56 (dt, J = 5.0, 1.6 Hz, 1H), 7.66 (td, J = 7.6, 1.6 Hz, 1H), 
7.42 – 7.50 (m, 2H), 7.19 ‒ 7.31 (m, 3H), 7.13 – 7.18 (m, 1H), 5.74 (s, 1H), 5.12 (br s, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 160.3, 147.6, 142.1, 137.2, 131.6, 128.7, 122.7, 121.8, 121.3, 
74.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = cm-1, 3136, 2919, 2896, 2848, 1738, 1591, 1570, 1489, 1469, 
1438, 1404, 1333, 1232, 1215, 1190, 1154, 1112, 1072, 1056, 1014, 1001, 946, 855, 846, 831, 808, 769, 
745, 714, 682.  
MS (EI, 70 eV): m/z (%) = 264 [M+H+] (16), 166 (6), 108 (31), 79 (100), 52 (10). 
HRMS (EI) for C12H11BrNO (264.0019): 263.9923 ([M+H]+). 
 
Synthesis of (3,4-dichlorophenyl)(pyridin-2-yl)methanol (42d): 
 
According to TP2, pyridine (40a, 158 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40 °C for 15 min. 3,4-
Dichlorobenzaldehyde (43d, 1.6 mmol, 280 mg) was added and the solution was slowly warmed to 
25 °C. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) 
followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 
and after filtration the solvents were evaporated in vacuo. Purification by flash column chromatography 
(silica gel, pentane / EtOAc = 1:1) furnished 42d as pale yellow oil (268 mg, 66%). 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.56 (dt, J = 4.7, 1.7 Hz, 1H), 7.66 (td, J = 7.7, 1.7 Hz, 1H), 
7.49 (d, J = 1.9 Hz, 1H), 7.40 (d, J = 8.3 Hz, 1H), 7.14 ‒ 7.26 (m, 3H), 5.70 (s, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 159.7, 148.0, 143.4, 137.1, 132.6, 131.7, 130.5, 128.9, 126.3, 
122.8, 121.2, 73.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3178, 1738, 1593, 1571, 1466, 1435, 1416, 1385, 1312, 1257, 
1230, 1216, 1190, 1148, 1129, 1099, 1045, 1029, 1002, 908, 895, 847, 811, 787, 748, 720, 706, 678. 
MS (EI, 70 eV): m/z (%) = 253 [M+] (33), 111 (12), 108 (38), 79 (100), 52 (11). 
HRMS (EI) for C12H9Cl2NO (253.0061): 253.0052 (M+). 
 
Synthesis of 2,2,2-trifluoro-1-phenyl-1-(pyridin-2-yl)ethanol (42e): 
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According to TP2, pyridine (40a, 158 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40 °C for 15 min. 2,2,2-Trifluoro-1-
phenylethanone (43e, 1.6 mmol, 279mg) was added and the solution was slowly warmed to 25 °C. The 
reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed 
by extraction with EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after 
filtration the solvents were evaporated in vacuo. Purification by flash column chromatography (silica 
gel, pentane / EtOAc = 3:1) furnished 42e as yellow oil (292 mg, 72%). 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.60 – 8.63 (m, 1H), 7.73 ‒ 7.79 (m, 1H), 7.64 – 7.69 (m, 2H), 
7.50 (dq, J = 8.0, 1.0 Hz 1H), 7.30 ‒ 7.40 (m, 4H), 6.02 (s, br, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 155.0, 147.2, 138.3, 137.4, 128.6, 128.4, 127.8 (q, JCF = 10 Hz) 
127.0 (q, JCF = 2.0 Hz), 125.0 (q, JCF = 286 Hz), 124.0, 122.9 (q, JCF = 2.0 Hz).  
IR (Diamond-ATR, neat): ~  / cm-1 =: 3286, 2928, 2856, 2362, 1734, 1718, 1594, 1576, 1498, 1468, 
1450, 1436, 1406, 1262, 1196, 1150, 1120, 1096, 1072, 1050, 1036, 1002, 966, 948, 932, 912, 780, 760, 
750, 736, 698, 684, 656, 628. 
MS (EI, 70 eV): m/z (%) = 253 [M+] (2), 111 (14), 97 (32), 85 (52), 83 (31), 71 (68), 69 (35), 57 (100), 
41 (25). 
HRMS (EI) for C13H10F3NO (253.0714): 253.0722 (M+). 
 
Synthesis of (4-bromophenyl)(quinolin-2-yl)methanol (42f): 
 
According to TP2, quinoline (40b, 302 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at -°C for 40 min. 4-Bromobenzaldehyde 
(43c, 1.6 mmol, 296 mg) was added and the reaction mixture was slowly warmed to -20 °C. The reaction 
mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by 
extraction with EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after 
filtration the solvents were evaporated in vacuo. Purification by flash column chromatography (silica 
gel, pentane / EtOAc = 5:1) furnished 42f as white solid (325 mg, 65%). 
M.p. (°C): 118.9-120.0. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.14 (d, J = 9.6 Hz, 1H), 8.08 (d, J 0 8.5 Hz, 1H), 7.74 – 7.84 
(m, 2H), 7.55 ‒ 7.60 (m, 1H), 7.45 – 7.50 (m, 2H), 7.27 ‒ 7.33 (m, 2H), 7.16 (d, J = 8.5 Hz, 1H), 5.84 
(s, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 159.8, 145.9, 141.8, 137.2, 131.7, 130.1, 129.1, 128.7, 127.6, 
127.5, 126.8, 122.0, 119.0, 74.5. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 2360, 2334, 1738, 1729, 1665, 1585, 1565, 1502, 1480, 1459, 
1427, 1392, 1316, 1293, 1274, 1248, 1230, 1209, 1179, 1165, 1109, 1067, 1045, 1008, 967, 958, 923, 
858, 846, 830, 794, 770, 741, 720, 693. 
MS (EI, 70 eV): m/z (%) = 313 [M+] (100), 298 (11), 217 (14), 158 (48), 129 (93), 77 (11). 
HRMS (EI) for C16H12BrNO (313.0102): 313.0089 (M+). 
 
Synthesis of 1-(4-bromophenyl)-2,2,2-trifluoro-1-(quinolin-2-yl)ethanol (42g): 
 
According to TP2, quinoline (40b, 302 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) and 
TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at -°C for 40 min. 1-(4-Bromophenyl)-
2,2,2-trifluoroethanone (43f, 1.6 mmol, 405 mg) was added and the reaction mixture was slowly warmed 
to 0 °C and stirred for 19 h at this temperature. The reaction mixture was quenched with sat. aq. NH4Cl 
solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined 
organic layers were dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. 
Purification by flash column chromatography (silica gel, pentane / EtOAc = 10:1) furnished 42g as 
colorless viscous oil (325 mg, 65%). 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.23 (d, J = 8.9 Hz, 1H), 8.17 (d, J = 8.6 Hz, 1H), 7.88 (d, J = 
8.3 Hz, 1H), 7.79 – 7.86 (m, 1H), 7.48 ‒ 7.68 (m, 6H).  
13C-NMR (100 MHz, CDCl3):  / ppm = 154.0 (q, JCF = 0.8 Hz), 145.2, 138.0, 137.1, 131.6, 130.6, 
128.8 (q, JCF = 2.0 Hz), 128.8, 127.9, 127.8, 127.5, 124.8 (q, JCF = 286 Hz), 123.0, 119.4 (q, JCF = 
2.6 Hz), 77.7 (q, JCF = 29 Hz). 
IR (Diamond-ATR, neat): ~  / cm-1 = 3264, 3065, 2353, 2323, 2155, 1738, 1620, 1596, 1573, 1504, 
1489, 1470, 1454, 1398, 1380, 1306, 1278, 1259, 1218, 1191, 1158, 1153, 1124, 1084, 1010, 989, 941, 
932, 870, 823, 809, 787, 776, 754, 736, 712, 665. 
MS (EI, 70 eV): m/z (%) = 381 [M+] (16), 314 (35), 256 (10), 226 (21), 204 (12), 128 (100). 
HRMS (EI) for C17H11BrF3NO (380.9976): 380.9973 (M+). 
 
Synthesis of (4-chlorophenyl)(3-(methylthio)pyrazin-2-yl)methanol (45a): 
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According to TP2, 2-(methylthio)pyrazine (44a, 252 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40°C for 10 min. 4-
Chlorobenzaldehyde (43b, 1.6 mmol, 225 mg) was added and the reaction mixture was stirred for 1 h at 
the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 
(conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried 
over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 5:1) furnished 45a as yellow solid (268 mg, 63%). 
M.p. (°C): 123.6-124.7. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.36 (s, 2H), 7.33 (s, 4H), 5.78 (s, 1H), 2.55 (s, 3H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 156.4, 150.8, 141.9, 141.4, 140.6, 133.9, 128.9, 128.1, 73.1, 
12.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3292, 2357, 2333, 1738, 1730, 1591, 1502, 1488, 1466, 1454, 
1411, 1378, 1371, 1366, 1334, 1324, 1284, 1276, 1268, 1233, 1217, 1195, 1112, 1092, 1070, 1029, 
1016, 960, 928, 901, 872, 842, 823, 771, 732, 702, 690. 
MS (EI, 70 eV): m/z (%) = 266 [M+] (100), 250 (32), 139 (37), 127 (73), 111 (23), 77 (27), 43 (36). 
HRMS (EI) for C12H11ClN2OS (266.0281): 266.0276 (M+). 
 
Synthesis of (4-bromophenyl)(3-(methylthio)pyrazin-2-yl)methanol (45b): 
 
According to TP2, 2-(methylthio)pyrazine (44a, 252 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40°C for 10 min. 4-
Bromobenzaldehyde (43c, 1.6 mmol, 296 mg) was added and the reaction mixture was stirred for 1 h at 
the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 
(conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried 
over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 5:1) furnished 45b as yellow solid (329 mg, 66%). 
M.p. (°C): 129.8-131.4. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.37 (d, J = 1.7 Hz, 1H), 8.34 (d, J = 1.7 Hz, 1H), 7.45 – 7.50 
(m, 2H), 7.24 ‒ 7.29 (m, 2H), 5.77 (s, 1H), 2.55 (s, 3H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 156.5, 150.7, 141.9, 141.4, 141.1, 131.8, 128.4, 122.1, 73.2, 
12.7. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3288, 2931, 2872, 2360, 1738, 1589, 1574, 1503, 1483, 1464, 
1406, 1333, 1293, 1282, 1265, 1234, 1192, 1112, 1072, 1065, 1028, 1011, 961, 928, 900, 871, 840, 818, 
769, 731, 725, 699, 668. 
MS (EI, 70 eV): m/z (%) = 228 [M+H+] (3), 127 (20), 77 (9), 61 (16), 45 (13), 43 (100). 
HRMS (EI) for C12H12BrN2OS (310.9848): 310.9771 ([M+H]+). 
 
Synthesis of (4-methoxyphenyl)(3-(methylthio)pyrazin-2-yl)methanol (45c): 
 
According to TP2, 2-(methylthio)pyrazine (44a, 252 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 40°C for 10 min. 4-
Methoxybenzaldehyde (43g, 1.6 mmol, 218 mg) was added and the reaction mixture was stirred for 1 h 
at the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and 
NH3 (conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were 
dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash 
column chromatography (silica gel, pentane / EtOAc = 5:1) furnished 45c as yellow solid (282 mg, 
67%). 
M.p. (°C): 65.7-67.8. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.34 (s, 2H), 7.22 – 7.31 (m, 2H), 6.82 ‒ 6.29 (m, 2H), 5.74 
(s, 1H), 3.76 (s, 3H), 3.66 (br, s, 1H), 2.53 (s, 3H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 159.4, 155.8, 151.6, 142.0, 141.2, 134.3, 128.1, 114.1, 73.4, 
55.2, 12.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3266, 3017, 2928, 1738, 1607, 1586, 1508, 1461, 1440, 1428, 
1366, 1352, 1337, 1305, 1286, 1242, 1228, 1205, 1181, 1133, 1116, 1057, 1025, 970, 960, 932, 895, 
871, 838, 828, 787, 755, 738, 709, 666. 
MS (EI, 70 eV): m/z (%) = 262 [M+] (68), 154 (17), 137 (100), 135 (72), 121 (29), 77 (26). 
HRMS (EI) for C13H14N2O2S (262.0776): 262.0770 (M+). 
 
Synthesis of (4-bromophenyl)(5-(dimethyl(phenyl)silyl)pyrazin-2-yl)methanol (45d): 
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According to TP2, 2-(dimethyl(phenyl)silyl)pyrazine (44b, 107 mg, 0.5 mmol) reacted with BF3·OEt2 
(78 mg, 0.55 mmol) and TMPMgCl·LiCl (14, 0.49 mL, 0.55 mmol, 1.13 M in THF) at 40°C for 15 min. 
4-Bromobenzaldehyde (43c, 0.6 mmol, 111 mg) was added and the reaction mixture was stirred for 5 h 
at the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and 
NH3 (conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were 
dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash 
column chromatography (silica gel, pentane / EtOAc = 9:1) furnished 45d as yellow oil (133 mg, 67%). 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.72 (d, J = 1.7 Hz, 1H), 8.53 (d, J = 1.7 Hz, 1H), 7.56 – 7.68 
(m, 2H), 7.46 ‒ 7.51 (m, 2H), 7.34 – 7.45 (m, 3H), 7.26 ‒ 7.31 (m, 2H), 5.79 (s, 1H), 0.65 (s, 6H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 154.7, 147.2, 146.0, 144.1, 140.9, 135.6, 134.1, 131.9, 129.8, 
128.5, 128.1, 122.2, 73.2, -3.5. 
IR (Diamond-ATR, neat): ~  / cm-1 = cm-1, 3067, 3047, 2958, 2854, 1665, 1585, 1564, 1500, 1486, 
1462, 1428, 1397, 1316, 1277, 1247, 1220, 1190, 1175, 1154, 1111, 1068, 1034, 1011, 998, 930, 920, 
869, 834, 807, 786, 775, 756, 749, 737, 699, 680, 667, 655. 
MS (EI, 70 eV): m/z (%) = 398 [M+] (71), 397 (100), 385(24), 383 (28), 381 (28), 213 (21), 182 (32), 
145 (19), 137 (23), 135 (63), 61 (18), 43 (81). 
HRMS (EI) for C19H18BrN2OS (397.0377): 397.0369 ([M-H]+). 
 
Synthesis of 1-(4-bromophenyl)furo[3,4-c]pyridin-3(1H)-one (48a): 
 
According to TP2, ethyl nicotinate (46a, 302 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) 
and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at -°C for 30 min. 4-
Bromobenzaldehyde (43c, 1.6 mmol, 296 mg) was added and the reaction mixture was slowly warmed 
to 25 °C. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) 
(1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried over 
Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 1:1) furnished 48a as white solid (416 mg, 72%).  
M.p. (°C): 155.5-157.3. 
1H-NMR (400 MHz, CDCl3):  / ppm = 9.24 (s, 1H), 8.86 (d, J = 5.3 Hz, 1H), 7.50 – 7.58 (m, 2H), 
7.34 (d, J = 5.3 Hz, 1H), 7.11 ‒ 7.19 (m, 2H), 6.39 (s, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 168.1, 157.3, 153.6, 148.1, 133.7, 132.5, 128.4, 124.1, 121.8, 
117.8, 81.5.  
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IR (Diamond-ATR, neat): ~  / cm-1 = 1758, 1606, 1590, 1487, 1421, 1410, 1334, 1301, 1241, 1212, 
1201, 1149, 1110, 1068, 1028, 1014, 984, 957, 944, 904, 862, 833, 824, 794, 762, 728, 695, 664. 
MS (EI, 70 eV): m/z (%) = 289 [M+] (90), 210 (43), 183 (34), 166 (100), 139 (26), 133 (21), 105 (51). 
HRMS (EI) for C13H8BrNO2 (288.9738): 288.9732 (M+). 
 
Synthesis of 1-phenylfuro[3,4-c]pyridin-3(1H)-one (48b): 
 
According to TP2, ethyl nicotinate (46a, 302 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) 
and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at -°C for 30 min. Benzaldehyde (43h, 
1.6 mmol, 212 mg) was added and the reaction mixture was slowly warmed to 25 °C. The reaction 
mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by 
extraction with EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 and after 
filtration the solvents were evaporated in vacuo. The crude product was recrystallized from a mixture of 
EtOAc/EtOH to give 48b as white solid (165 mg, 62%).  
1H-NMR (400 MHz, CDCl3):  / ppm = 9.15 (d, J = 1.2 Hz, 1H), 8.75 (d, J = 6.2 Hz, 1H), 7.32 (dd, J 
= 1.4, 6.1 Hz, 1H), 7.25 – 7.48 (m, 5H), 6.61 (s, 1H) 
The analytical data was found to match the literature.
120
 
 
Synthesis of 1-phenyl-1-(trifluoromethyl)furo[3,4-c]pyridin-3(1H)-one (48c): 
 
According to TP2, ethyl nicotinate (46a, 302 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 2.2 mmol) 
and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at -°C for 30 min. 2,2,2-Trifluoro-1-
phenylethan-1-one (43e, 1.6 mmol, 296 mg) was added and the reaction mixture was slowly warmed to 
25 °C. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) 
followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried over Na2SO4 
and after filtration the solvents were evaporated in vacuo. Purification by flash column chromatography 
(silica gel, pentane / EtOAc = 5:1) furnished 48c as slightly yellow solid (295 mg, 65%).  
                                                     
120 S. Broussy, V. Bernardes-Génisson, H. Gornitzka, J. Bernadou, B. Meuniera Org. Biomol. Chem. 2005, 3, 666. 
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M.p. (°C): 92.8-94.4. 
1H-NMR (400 MHz, CDCl3):  / ppm = 9.26 (s, 1H), 9.02 (d, J = 5.2 Hz, 1H), 7.88 (d, J = 5.2 Hz, 1H), 
7.65 – 7.80 (m, 2H), 7.37 ‒ 7.53 (m, 3H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 166.0, 154.4, 148.9, 137.4, 130.8, 130.4, 126.3 (q, JCF = 
1.5 Hz), 123.4, 122.6 (q, JCF = 284 Hz), 121.7, 118.7, 85.5 (q, JCF = 33 Hz). 
IR (Diamond-ATR, neat): ~  / cm-1 = 3043, 2984, 2360, 1795, 1754, 1722, 1604, 1592, 1493, 1451, 
1427, 1368, 1313, 1282, 1257, 1228, 1188, 1166, 1150, 1113, 1093, 1070, 1042, 1023, 1000, 965, 946, 
916, 847, 835, 822, 784, 762, 746, 720, 710, 695, 672, 655. 
MS (EI, 70 eV): m/z (%) = 279 [M+] (21), 211 (50), 210 (100), 127 (29), 105 (25), 77 (39), 51 (18), 42 
27). 
HRMS (EI) for C14H8F3NO2 (279.0507): 279.0497 (M+). 
 
Synthesis of (4-bromophenyl)(3-fluoropyridin-4-yl)methanol (48d): 
 
According to TP2, 3-fluoropyridine (46b, 194 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 78 °C for 10 min. 4-
Bromobenzaldehyde (43c, 1.6 mmol, 296 mg) was added and the reaction mixture was stirred for 45 min 
at the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and 
NH3 (conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were 
dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash 
column chromatography (silica gel, pentane / EtOAc = 3:2) furnished 48d as white solid (364 mg, 81%). 
M.p. (°C): 161.6-163.2. 
1H-NMR (400 MHz,THF-d8):  / ppm = 8.36 (d, J = 4.9 Hz, 1H), 8.32 (s, 1H), 7.59 (t, J = 4.9 Hz, 1H), 
7.48 – 7.82 (m, 2H), 7.30 ‒ 7.36 (m, 2H), 6.00 (d, J = 2.6 Hz, 1H), 5.50 (d, J = 3.5 Hz, 1H). 
13C-NMR (100 MHz, THF-d8):  / ppm = 157.7 (d, JCF = 254 Hz), 147.2 (d, JCF = 5 Hz), 143.6 (d, JCF 
= 0.8 Hz), 141.2 (d, JCF = 11 Hz), 138.5 (d, JCF = 23 Hz), 132.4, 129.4 122.4, 122.3, 68.6 (d, JCF = 2 Hz). 
IR (Diamond-ATR, neat): ~  / cm-1 = 3124, 2854, 2682, 2351, 2199, 1973, 1754, 1738, 1729, 1715, 
1612, 1588, 1494, 1482, 1470, 1462, 1453, 1446, 1434, 1413, 1401, 1378, 1372, 1332, 1313, 1275, 
1240, 1227, 1194, 1184, 1166, 1151, 1103, 1069, 1052, 1010, 960, 909, 875, 840, 825, 795, 754, 738, 
714, 676.  
MS (EI, 70 eV): m/z 281 (M+, 68%), 202 (100), 187 (25), 157 (18), 124 (71), 97 (20), 77 (22). 
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HRMS (EI) for C12H9BrFNO (280.9852): 280.9842 (M+). 
 
Synthesis of (4-chlorophenyl)(3-chloropyridin-4-yl)methanol (48e): 
 
According to TP2, 3-chloropyridine (46c, 227 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 78 °C for 45 min. 4-
Chlorobenzaldehyde (43b, 1.6 mmol, 225 mg) was added and the reaction mixture was stirred for 1 h at 
the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 
(conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried 
over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 3:2) furnished 48e as white solid (293 mg, 71%). 
M.p. (°C): 139.9-140.7. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.46 (d, J = 5.0 Hz, 1H), 8.43 (s, 1H), 7.66 (d, J = 5.0 Hz, 1H), 
7.31 (s, 4H), 6.09 (s, 1H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 149.5, 149.2, 148.0, 139.2, 134.3, 130.0, 128.9, 128.5, 121.9, 
71.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3116, 2846, 2359, 1908, 1590, 1488, 1475, 1434, 1403, 1331, 
1314, 1288, 1269, 1216, 1180, 1165, 1104, 1092, 1064, 1041, 1013, 982, 960, 868, 856, 836, 825, 808, 
750, 732, 714, 692.  
MS (EI, 70 eV): m/z (%) = 253 [M+] (100), 218 (85), 139 (84), 111 (37), 77 (47). 
HRMS (EI) for C12H9Cl2NO (253.0061): 253.0060 (M+). 
 
Synthesis of (4-bromophenyl)(3-chloropyridin-4-yl)methanol (48f): 
 
According to TP2, 3-chloropyridine (46c, 227 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 78 °C for 45 min. 4-
Bromobenzaldehyde (43c, 1.6 mmol, 225 mg) was added and the reaction mixture was stirred for 3 h at 
the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL) and NH3 
(conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried 
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over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 1:1) furnished 48f as white solid (339 mg, 71%). 
M.p. (°C): 148.9-151.2 
1H-NMR (400 MHz, THF-d8):  / ppm = 8.39 – 8.53 (m, 2H), 7.68 (d, J = 5.0 Hz, 1H), 7.41 – 7.49 (m, 
2H), 7.23 – 7.37 (m, 2H), 6.00 (d, J = 3.4 Hz, 1H), 5.54 (d, J = 3.8 Hz, 1H). 
13C-NMR (100 MHz, THF-d8):  / ppm = 151.5, 150.2, 149.3, 142.9, 132.4, 130.0, 123.1, 122.3, 108.5, 
71.5. 
IR (Diamond-ATR, neat): ~  / cm-1 =cm-1, 3112, 3027, 2970, 2845, 2360, 2337, 1739, 1729, 1588, 
1574, 1485, 1470, 1462, 1445, 1434, 1415, 1400, 1366, 1332, 1313, 1286, 1267, 1228, 1217, 1210, 
1180, 1166, 1104, 1094, 1064, 1041, 1009, 982, 959, 867, 855, 836, 823, 804, 746, 730, 711, 676.  
MS (EI, 70 eV): m/z (%) = 297 [M+] (57), 218 (100), 187 (46), 183 (15), 159 (17), 157 (20), 140 (74), 
115 (16), 77 (28), 61 (19), 43 (68). 
HRMS (EI) for C12H9BrClNO (296.9556): 296.9544 (M+). 
 
Synthesis of 4-((3,4-dichlorophenyl)(hydroxy)methyl)-N,N-diethylnicotinamide (48g): 
 
According to TP2, N,N-diethylnicotinamide (46d, 366 mg, 2.0 mmol) reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPMgCl·LiCl (14, 1.95 mL, 2.2 mmol, 1.13 M in THF) at 78 °C for 10 min. 3,4-
Dichlorobenzaldehyde (43d, 280 mg, 1.6 mmol) was added and the reaction mixture was stirred for 1 h 
at the same temperature. The reaction mixture was quenched with sat. aq. NH4Cl solution (9 mL), NH3 
(conc.) (1 mL) followed by extraction with EtOAc (3x30 mL). The combined organic layers were dried 
over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash column 
chromatography (silica gel, pentane / EtOAc = 1:5) furnished 48g as white solid (360 mg, 80%). 
M.p. (°C): 108.8-110.0. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.64 (d, J = 5.0 Hz, 1H), 8.44 (s, 1H), 7.35 ‒ 7.48 (m, 3H), 
7.09 ‒ 7.16 (m, 1H), 5.75 (s, 1H), 3.24 ‒ 3.53 (m, 2H), 2.68 ‒ 3.01 (m, 2H), 0.37 ‒ 0.84 (m, 6H). 
13C-NMR (100 MHz, CDCl3):  / ppm = 168.8, 151.2, 150.1, 147.0, 142.0, 132.5, 131.7, 130.6, 130.2, 
128.7, 128.5, 126.0, 77.2, 43.3, 39.4, 13.7, 12.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3075, 3063, 2996, 2975, 2877, 2838, 1628, 1597, 1566, 1504, 
1462, 1437, 1408, 1396, 1375, 1364, 1348, 1339, 1318, 1308, 1295, 1274, 1244, 1227, 1215, 1200, 
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1183, 1151, 1126, 1103, 1082, 1066, 1057, 1029, 998, 981, 957, 944, 902, 882, 869, 849, 834, 808, 792, 
776, 748, 734, 701, 678.  
HRMS (ESI) for C17H19Cl2N2O2+ (353.0818): 353.0815 ([M+H]+). 
 
3.3. Synthesis and Spectra of the Intermediates 
Low temperature NMR-studies of the metalated intermediate 47a 
 
In order to provide structural information on the 4-metalated pyridines of type 47 we investigated the 
metalation of ethyl nicotinate (46a) with TMPMgCl·BF3 (21) at -40 °C (the metalation of the other 3-
substituted pyridines 46b-d could not be examined due to the low stability of the metalated 
intermediates). Therefore 0.55 mmol (0.49 mL, 1.13 M in THF) of TMPMgCl·LiCl (14) were put in a 
dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar. The solvent was 
removed in vacuo to give TMPMgCl·LiCl (14) as a light brown slurry. The base was redissolved in 
THF-d8 (ca. 0.5 mL) and reacted with BF3·OEt2 (0.55 mmol, 78 mg, see TP2). Ethyl nicotinate (46a, 
0.5 mmol, 75.6 mg), dissolved in 1.5 mL THF-d8, was slowly added at -40 °C and the reaction was 
stirred for 30 min. Then the Schlenk-tube was cooled down to -50 °C and ca. 0.7 mL of the reaction 
mixture were cannulated in a dry, argon flushed NMR-tube, which was cooled at -78 °C. Then several 
NMR studies were performed at -50 °C, including 1H-, 13C- 11B and 19F-NMR. The spectra showed in 
addition to the characteristic signals of the BF3-complex 47a also the signals of free TMPH and 
BF3·OEt2 in addition the BF3 complex 49.  
1H-NMR (400 MHz, THF-d8): δ / ppm: 8.68 (s, 2-H, 1H), 8.42 (d, J56 = 4.0 Hz, 6-H, 1H), 8.18 (d, J56 
4.0 Hz, 5-H, 1H), 4.43 (q, JCH2CH3 = 6.8 Hz, CH2, 2H), 1.46 (t, JCH2CH3 = 6.8 Hz, CH3, 3H). 
13C-NMR (100 MHz, THF-d8): δ / ppm: 223.0 (4-C), 173.6 (C=O), 137.2 (6-C), 137.0 (2-C), 136.6 (5-
C), 135.9 (3-C), 63.8 (CH2), 13.7 (CH3). 
11B-NMR (128 MHz, THF-d8): δ / ppm: -0.5. 
19F-NMR (376 MHz, THF-d8): δ / ppm: -151.64 (10B isotopomer), -151.71 (11B isotopomer). 
 
Synthesis and NMR-studies of (3-(ethoxycarbonyl)pyridin-1-ium-1-yl)trifluoroborate (49) 
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A dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
45 mg ethyl nicotinate (46a, 0.3 mmol) in 0.6 mL THF-d8 and cooled to 0 °C. BF3·OEt2 (47 mg, 
0.33 mmol) was added and the reaction mixture was stirred for 15 min at the same temperature. The 
complex 49 was then transferred in a dry, argon flushed NMR-tube which was cooled at -50 °C, and 
characterized with 1H-, 13C- 11B and 19F-NMR. The spectra showed in addition to the characteristic 
signals of the BF3-complex 49 also the signals of free BF3·OEt2. 
1H-NMR (400 MHz, THF-d8): δ / ppm: 9.14 (s, 2-H, 1H), 9.00 (d, J56 = 5.6 Hz, 6-H, 1H), 8.94 (dt, J45 
= 8.0 Hz, J46 1.6 Hz, 4-H, 1H), 8.12 (dd, J45 = 8.0 Hz, J56 = 5.6 Hz, 5-H, 1H), 4.44 (q, JCH2CH3 = 7.2 Hz, 
CH2, 2H), 1.43 (t, JCH2CH3 = 7.2 Hz, CH3, 3H).  
13C-NMR (100 MHz, THF-d8): δ / ppm: 162.4 (C=O), 146.8 (q, JCF 2.0 Hz, 6-C), 144.0 (4-C), 143.9 
(q, JCF 2.2 Hz, 2-C), 129.5 (3-C), 127.1 (5-C), 62.4 (CH2), 13.6 (CH3). 
11B-NMR (128 MHz, THF-d8): δ / ppm: -0.4. 
19F-NMR (376 MHz, THF-d8): δ / ppm: -151.15 (10B isotopomer), -151.22 (11B isotopomer). 
When complex 49 was treated with another equivalent of BF3·OEt2 (47 mg, 0.33 mmol) at 0 °C in THF-
d8, no shift change for the carbonyl group could be observed in the 13C-NMR indicating that the ester 
group coordinates to the excess Lewis acid. However, what can be observed is a coordination of the BF3 
to the THF-d8 resulting in a low field shift in the 13C-NMR from 66.7 to 69.4 ppm and 24.4 to 25.5 ppm, 
respectively (see Figure 5 and Figure 6).  
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Figure 5: 13C-NMR spectrum of complex 49 with another 1.1 equivalents of BF3·OEt2 in THF-d8 at -50 °C. 
 
 
Figure 6: Expansion of the THF-d8 signals of Figure 5. 
 
The same effect can be observed, when ethyl benzoate (52, 45 mg, 0.3 mmol) is treated with 
1.1 equivalents of BF3·OEt2 (47 mg, 0.33 mmol) in THF-d8 (0.6 mL) under the same conditions (Figure 
7 and Figure 8).  
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Figure 7: 13C-NMR spectrum of ethyl benzoate with 1.1 equivalents of BF3·OEt2 in THF-d8 at -50 °C.  
 
 
Figure 8: Expansion of the THF-d8 signals of Figure 7. 
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Synthesis and NMR-studies of trifluoro(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)borate (50) 
 
A dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
42 mg 2,2,6,6-tetramethylpiperidine (0.3 mmol) in 0.6 mL THF-d8 and cooled to 0 °C. BF3·OEt2 (47 mg, 
0.33 mmol) was added and the reaction mixture was stirred for 15 min at the same temperature. The 
solution of complex 50 was then transferred in a dry, argon flushed NMR-tube which was cooled 
at -50 °C, and characterized. The spectra showed in addition to the characteristic signals of the BF3-
complex 12 also the signals of free TMPH and BF3·OEt2. Due to superposition of those signals in the 
1H-NMR spectrum no clear assignment for the 1H-NMR signals was possible. 
13C-NMR (100 MHz, THF-d8): δ / ppm: 58.1 (2-C, 6-C), 40.6 (3-C, 5-C), 31.5 (q, JCF = 4.4 Hz, CH3), 
22.2 (q, JCF = 3.2 Hz, CH3), 16.5 (4-C). 
11B-NMR (128 MHz, THF-d8): δ / ppm: -0.5 (q, JBF = 20.8 Hz). 
19F-NMR (376 MHz, THF-d8): δ / ppm: -132.35 (d, JBF = 20.3 Hz, 10B isotopomer), -132.46 (d, JBF = 
20.3 Hz, 11B isotopomer).  
 
The experiments described above show clearly, that in the case of 47a the BF3 is bonded neither to 
TMPH nor to THF. It is also reasonable to conclude, that the BF3 does not coordinate to the ester group 
of the metalated ethyl nicotinate (47a). Unfortunately the 13C-NMR signals of the metalated species 47a 
are broad (Δ1/2 ca. 5 Hz) and do not show any evidence for a splitting due to coupling with fluorine. 
Thus we have no evidence for the coordination of BF3 to the pyridine nitrogen atom. 
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4. REGIOSELECTIVE METALATIONS OF PYRIMIDINES BY USING FRUSTRATED LEWIS 
PAIRS OF BF3·OET2 AND HINDERED MAGNESIUM AND ZINC AMIDE BASES 
4.1. Typical Procedures 
Typical Procedure for Metalations with TMP-Metal Bases (TP3): 
A dry argon flushed Schlenk-flask was charged with a solution of the N-heterocycle (1.0 equiv) in dry 
THF. After cooling to the given temperature, a THF-solution of the indicated metal TMP-amide base 
was added dropwise and the reaction mixture was stirred for the given time. Complete metalation was 
monitored by GC analysis of reaction aliquots, quenched with iodine in dry THF. 
Typical Procedure for BF3-directed Metalations (TP4): 
A dry argon flushed Schlenk-flask was charged with a solution of the N-heterocycle (1.0 equiv) in dry 
THF. After cooling to 0 °C, BF3·OEt2 (1.1 equiv.) was added dropwise and the mixture was stirred for 
15 min at this temperature. Then, the reaction mixture was cooled to the given temperature followed by 
dropwise addition of a THF-solution of the indicated metal TMP-amide base and stirred for the given 
time. Complete metalation was monitored by GC analysis of reaction aliquots, quenched with iodine in 
dry THF. 
 
4.2. Synthesisof Pyrimidines of Type 55 
Note: The starting materials 55b, 55c and 55f were prepared by Drs. Aleksei Bredihhin and Xavier 
Mollat du Jourdin. 
Synthesis of 4-butoxypyrimidine (55b): 
 
To a stirred solution of 4,6-dichloropyrimidine (1.56 g, 10.5 mmol) in n-butanol (20 mL) sodium 
butanolate (5.04 g, 10.5 mmol) was added at 25 °C. The reaction mixture was stirred at this temperature 
till completion. The reaction mixture was quenched with sat. aq. NH4Cl (20 mL) followed by extraction 
with EtOAc (3 × 40 mL). After drying (Na2SO4), the solvents were removed in vacuo. The crude product 
was redissolved in DCM (50 mL) and nondissolved solids were removed by filtration. Dichloromethane 
was evaporated in vacuo to give the crude 4-butoxy-6-chloropyrimidine (1.95 g, 10.5 mmol) which was 
used without further purification. To a stirred solution of crude 4-butoxy-6-chloropyrimidine (1.95 g, 
10.5 mmol) in MeOH (20 mL), Pd/C (400 mg, 10% active Pd, 0.38 mmol, 4 mol%) and NH4HCO2 
(2.65 g, 42.0 mmol) were added successively at 40 °C. The reaction mixture was stirred at 40 °C for 1 h 
and then filtered over celite. The celite was washed with MeOH and the filtrate concentrated in vacuo. 
The crude product was redissolved in DCM (50 mL) and nondissolved solids were removed by filtration. 
Dichloromethane was evaporated in vacuo to give without further purification the desired 4-
butoxypyrimidine (55b, 1.43 g, 89%) as a colorless oil. 
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1H-NMR (300 MHz, CDCl3): δ / ppm = 8.75 (s, 1H), 8.40 (d, J = 5.89 Hz, 1H), 6.71 (dt, J = 5.88, 
0.59 Hz, 1H), 4.36 (t, J = 6.66 Hz, 2H), 1.68 – 1.81 (m, 2H), 1.38 – 1.53 (m, 2H), 0.96 (t, J = 7.36 Hz, 
3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 169.2, 158.2, 156.5, 108.7, 66.4, 30.7, 19.1, 13.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3049, 2960, 2935, 2874, 1715, 1579, 1559, 1532, 1480, 1463, 
1399, 1376, 1301, 1266, 1225, 1168, 1119, 1062, 1002, 986, 962, 895, 833, 808, 774, 739, 672. 
MS (EI, 70 eV): m/z (%) = 152 [M]+ (1), 123 (16), 98 (6), 97 (100), 96 (24), 80 (15), 79 (15), 68 (7). 
HRMS for C8H12N2O (152.0950): 152.0980 (M+). 
 
Synthesis of 6-chloro-N,N-dimethylpyrimidin-4-amine (55c): 
 
To a stirred solution of 4,6-dichloropyrimidine (1.00 g, 6.70 mmol) in THF (7.0 mL) dimethylamine 
(1.51 g, 13.4 mmol) was added at 25 °C and stirred for 1 h. The reaction was quenched with brine 
(50 mL) followed by extraction with EtOAc (3 × 50 mL). After drying (Na2SO4), the solvents were 
removed in vacuo to give without further purification the desired 6-chloro-N,N-dimethylpyrimidin-4-
amine (55c, 1.01 g, 96%) as a white solid.  
M.p. (°C): 106-107. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.34 (s, 1H), 6.39 (s, 1H), 3.09 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 162.7, 159.4, 157.7, 100.9, 37.2. 
IR (Diamond-ATR, neat): ~  / cm-1= 3854, 3746, 3079, 2920, 2873, 2362, 2338, 1718, 1616, 1576, 
1560, 1541, 1522, 1506, 1498, 1458, 1431, 1417, 1396, 1343, 1298, 1262, 1217, 1200, 1183, 1106, 
1068, 987, 965, 857, 815, 760, 744, 738. 
MS (EI, 70 eV): m/z (%) = 157 [M]+ (26), 142 (34), 128 (38), 58 (28), 44 (100), 42 (22). 
HRMS for C6H8ClN3 (157.0407): 157.0402 (M+). 
 
Synthesis of 5-neopentylpyrimidine (55d): 
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To a stirred solution of neopentyllithium (26 mL, 12.5 mmol, 0.48 M in hexane) in a dry and argon 
flushed Schlenk-flask 12.5 mmol of ZnCl2 (1 M in THF) were added ad 25 °C. After stirring this mixture 
for 20 min at the same temperature Pd(OAc)2 (22.5 mg, 0.1 mmol), SPhos (82 mg, 0.2 mmol) and 5-
bromopyrimidine (1.59 g, 10 mmol) were added successively. After stirring for 2.5 h at 25 °C the 
reaction mixture was quenched with aq. NH4Cl-solution (50 mL) and extracted with Et2O (3 x 50 mL). 
The combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated 
in vacuo. Purification by flash column chromatography (silica gel, pentane / Et2O = 1:1) furnished 55d 
as off-white solid (1.28 g, 85%) 
M.p. (°C): 53.9-55.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.05 (s, 1H), 8.51 (s, 2H), 2.45 (s, 2H), 0.90 (s, 9H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 157.8, 156.5, 132.7, 44.4, 31.6, 28.9. 
IR (Diamond-ATR, neat): ~  / cm-1= 2957, 2950, 2937, 2918, 2866, 2851, 1582, 1560, 1476, 1438, 
1405, 1364, 1327, 1235, 1206, 1170, 1150, 1139, 1112, 1050, 1032, 988, 920, 900, 832, 806, 764, 744, 
730, 652. 
MS (EI, 70 eV): m/z (%) = 150 [M+] (5), 135 (10), 94 (100), 66 (5), 57 (44), 41 (16). 
HRMS for C9H14N2 (150.1157): 150.1150 (M+). 
 
Synthesis of 5-octylpyrimidine (55e): 
 
To a stirred solution of OctylMgBr (25.3 mL, 20 mmol, 0.89 M in THF) in a dry and argon flushed 
Schlenk-flask 20 mmol of ZnCl2 (1 M in THF) were added ad 0 °C. After stirring this mixture for 20 min 
at the same temperature Pd(OAc)2 (22.5 mg, 0.1 mmol), SPhos (82 mg, 0.2 mmol) and 5-
bromopyrimidine (2.54 g, 16 mmol) were added successively. The solution was slowly brought to 25 °C 
and after stirring for 2.5 h at this temperature the reaction mixture was quenched with aq. NH4Cl-solution 
(50 mL) and extracted with Et2O (3 x 50 mL). The combined organic layers were dried over Na2SO4 
and after filtration the solvents were evaporated in vacuo. Purification by flash column chromatography 
(silica gel, iso-hexane / Et2O = 1:1) furnished 55e as colorless oil (1.37 g, 71%) 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.04 (s, 1H), 8.55 (s, 2H), 2.67 – 2.49 (m, 2H), 1.71 – 1.51 (m, 
2H), 1.40 – 1.14 (m, 10H), 0.89 – 0.78 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 156.6, 156.4, 135.5, 31.7, 30.6, 30.4, 29.20, 29.1, 29.0, 22.6, 
14.0. 
IR (Diamond-ATR, neat): ~  / cm-1= 3045, 3020, 2955, 2925, 2855, 1582, 1559, 1465, 1436, 1409, 
1378, 1232, 1195, 1169, 1127, 1046, 903, 829, 797, 728. 
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MS (EI, 70 eV): m/z (%) = 192 [M+] (10), 135 (21), 121 (15), 107 (100), 94 (84), 66 (15), 57 (19), 43 
(23), 41 (24). 
HRMS for C12H20N2 (192.1626): 192.1628 (M+). 
 
Synthesis of 5-Phenylpyrimidine (55f): 
 
A solution of PhMgCl (17.0 mL, 30.0 mmol, 1.76 M in THF) was cooled at 0 °C. ZnCl2 (33 mmol, 
33 mL, 1.0 M in THF) was added and the mixture was stirred for 15 min at the same temperature. Then, 
a suspension of 5-bromopyrimidine (4.77 g, 30 mmol), Pd(dba)2 (517 mg, 0.90 mmol) and PPh3 
(944 mg, 3.6 mmol) in THF (10 mL) was added and the suspension was heated at 60 °C for 3 h. The 
reaction was quenched with brine (40 mL), NH3 (conc., 20 mL) and water (20 mL) followed by 
extraction with EtOAc (4 × 100 mL) and DCM (1 × 100 mL). After drying (MgSO4), removal of the 
solvents in vacuo and flash column chromatography (silica gel, iso-hexane / EtOAc / NEt3 = 2:1:0.15) 
the desired 5-phenylpyrimidine (55f, 4.27 g, 91%) was obtained as a colorless liquid. 
The analytical data were found to match the literature data.
121
 
 
4.3. Preparation of Pyrimidines of Type 56 
Synthesis of 5-iodo-4,6-dimethoxypyrimidine (56a): 
 
According to TP3, a mixture of 4,6-dimethoxypyrimidine (55a, 140 mg, 1.0 mmol) in dry THF (2.0 mL) 
reacted with TMPMgCl·LiCl (14, 0.96 mL, 1.1 mmol, 1.15 M in THF) for 40 min at 0 °C. Then, a 
solution of iodine (508 mg, 2.0 mmol) in THF (2.0 mL) was added at the same temperature. The reaction 
mixture was allowed to warm to 25 °C over 30 min, sat. aq. NaS2O3 (5 mL) was added and the aqueous 
layer was extracted with EtOAc (3 × 10 mL). The combined organic phases were dried (Na2SO4). 
Evaporation of the solvents in vacuo and purification by column chromatography (silica gel, iso-hexane 
/ DCM = 1:1) afforded the desired product 56a (225 mg, 85%) as a white solid. 
M. p. (°C): 155-156. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.26 (s, 1H), 4.03 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 169.4, 156.6, 62.1, 55.3. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3011, 2992, 2956, 2926, 2855, 1928, 1890, 1571, 1548, 1522, 
1466, 1443, 1407, 1382, 1299, 1283, 1259, 1207, 1175, 1108, 1036, 1023, 967, 893, 826, 776. 
MS (EI, 70 eV): m/z (%) = 267 [M-H]+ (100), 237 (14), 109 (12), 82 (20), 42 (17). 
HRMS (EI) for C6H7IN2O2 (265.9552): 265.9547 (M+). 
 
Synthesis of 2-(cyclohex-2-en-1-yl)-4,6-dimethoxypyrimidine (56b): 
 
According to TP4, 4,6-dimethoxypyrimidine (55a, 280 mg, 2.0 mmol) in dry THF (2.0 mL) reacted 
with BF3·OEt2 (312 mg, 0.27 mL, 2.2 mmol) and TMPZnCl·LiCl (20, 2.25 mL, 2.2 mmol, 0.98 M in 
THF) at -20 °C for 1 h. The reaction mixture was cooled to -40 °C and CuCN·2LiCl (1.1 mL, 1.1 mmol, 
1.0 M in THF) was added. After stirring for 15 min at this temperature, 3-bromocyclohexene (57a, 
580 mg, 0.42 mL, 3.6 mmol) was added dropwise and the reaction mixture was slowly warmed to 25 °C. 
The reaction was quenched with sat. aq. NH4Cl (9 mL) and NH3 (conc., 1 mL) followed by extraction 
with DCM (3 × 20 mL). After drying (MgSO4), removal of the solvents in vacuo and flash column 
chromatography (silica gel, iso-hexane / DCM = 10:1) the desired product 56b (407 mg, 92%) was 
obtained as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 5.90 ‒ 6.01 (m, 1H), 5.75 ‒ 5.90 (m, 2H), 3.92 (s, 6H), 3.43 ‒ 
3.59 (m, 1H), 2.02 ‒ 2.16 (m, 3H), 1.83 ‒ 2.01 (m, 2H), 1.58 ‒ 1.75 (m, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 172.5, 171.4, 128.3, 127.7, 86.4, 53.8, 44.3, 27.8, 24.9, 21.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3024, 2988, 2950, 2934, 2862, 2838, 1678, 1582, 1564, 1460, 
1390, 1372, 1296, 1280, 1258, 1242, 1214, 1186, 1158, 1094, 1054, 988, 958, 936, 864, 828, 798, 748, 
724, 660, 620. 
MS (EI, 70 eV): m/z (%) = 220 [M+] (50), 219 (20), 205 (40), 191 (100), 179 (23), 154 (18), 77 
(19), 68 (17). 
HRMS for C12H16N2O2 (220.1212): 220.1198 (M+). 
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Synthesis of 4,6-dimethoxy-2-(4-methoxyphenyl)pyrimidine (56c): 
 
According to TP4, 4,6-dimethoxypyrimidine (55a, 280 mg, 2.0 mmol) in dry THF (2.0 mL) reacted 
with BF3·OEt2 (312 mg, 0.27 mL, 2.2 mmol) and TMPZnCl·LiCl (20, 2.25 mL, 2.2 mmol, 0.98 M in 
THF) at -20 °C for 1 h. Pd(dba)2 (35 mg, 0.06 mmol, 3 mol%), TFP (28 mg, 0.12 mmol, 6 mol%) and 
1-iodo-4-methoxybenzene (57b, 468 mg, 2.0 mmol) were added successively and the reaction mixture 
was stirred at 25 °C for 15 h. The reaction was quenched with sat. aq. NH4Cl (9 mL) and NH3 (conc., 
1 mL) followed by extraction with DCM (3 × 20 mL). After drying (MgSO4), removal of the solvents 
in vacuo and flash column chromatography (silica gel, iso-hexane / DCM = 1:5) the desired product 56c 
(437 mg, 89%) was obtained as a yellow solid. 
M.p. (°C): 90-92. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.42 (d, J = 8.9 Hz, 2H), 6.98 (d, J = 9.0 Hz, 2H), 5.92 (s, 1H), 
4.04 (s, 6H), 3.88 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 171.4, 163.1, 161.8, 130.1, 129.9, 113.5, 87.0, 55.3, 53.7. 
IR (Diamond-ATR, neat): ~  / cm-1= 3024, 2998, 2952, 2938, 2842, 1592, 1564, 1554, 1512, 1492, 
1458, 1440, 1418, 1384, 1372, 1304, 1292, 1266, 1250, 1188, 1158, 1130, 1104, 1050, 1030, 988, 918, 
898, 842, 814, 790, 778, 732, 696, 678, 668, 634, 620. 
MS (EI, 70 eV): m/z (%) = 246 (100), 217 (14), 201 (14), 148 (25), 134 (62), 90 (10), 68 (27). 
HRMS for C13H15N2O3 (247.1077): 247.1075 ([M+H]+). 
 
Synthesis of 4-butoxy-2-iodopyrimidine (56d): 
 
According to TP4, 4-butoxypyrimidine (55b, 159 mg, 1.0 mmol) in dry THF (1.0 mL) reacted with 
BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 0.89 mL, 1.2 mmol, 1.35 M in THF) 
at -20 °C for 1 h. Then, a solution of iodine (508 mg, 2.0 mmol) in THF (2.0 mL) was added at the same 
temperature. The reaction mixture was allowed to warm to 25 °C over 30 min, sat. aq. NaS2O3 (5 mL) 
and NH3 (conc., 1 mL) were added and the aqueous layer was extracted with EtOAc (3 × 10 mL). After 
drying (Na2SO4), removal of the solvents in vacuo and flash column chromatography (silica gel, iso-
hexane / EtOAc = 9:1) the desired product 56d (239 mg, 86%) was obtained as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.10 (d, J = 5.80 Hz, 1H), 6.68 (d, J = 5.6 Hz, 1H), 4.36 (t, J 
= 6.6 Hz, 2H), 1.69 – 1.81 (m, 2H), 1.39 ‒ 1.54 (m, 2H), 0.98 (t, J = 7.3 Hz, 3H). 
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13C-NMR (75 MHz, CDCl3): δ / ppm = 168.3, 157.7, 127.5, 108.0, 67.4, 30.5, 19.0, 13.7.  
IR (Diamond-ATR, neat): ~  / cm-1 = 2958, 2932, 2872, 1562, 1531, 1465, 1437, 1382, 1312, 1267, 
1210, 1165, 1147, 1122, 1071, 1059, 1018, 1002, 976, 962, 912, 880, 868, 829, 771, 763, 739, 695. 
MS (EI, 70 eV): m/z (%) = 278 [M+] (3), 222 (100), 206 (7), 194 (6), 56 (5), 41 (12). 
HRMS (EI) for C8H11IN2O (277.9916): 277.9909 (M+). 
 
Synthesis of 4-butoxy-2-(3-(trifluoromethyl)phenyl)pyrimidine (56e): 
 
According to TP4, 4-butoxypyrimidine (55b, 159 mg, 1.0 mmol) in dry THF (1.0 mL) reacted with 
BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 0.89 mL, 1.2 mmol, 1.35 M in THF) 
at -20 °C for 1 h. Pd(dba)2 (17 mg, 0.03 mmol, 3 mol%), TFP (14 mg, 0.06 mmol, 6 mol%) and 1-iodo-
3-(trifluoromethyl)benzene (57c, 385 mg, 1.4 mmol) were added successively and the reaction mixture 
was slowly warmed to 25 °C. The reaction mixture was quenched with sat. aq. NH4Cl (9 mL) and NH3 
(conc., 1 mL) followed by extraction with DCM (3 × 20 mL). After drying (Na2SO4), removal of the 
solvents in vacuo and flash column chromatography (silica gel, iso-hexane / DCM = 4:1) the desired 
product 56e (190 mg, 66%) was obtained as colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.72 (s, 1H), 8.63 (d, J = 7.3 Hz, 1H), 8.52 (d, J = 5.7 Hz, 1H), 
7.73 (d, J = 7.8 Hz, 1H), 7.60 (t, J = 7.8 Hz, 1H), 6.66 (d, J = 5.7 Hz, 1H), 4.52 (t, J = 6.6 Hz, 2H), 1.77 
– 1.90 (m, 2H), 1.45 – 1.61 (m, 2H), 1.02 (t, J = 7.4 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 169.5, 162.8, 157.4, 138.4, 131.3 (q, J = 1 Hz), 130.9 (q, J = 
32 Hz), 128.9, 127.1 (q, J = 4 Hz), 125.0 (q, J = 4 Hz), 124.2 (q, J = 272 Hz), 107.0, 66.4, 30.8, 19.2, 
13.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2962, 2876, 1616, 1597, 1572, 1559, 1491, 1461, 1435, 1392, 
1324, 1294, 1272, 1256, 1225, 1164, 1122, 1113, 1091, 1069, 1019, 1001, 987, 973, 921, 832, 814, 802, 
785, 724, 709, 694, 668. 
MS (EI, 70 eV): m/z (%) = 296 [M+] (11), 267 (25), 253 (36), 240 (83), 223 (52), 212 (41), 172 (100), 
69 (90), 41 (19). 
HRMS for C15H15F3N2O (296.1136): 296.1129 (M+). 
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Synthesis of 6-chloro-2-(4-methoxyphenyl)-N,N-dimethylpyrimidin-4-amine (56f): 
Note: This example was performed by Dr. Xavier Mollat du Jourdin. 
 
According to TP4, 6-chloro-N,N-dimethylpyrimidin-4-amine (55c, 157 mg, 1.0 mmol) in dry THF 
(1.0 mL) reacted with BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 1.11 mL, 
1.5 mmol, 1.35 M in THF) at -20 °C for 1 h. Pd(dba)2 (17 mg, 0.03 mmol, 3 mol%), TFP (14 mg, 
0.06 mmol, 6 mol%) and 1-iodo-4-methoxybenzene (57b, 397 mg, 1.7 mmol) were added successively 
and the reaction mixture was slowly warmed to 25 °C. The reaction was quenched with sat. aq. NH4Cl 
(9 mL) and NH3 (conc., 1 mL) followed by extraction with DCM (3 × 20 mL). After drying (Na2SO4), 
removal of the solvents in vacuo and flash column chromatography (silica gel, iso-hexane / DCM = 
1:1→1:4) the desired product 56f was obtained as a pale brown solid (185 mg, 70%). 
M.p. (°C): 141-143. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.37 (d, J = 9.2 Hz, 2H), 6.95 (d, J = 9.0 Hz, 2H), 6.28 (s, 1H), 
3.87 (s, 3H), 3.17 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 163.4, 163.0, 161.8, 159.9, 130.0, 129.9, 113.5, 98.0, 55.3, 
37.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3010, 2961, 2932, 2833, 1716, 1607, 1588, 1572, 1512, 1492, 
1461, 1451, 1430, 1421, 1415, 1384, 1366, 1303, 1271, 1246, 1199, 1176, 1166, 1144, 1105, 1095, 
1066, 1030, 994, 968, 944, 850, 814, 800, 772, 728, 696, 672. 
MS (EI, 70 eV): m/z (%) = 263 [M+] (83), 248 (65), 234 (100), 219 (14), 185 (18), 134 (48), 115 
(13), 80 (14). 
HRMS for C13H15ClN3O (264.0898): 264.0896 ([M+H]+). 
 
Synthesis of ethyl 4-(4-chloro-6-(dimethylamino)pyrimidin-2-yl)benzoate (56g): 
 
According to TP4, 6-chloro-N,N-dimethylpyrimidin-4-amine (55c, 157 mg, 1.0 mmol) in dry THF 
(1.0 mL) reacted with BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 1.11 mL, 
1.5 mmol, 1.35 M in THF) at -20 °C for 1 h. Pd(dba)2 (17 mg, 0.03 mmol, 3 mol%), TFP (14 mg, 
0.06 mmol, 6 mol%) and ethyl 4-iodobenzoate (57d, 483 mg, 1.7 mmol) were added successively and 
C. Experimental Section 
 
 
122 
the reaction mixture stirred for 2.5 h, without additional cooling. The reaction mixture was quenched 
with sat. aq. NH4Cl solution (9 mL) and NH3 (conc., 1 mL) followed by extraction with DCM (3 × 
20 mL). After drying (Na2SO4), removal of the solvents in vacuo and flash column chromatography 
(silica gel, iso-hexane / DCM = 1:1→1:4) the desired product 56g (212 mg, 69%) was obtained as a pale 
brown solid. 
M.p. (°C): 102-103. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.46 (d, J = 8.8 Hz, 2H), 8.10 (d, J = 8.8 Hz, 2H), 6.36 (s, 1H), 
4.41 (q, J = 7.1 Hz, 2H), 3.19 (br s, 6H), 1.42 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 166.4, 163.0, 162.7, 160.1, 141.3, 132.1, 129.4, 128.2, 99.3, 
61.0, 37.3, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3521, 2981, 2942, 2931, 2909, 2870, 1716, 1681, 1610, 1585, 
1571, 1543, 1493, 1480, 1441, 1434, 1418, 1407, 1389, 1366, 1302, 1276, 1197, 1142, 1123, 1109, 
1101, 1074, 1023, 992, 968, 872, 835, 823, 802, 789, 751, 705, 694, 666.  
MS (EI, 70 eV): m/z (%) = 305 [M+] (76), 290 (45), 276 (100), 260 (24), 176 (21), 148 (25), 130 
(15), 102 (15), 80 (19). 
HRMS for C15H17ClN3O2 (306.1004): 306.1002 ([M+H]+). 
 
Synthesis of 6-chloro-2-(cyclohex-2-en-1-yl)-N,N-dimethylpyrimidin-4-amine (56h): 
 
According to TP4, 6-chloro-N,N-dimethylpyrimidin-4-amine (55c, 157 mg, 1.0 mmol) in dry THF 
(1.0 mL) reacted with BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 1.11 mL, 
1.5 mmol, 1.35 M in THF) at -20 °C for 1 h. The reaction mixture was cooled to -45 °C and CuCN·2LiCl 
(0.10 mL, 0.10 mmol, 1.0 M in THF) and 3-bromocyclohexene (57a, 274 mg, 1.7 mmol) were added 
successively. After stirring for 3 h at the same temperature the reaction mixture was quenched with sat. 
aq. NH4Cl (9 mL) and NH3 (conc., 1 mL) followed by extraction with DCM (3 × 20 mL). After drying 
(Na2SO4), removal of the solvents in vacuo and flash column chromatography (silica gel, iso-hexane / 
DCM = 1:4) the desired product 56h (169 mg, 71%) was obtained as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 6.24 (s, 1H), 5.87 – 5.98 (m, 1H), 5.76 – 5.86 (m, 1H), 3.44 – 
3.56 (m, 1H), 3.10 (s, 6H), 1.97 – 2.19 (m, 3H), 1.81 – 1.96 (m, 2H), 1.57 – 1.75 (m, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 172.8, 163.1, 159.7, 128.2, 127.8, 98.0, 44.6, 37.1, 28.2, 24.8, 
21.5. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3025, 2931, 2862, 1576, 1545, 1496, 1456, 1448, 1424, 1391, 
1340, 1297, 1218, 1194, 1157, 1129, 1062, 1049, 987, 971, 936, 920, 897, 825, 809, 786, 734, 723, 668. 
MS (EI, 70 eV): m/z (%) = 237 [M+] (79), 222 (45), 208 (100), 39 (171), 95 (32), 80 (22). 
HRMS for C12H17ClN3 (238.1106): 238.1104 ([M+H]+). 
 
Synthesis of 2-iodo-5-neopentylpyrimidine (56i) 
 
According to TP4, 5-neopentylpyrimidine (55d, 300 mg, 2.0 mmol) in dry THF (8.0 mL) reacted with 
BF3·OEt2 (312 mg, 0.27 mL, 2.2 mmol) and TMPZnCl·LiCl (20, 1.62 mL, 2.4 mmol, 1.48 M in THF) 
at 0 °C for 1 h. A solution of iodine (1.65 g, 6.5 mmol) in dry THF (5.0 mL) was dropwise added and 
the reaction mixture was stirred for 5 min at the same temperature. The reaction mixture was quenched 
with sat. aq. Na2S2O3 (18 mL) and NH3 (conc, 2 mL) followed by extraction with Et2O (3 × 20 mL). 
After drying (Na2SO4), removal of the solvents in vacuo and flash column chromatography (silica gel, 
iso-hexane / Et2O = 5:1) the desired product 56i (510 mg, 92%) was obtained as a white solid. 
M.p. (°C): 76.6-78.2 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.23 (s, 2H), 2.40 (s, 2H), 0.91 (s, 9H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 159.6, 132.0, 126.4, 43.8, 31.6, 28.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2958, 2910, 2866, 1564, 1532, 1474, 1444, 1379, 1363, 1320, 
1249, 1234, 1202, 1135, 1106, 1043, 951, 930, 903, 837, 808, 762, 740, 670. 
MS (EI, 70 eV): m/z (%) = 276 [M+] (29), 220 (100), 59 (10), 57 (83), 44 (11), 41 (23). 
HRMS (EI) for C9H13IN2 (276.0123): 276.0118 (M+). 
 
Synthesis of 2-iodo-5-octylpyrimidine (56j) 
 
According to TP4, 5-octylpyrimidine (55e, 192 mg, 1.0 mmol) in dry THF (4.0 mL) reacted with 
BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 0.86 mL, 1.2 mmol, 1.39 M in THF) 
at 0 °C for 30 min. A solution of iodine (508 g, 2.0 mmol) in dry THF (2.0 mL) was dropwise added 
and the reaction mixture was stirred for 5 min at the same temperature. The reaction mixture was 
quenched with sat. aq. Na2S2O3 (9 mL) and NH3 (conc, 1 mL) followed by extraction with Et2O (3 × 
10 mL). After drying (Na2SO4), removal of the solvents in vacuo and flash column chromatography 
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(silica gel, iso-hexane / Et2O = 10:1) the desired product 56j (261 mg, 86%) was obtained as a colorless 
oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.29 (s, 2H), 2.54 (d, J = 7.7 Hz, 2H), 1.54 – 1.68 (m, 2H), 
1.20 – 1.37 (m, 10H), 0.84 – 0.92 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 158.6, 135.0, 125.9, 31.7, 30.5, 29.7, 29.2, 29.1, 29.0, 22.6, 
14.0. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3017, 2954, 2923, 2854, 2493, 2411, 1568, 1534, 1464, 1380, 
1242, 1227, 1165, 1112, 1040, 928, 831, 799, 757, 722, 655. 
MS (EI, 70 eV): m/z (%) = 318 [M+] (6), 220 (35), 191 (100), 107 (10), 93 (18). 
HRMS (EI) for C12H19IN2 (318.0593): 318.0576. 
 
Synthesis of 2-iodo-5-phenylpyrimidine (56k): 
Note: This example was performed by Dr. Aleksei Bredihhin 
 
According to TP4, 5-phenylpyrimidine (55f, 781 mg, 5.0 mmol) in dry THF (5.0 mL) reacted with 
BF3·OEt2 (780 mg, 0.68 mL, 5.5 mmol) and TMPZnCl·LiCl (20, 4.60 mL, 5.5 mmol, 1.13 M in THF) 
at -20 °C for 1 h. A solution of iodine (1.65 g, 6.5 mmol) in dry THF (5.0 mL) was dropwise added and 
the reaction mixture was stirred for 5 min at the same temperature. The reaction mixture was quenched 
with sat. aq. Na2S2O3 (18 mL) and NH3 (conc, 2 mL) followed by extraction with DCM (3 × 100 mL). 
After drying (MgSO4), removal of the solvents in vacuo and flash column chromatography (silica gel, 
iso-hexane / EtOAc / NEt3 = 2:1:0.15) the desired product 56k (1.09 g, 77%) was obtained as a white 
solid. 
M.p. (°C): 164-166. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.66 (s, 2H), 7.42 – 7.60 (m, 5H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 156.5, 133.7, 133.0, 129.5, 129.4, 127.3, 126.8. 
IR (Diamond-ATR, neat): ~  / cm-1= 3042, 2682, 2496, 1904, 1578, 1564, 1516, 1444, 1380, 1370, 
1324, 1302, 1284, 1238, 1160, 1116, 1082, 1064, 1034, 1002, 946, 924, 876, 858, 782, 766, 754, 700, 
636, 614. 
MS (EI, 70 eV): m/z (%) = 282 [M]+ (71), 155 (100), 128 (18), 103 (26), 102 (16), 77 (21). 
HRMS for C10H7IN2 (281.9654): 281.9638 (M+) 
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Synthesis of ethyl 4-(5-phenylpyrimidin-2-yl)benzoate (56l): 
Note: This example was performed by Dr. Aleksei Bredihhin. 
 
According to TP4, 5-phenylpyrimidine (55f, 312 mg, 2.0 mmol) in dry THF (4.0 mL) reacted with 
BF3·OEt2 (312 mg, 0.27 mL, 2.2 mmol) and TMPZnCl·LiCl (20, 2.25 mL, 2.2 mmol, 0.98 M in THF) 
at -20 °C for 1.5 h. Pd(dba)2 (35 mg, 0.06 mmol, 3 mol%), TFP (28 mg, 0.12 mmol, 6 mol%) and ethyl 
4-iodobenzoate (57d, 552 mg, 2.0 mmol) were added subsequently and the reaction mixture was heated 
to 50 °C for 4 h. The reaction mixture was quenched with sat. aq. NH4Cl (9 mL) and NH3 (conc., 1 mL) 
followed by extraction with DCM (3 × 20 mL). After drying (MgSO4), removal of the solvents in vacuo 
and flash column chromatography (silica gel, iso-hexane / DCM / NEt3 = 5:1:0.5) the desired product 
56l (407 mg, 67%) was obtained as an off-white solid. 
M.p. (°C): 172.6-173.7. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.04 (s, 2H), 8.57 (d, J = 8.2 Hz, 2H), 8.18 (d, J = 8.4 Hz, 2H), 
7.59 – 7.69 (m, 2H), 7.42 – 7.58 (m, 3H), 4.42 (q, J = 7.1 Hz, 2H), 1.44 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 166.3, 162.4, 155.2, 141.1, 134.2, 132.2, 132.2, 129.8, 129.4, 
128.9, 128.0, 126.8, 61.1, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3056, 3028, 2972, 1956, 1828, 1720, 1582, 1534, 1450, 1436, 
1406, 1390, 1374, 1364, 1314, 1302, 1280, 1246, 1182, 1168, 1128, 1120, 1106, 1096, 1078, 1018, 970, 
954, 914, 870, 854, 808, 790, 756, 692, 656, 632. 
MS (EI, 70 eV): m/z (%) = 305 (22), 304 [M+] (90), 276 (39), 260 (24), 259 (100), 231 (32), 102 
(48). 
HRMS for C19H16N2O2 (304.1212): 304.1207 (M+). 
 
4.4. Preparation of Thienopyrimidines  
Synthesis of N,N-Dimethylthieno[2,3-d]pyrimidin-4-amine (58a): 
 
To a stirred solution of 4-chlorothieno[2,3-d]pyrimidine (850 mg, 5.0 mmol) in THF (5.0 mL) 
dimethylamine (2.25 g, 20.0 mmol) was added at 25 °C and stirred for 3 h. The reaction mixture was 
quenched with brine (50 mL) followed by extraction with EtOAc (3 × 50 mL). After drying (Na2SO4), 
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the solvents were removed in vacuo. Flash column chromatography (silica gel, iso-hexane / EtOAc = 
1:2) furnished the desired N,N-dimethylthieno[2,3-d]pyrimidin-4-amine (58a, 877 mg, 98%) as an off-
white solid. 
M.p. (°C): 86-88. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.44 (s, 1H), 7.46 (d, J = 6.1 Hz, 1H), 7.18 (d, J = 6.1 Hz, 1H), 
3.38 (s, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 168.9, 158.4, 152.9, 121.4, 120.3, 115.9, 40.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3751, 3108, 2924, 2362, 1559, 1522, 1500, 1480, 1457, 1418, 
1402, 1388, 1331, 1279, 1246, 1212, 1188, 1140, 1088, 1063, 1002, 980, 874, 853, 803, 790, 700. 
MS (EI, 70 eV): m/z (%) = 179 [M+] (68), 164 (45), 149 (100), 135 (45), 109 (29). 
HRMS for C8H9N3S (179.0517): 179.0513 (M+). 
 
Synthesis of ethyl 4-(4-(dimethylamino)thieno[2,3-d]pyrimidin-6-yl)benzoate (59a): 
 
According to TP3, N,N-dimethylthieno[2,3-d]pyrimidin-4-amine (58a, 179 mg, 1.0 mmol) in dry THF 
(2.0 mL) reacted with TMPZnCl·LiCl (20, 1.11 mL, 1.5 mmol, 1.35 M in THF) at 25 °C for 12 h. 
Pd(dba)2 (17 mg, 0.03 mmol, 3 mol%), TFP (14 mg, 0.06 mmol, 6 mol%) and ethyl 4-iodobenzoate 
(57d, 483 mg, 1.7 mmol) were added successively and the reaction mixture stirred for 3 h. The reaction 
mixture was quenched with sat. aq. NH4Cl (9 mL) and NH3 (conc., 1 mL) followed by extraction with 
DCM (3 × 20 mL). After drying (Na2SO4), removal of the solvents in vacuo and flash column 
chromatography (silica gel, iso-hexane / EtOAc = 1:1 to 1:4) the desired product 59a (274 mg, 83%) 
was obtained as an off-white solid. 
M.p. (°C): 142-145. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.44 (s, 1H), 8.07 (d, J = 8.6 Hz, 2H), 7.63 – 7.75 (m, 3H), 
4.40 (q, J = 7.2 Hz, 2H), 3.44 (s, 6H), 1.42 (t, J = 7. Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 168.9, 166.0, 158.1, 153.2, 137.9, 136.5, 130.2, 129.9, 125.7, 
118.3, 117.2, 61.1, 40.3, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1= 3121, 2984, 2940, 2901, 1703, 1663, 1620, 1603, 1565, 1503, 
1477, 1451, 1441, 1406, 1363, 1336, 1327, 1313, 1271, 1242, 1228, 1181, 1137, 1123, 1109, 1063, 
1020, 1007, 972, 953, 913, 867, 853, 835, 764, 692, 654. 
MS (EI, 70 eV): m/z (%) = 327 [M+] (88), 312 (21), 298 (100), 284 (18), 270 (21). 
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HRMS for C17H17N3O2S (327.1041): 327.1036 (M+). 
 
Synthesis of ethyl 4-(4-(dimethylamino)thieno[2,3-d]pyrimidin-2-yl)benzoate (60a): 
 
According to TP4, N,N-dimethylthieno[2,3-d]pyrimidin-4-amine (58a, 179 mg, 1.0 mmol) in dry THF 
(2.0 mL) reacted with BF3·OEt2 (156 mg, 0.14 mL, 1.1 mmol) and TMPZnCl·LiCl (20, 1.11 mL, 
1.5 mmol, 1.35 M in THF) at 0 °C for 2 h. Pd(dba)2 (17 mg, 0.03 mmol, 3 mol%), TFP (14 mg, 
0.06 mmol, 6 mol%) and ethyl 4-iodobenzoate (57d, 483 mg, 1.7 mmol) were added subsequently and 
the reaction mixture stirred for 3 h. The reaction mixture wasquenched with sat. aq. NH4Cl (9 mL) and 
NH3 (conc., 1 mL) followed by extraction with DCM (3 × 20 mL). After drying (Na2SO4), removal of 
the solvents in vacuo and flash column chromatography (silica gel, iso-hexane / EtOAc = 3:1) the desired 
product 60a (230 mg, 70%) was obtained as an off-white solid. 
M.p. (°C): 143-147. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.55 (d, J = 8.8 Hz, 2H), 8.12 (d, J = 8.8 Hz, 2H), 7.47 (d, J = 
6.2 Hz, 1H), 7.19 (d, J = 6.2 Hz, 1H), 4.41 (q, J = 7.1 Hz, 2H), 3.45 (s, 6H), 1.43 (t, J = 7.1 Hz, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 170.1, 166.6, 158.3, 157.7, 142.5, 131.3, 129.4, 128.0, 121.5, 
120.7, 114.6, 60.9, 40.0, 14.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3077, 2977, 2898, 1710, 1609, 1578, 1550, 1510, 1502, 1468, 
1413, 1404, 1385, 1364, 1347, 1299, 1263, 1246, 1186, 1171, 1158, 1122, 1108, 1098, 1059, 1018, 
1006, 888, 866, 858, 852, 819, 796, 773, 763, 716, 698, 676, 666. 
MS (EI, 70 eV): m/z (%) = 327 [M+] (54), 298 (100), 284 (10), 270 (16), 255 (25), 211 (16), 109 (11). 
HRMS for C17H18N3O2S (328.1114): 328.1112 ([M+H]+) 
 
Synthesis of 2-(cyclohex-2-en-1-yl)-4-methoxythieno[2,3-d]pyrimidine (60b): 
 
According to TP4, 4-methoxythieno[2,3-d]pyrimidine (58b, 332 mg, 2.0 mmol) in dry THF (7.0 mL) 
reacted with BF3·OEt2 (312 mg, 0.27 mL, 2.2 mmol) and TMPZnCl·LiCl (20, 1.7 mL, 2.2 mmol, 1.27 M 
in THF) at -40 °C for 1 h. CuCN·2LiCl (0.20 mL, 0.20 mmol, 1.0 M in THF) and 3-bromocyclohexene 
(57a, 419 mg, 0.30 mL, 2.6 mmol) were added subsequently and the reaction mixture was slowly 
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warmed to 25 °C. The reaction mixture was quenched with sat. aq. NH4Cl (9 mL) and NH3 (conc., 1 mL) 
followed by extraction with DCM (3 × 20 mL). After drying (Na2SO4), removal of the solvents in vacuo 
and flash column chromatography (silica gel, iso-hexane / DCM = 1:5) the desired product 60b (374 mg, 
77%) was obtained as a colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.23 – 7.34 (m, 2H), 5.94 – 6.07 (m, 1H), 5.84 – 5.95 (m, 1H), 
4.12 (s, 3H), 3.68 – 3.79 (m, 1H), 2.07 – 2.25 (m, 3H), 1.87 – 2.05 (m, 2H), 1.62 – 1.82 (m, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 169.1, 168.7, 164.0, 128.3, 128.0, 123.3, 118.2, 116.7, 53.6, 
44.7, 28.8, 24.9, 21.6. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3085, 3024, 2931, 2860, 2835, 1573, 1535, 1468, 1410, 1368, 
1346, 1318, 1270, 1249, 1218, 1194, 1174, 1153, 1135, 1092, 1038, 1008, 953, 929, 892, 874, 851, 800, 
794, 787, 696. 
MS (EI, 70 eV): m/z (%) = 246 [M+] (82), 245 (24), 231 (53), 218 (20), 217 (100), 205 (17), 203 (16), 
180 (24). 
HRMS for C13H14N2OS (246.0827): 246.0812 (M+). 
 
4.5. Synthesis and Spectra of the Intermediates 
Synthesis and NMR-studies of (5-(neopenthyl)pyrimidin-1-ium-1-yl)trifluoroborate (61) 
 
A dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
38 mg 5-neopentylpyrimidine (55d, 0.25 mmol) in 1.0 mL THF-d8 and cooled to 0 °C. BF3·OEt2 (39 mg, 
0.275 mmol) was added and the reaction mixture was stirred for 15 min at the same temperature. The 
complex 61 was then transferred in a dry, argon flushed NMR-tube which was cooled at -20 °C, and 
characterized with 1H-, 13C- 11B and 19F-NMR. The spectra showed in addition to the characteristic 
signals of the BF3-complex 49 also the signals of free BF3·OEt2. 
1H-NMR (400 MHz, THF-d8): δ / ppm: 9.36 (s, 2-H, 1H), 9.12 (d, J = 2.5 Hz, 6-H, 1H), 8.86 (s, 4-H, 
1H), 2.75 (s, CH2, 2H), 0.94 (s, CH3, 9H). 
13C-NMR (100 MHz, THF-d8): δ / ppm: 164.3 (4-C), 157.4 (q, 3JC-F = 2.0 Hz, 6-C), 151.3 (q, 3JC-F = 
2.8 Hz, 2-C), 135.0 (5-C), 42.9 (CH2), 31.6 (Cq(CH3)3), 28.0 (CH3).  
11B-NMR (128 MHz, THF-d8): δ / ppm: -0.45. 
19F-NMR (376 MHz, THF-d8): δ / ppm: 150.64 (10B isotopomer), 150.68 (11B isotopomer). 
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The two carbons at position 2 and six display a distint 3JC-F coupling which can be seen in Figure 9. 
 
Figure 9: Signals of 2-C (left) and and 6-C (right) of 61. 
 
NMR-studies of the zinc species 62 in the presence of BF3·OEt2 
 
A dry and argon flushed 10 mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
38 mg 5-neopentylpyrimidine (55d, 0.25 mmol) in 1.0 mL THF-d8 and cooled to 0 °C. BF3·OEt2 (39 mg, 
0.275 mmol) was added and the reaction mixture was stirred for 15 min at the same temperature. Then 
0.3 mmol of TMPZnCl·LiCl (20, 0.2 mL, 1.5 M in THF-d8) were added and the mixture was stirred at 
0 °C for 45 min. The solution was then transferred in a dry, argon flushed NMR-tube which was cooled 
at -20 °C, and characterized with 1H-, 13C- 11B and 19F-NMR. The spectra showed in addition to the 
characteristic signals of zinc species 62 also the signals of free BF3·OEt2, free TMPH the BF3 complex 
61 and the TMPH-BF3 adduct 50.  
1H-NMR (400 MHz, THF-d8): δ / ppm: 9.08 (s, 6-H, 1H), 8.86 (s, 4-H, 1H), 7.74 (s, CH2, 2H), 0.91 
(s, CH3, 9H). 
13C-NMR expansion of 61 
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13C-NMR (100 MHz, THF-d8): δ / ppm: 194.6 (2-C), 159.4 (6-C), 151.4 (4-C), 132.1 (5-C), 42.6 (CH2), 
31.6 (Cq(CH3)3), 28.0 (CH3). 
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5. TMPZNOPIV·LICL: A NEW BASE FOR THE PREPARATION OF AIR-STABLE SOLID 
ZINC PIVALATES OF SENSITIVE AROMATICS AND HETEROAROMATICS 
5.1. Titration and Stability Studies of Solid Zinc Pivalates 
Titration of organozinc reagents using GC-analysis: 
First of all, the iodinated compounds of all organic zinc pivalates (65 and 67) were isolated. Stock 
solutions of the iodides (0.1 M) and of an internal standard (0.1 M) were prepared. As internal standard 
for all calibration curves n-octadacane was used, with exception of 67e where n-tetradecane was used, 
since the iodinated product had the same GC-retention time as n-octadecane. For each iodinated 
compound GC-samples of different iodide/internal standard ratios were prepared and measured (at least 
eight for each iodide) and these ratios were plotted against the area ratios of the corresponding GC-
analysis to give a linear graph with a determined equation. With these equations the amount of iodinated 
substance of the organozinc pivalates could be calculated. 
 
Stability studies of organozinc reagents towards air: 
To evaluate the stability of organozinc reagents towards air, accurately weighted aliquots of the solid 
organo-zinc pivalate were placed at 25 °C in open Schlenk-flasks. After exposure to air for a given time, 
the flasks were closed, evacuated, filled with argon and the organozinc pivalate was dissolved in dry 
THF. Then, an excess of iodine was added and the solution stirred for 10 min at 25 °C followed by 
addition of 100 µL of a 0.1 M stock-solution of n-octadecane in toluene (n-tetradecane for 6d). An aliquot 
(ca. 0.1 mL) of this reaction mixture was then quenched with sat. aqueous Na2S2O3 solution (ca. 0.5 mL) 
and extracted with EtOAc (ca. 1 mL). The molar n-octadecane/iodinated heteroarene ratio was 
determined via GC-analysis. 
 
5.2. Typical Procedures 
Typical Procedure for the metalation of heteroaromatics with TMPZnOPiv·Mg(OPiv)Cl·LiCl 
(63) (TP5): 
A dry and argon flushed 20-mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
a 0.5 M solution of the corresponding N-heteroarene in dry THF. The solution was brought to the given 
temperature followed by dropwise addition of TMPZnOPiv·Mg(OPiv)Cl·LiCl (63, 0.85 M in THF, 1.1 
– 2.0 equiv.) and stirred at the indicated temperature for the given time. Complete metalation was 
monitored by GC analysis of reaction aliquots, quenched with iodine in dry THF using tetradecane as 
internal standard. The solvent was carefully removed in vacuo and the content of active zinc species was 
determined as described above. 
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Typical Procedure for the BF3·OEt2-triggered metalation of heteroaromatics with 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (63) (TP6): 
A dry and argon flushed 20-mL Schlenk-tube, equipped with a magnetic stirring bar, was charged with 
a solution of the corresponding heteroarene (1.0 mmol) in dry THF (2 mL) and cooled to -20 °C. 
BF3·OEt2 (156 mg, 1.1 mmol) was slowly added and stirred for 30 min at the same temperature. The 
reaction mixture was cooled down to -30 °C and after dropwise addition of 
TMPZnOPiv·Mg(OPiv)Cl·LiCl (63, 0.85 m in THF, 1.1 equiv.) the mixture was stirred for 1 h at -30 °C.  
 
5.3. Praparation of the Solid Organozinc Pivalates of Type 65 and 67 
Synthesis of (2,6-difluoro-3-nitrophenyl)zinc pivalate (65a): 
 
According to TP5 2,4-difluoro-1-nitrobenzene (64a, 318 mg, 2.0 mmol) in 4 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 M, 2.2 mmol) at 25 °C and stirred at this temperature for 45 min. 
After solvent removal in vacuo 65a (2.05 g) was obtained as a light brown solid. GC-analysis of an 
iodinated sample (see above) gave a concentration of the active zinc species of 0.81 mmol/g, which 
corresponds to a yield of 83%. 
 
Synthesis of (2-bromo-3-cyano-6-fluorophenyl)zinc pivalate (65b): 
 
According to TP5 2-bromo-4-fluorobenzonitrile (64b, 600 mg, 3.0 mmol) in 6 mL dry THF reacted 
with TMPZnOPiv·LiCl (63, 3.8 mL, 0.86 M, 3.3 mmol) at 50 °C (oil bath) and for 2 h. After solvent 
removal in vacuo 65b (3.49 g) was obtained as an orange solid. GC-analysis of an iodinated sample (see 
above) gave a concentration of the active zinc species of 0.78 mmol/g, which corresponds to a yield of 
91%. 
 
Synthesis of (2,4,6-trichlorophenyl) zinc pivalate (65c): 
 
According to TP5 1,3,5-trichlorobenzene (64c, 544 mg, 3.0 mmol) in 3 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 5.5 mL, 0.81 M, 4.5 mmol) at 160 °C (microwave) for 1 h. After solvent removal 
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in vacuo 65c (3.33 g) was obtained as an slightly orange solid. A titration with iodine67 gave a 
concentration of the active zinc species of 0.68 mmol/g, which corresponds to a yield of 76%. 
 
Synthesis of 5-(4,6-Dichloropyrimidinyl)zinc pivalate (67a): 
 
According to TP5 4,6-dichloropyrimidine (66a, 298 mg, 2.0 mmol) in 4 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 m, 2.2 mmol) at 25 °C and stirred at this temperature for 0.5 h. 
After solvent removal in vacuo 67a (2.06 g) was obtained as a yellow solid. GC-analysis of an iodinated 
sample (see above) gave a concentration of the active zinc species of 0.81 mmol/g, which corresponds 
to a yield of 78%.  
 
Synthesis of (5-bromo-2,6-dimethoxypyrimidin-4-yl)zinc pivalate (67b): 
 
According to TP5 5-bromo-2,4-dimethoxypyrimidine (66b, 438 mg, 2.0 mmol) in 4 mL THF reacted 
with TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 m, 2.2 mmol) at 25 °C and stirred at this temperature for 3 h. 
After solvent removal in vacuo 67b (1.83 g) was obtained as an orange-brown solid. GC-analysis of an 
iodinated sample (see above) gave a concentration of the active zinc species of 0.79 mmol/g, which 
corresponds to a yield of 72%.  
 
Synthesis of (3-chloropyrazin-2-yl)zinc pivalate (67c): 
 
According to TP5 2-chloropyrazine (66c, 345 mg, 3.0 mmol) in 3 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 3.8 mL, 0.86 M, 3.3 mmol) at 90 °C (microwave) for 2 h. After solvent removal 
in vacuo 67c (2.68 g) was obtained as an orange solid. GC-analysis of an iodinated sample (see above) 
gave a concentration of the active zinc species of 0.85 mmol/g, which corresponds to a yield of 75%.  
 
 
 
 
C. Experimental Section 
 
 
134 
Synthesis of (3,6-dichloropyridazin-4-yl)zinc pivalate (67d): 
 
According to TP5 3,6-dichloropyridazine (66d, 745 mg, 5.0 mmol) in 10 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 6.4 mL, 0.86 M, 5.5 mmol) at 25 °C for 0.5 h. After solvent removal in vacuo 
67d (4.81 g) was obtained as a yellow solid. GC-analysis of an iodinated sample (see above) gave a 
concentration of the active zinc species of 0.74 mmol/g, which corresponds to a yield of 75%. 
 
Synthesis of 3-(2-ethoxycarbonyl-5-nitrofuranyl)zinc pivalate (67e) 
 
According to TP5 ethyl 5-nitrofuran-2-carboxylate (66e, 370 mg, 2.0 mmol) in 4 mL dry THF reacted 
with TMPZnOPiv·LiCl (63, 4.7 mL, 0.85 M, 4.0 mmol) at -10 °C and stirred at this temperature for 1 h. 
After warming to 25 °C and solvent removal in vacuo 67e (2.04 g) was obtained as a dark red-brown 
solid. GC-analysis of an iodinated sample (see above) gave a concentration of the active zinc species of 
0.75 mmol/g, which corresponds to a yield of 77%.  
 
Synthesis of (3-formyl-1-methyl-1H-indol-2-yl)zinc pivalate (67f): 
 
According to TP5 1-methyl-1H-indole-3-carbaldehyde (66f, 318 mg, 2.0 mmol) in 4 mL THF reacted 
with TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 M, 2.2 mmol) at 25 °C and stirred at this temperature for 0.5 h. 
After solvent removal in vacuo 67f (2.06 g) was obtained as a yellow solid. GC-analysis of an iodinated 
sample (see above) gave a concentration of the active zinc species of 0.85 mmol/g, which corresponds 
to a yield of 88%.  
 
Synthesis of (3-formylbenzo[b]thiophen-2-yl)zinc pivalate (67g): 
 
According to TP5 benzo[b]thiophene-3-carbaldehyde (66g, 486 mg, 3.0 mmol) in 6 mL dry THF reacted 
with TMPZnOPiv·LiCl (63, 3.84 mL, 0.86 M, 3.3 mmol) at 25 °C for 0.5 h. After solvent removal in 
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vacuo 67g (3.12 g) was obtained as a yellow solid. GC-analysis of an iodinated sample (see above) gave 
a concentration of the active zinc species of 0.86 mmol/g, which corresponds to a yield of 89% 
 
Synthesis of (6-nitrobenzo[d]thiazol-2-yl)zinc pivalate (67h) 
 
According to TP5 ethyl 6-nitrobenzothiazol (66h, 360 mg, 2.0 mmol) in 4 mL dry THF reacted with 
TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 m, 2.2 mmol) at 25 °C and stirred at this temperature for 10 min. 
After solvent removal in vacuo 67h (1.98 g) was obtained as a dark red-brown solid. GC-analysis of an 
iodinated sample (see above) gave a concentration of the active zinc species of 0.75 mmol/g, which 
corresponds to a yield of 74%. 
 
Synthesis of (1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)zinc pivalate (67i): 
 
According to TP5 caffeine (66i, 583 mg, 3.0 mmol) in 6 mL dry THF reacted with TMPZnOPiv·LiCl 
(63, 3.84 mL, 0.86 M, 3.3 mmol) at 25 °C for 0.5 h. After solvent removal in vacuo 67i (3.68 g) was 
obtained as a yellow solid. A titration with iodine gave a concentration of the active zinc species of 
0.77 mmol/g, which corresponds to a yield of 95%.  
 
Synthesis of (2-oxo-2H-chromen-3-yl)zinc pivalate (67j): 
 
According to TP5 coumarin (66j, 438 mg, 2.0 mmol) in 4 mL dry THF reacted with TMPZnOPiv·LiCl 
(63, 2.6 mL, 0.85 m, 2.2 mmol) at 25 °C and stirred at 80 °C in the microwave for 1 h. After cooling to 
25 °C and solvent removal in vacuo 67j (2.23 g) was obtained as a orange solid. GC-analysis of an 
iodinated sample (see above) gave a concentration of the active zinc species of 1.11 mmol/g, which 
corresponds to a yield of 82%.  
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Synthesis of (4-oxo-4H-chromen-2-yl) zinc pivalate (67k) 
 
According to TP6 chromone (66k, 292 mg, 2.0 mmol) in 4 mL THF reacted with BF3·OEt2 (312 mg, 
2.2 mmol) and TMPZnOPiv·LiCl (63, 2.6 mL, 0.85 m, 2.2 mmol). After solvent removal in vacuo 67k 
(1.89 g) was obtained as a dark red solid. GC-analysis of an iodinated sample (see above) gave a 
concentration of the active zinc species of 0.60 mmol/g, which corresponds to a yield of 55%. However, 
when used as a solution overall yields higher than 55% were obtained, indicating, that the BF3 containing 
zinc pivalate 67k decomposes during the solvent removal. Therefore all yields are referring over two 
steps (metalation and reaction with electrophile). 
 
5.4. Preparation of the Compounds Type 69-72 
Synthesis of (3,6-dichloropyridazin-4-yl)(phenyl)methanone (69a): 
 
(3,6-Dichloropyridazin-4-yl)zinc-pivalate (67d, 676 mg, 0.74 mmol/g, 0.5 mmol) dissolved in 1.5 mL 
dry THF was cooled down to -20 °C. TMSCl (0.4 mL, 2.8 mmol) was added followed by 30 min stirring. 
Then CuCN·2LiCl (0.5 mL, 1 M, 0.5 mmol) and benzoyl chloride (68a, 165 mg, 1.2 mmol) were added 
subsequently. The reaction mixture was stirred for 1 h at -20 °C. After quenching with aqueous 
NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted with ethylacetate (5 × 8 mL). The combined 
organic layers were dried over Na2SO4 and after filtration, the solvents were evaporated in vacuo. 
Purification by flash chromatography (silica gel, iso-hexane / Et2O = 5:1) afforded the product 69a 
(114 mg, 96%) as a white solid. 
M.p. (°C): 98.9-100. 
1H-NMR (400 MHz, CDCl3): δ = 7.77 (dd, J = 8.4, 1.3 Hz, 2H), 7.71 (tt, J = 7.5, 1.3 Hz, 1H), 7.54 (tt, 
J = 7.8, 1.7 Hz, 2H), 7.51 (s, 1H). 
13C-NMR (100 MHz, CDCl3): δ = 189.0, 156.2, 151.7, 140.0, 135.5, 133.9, 130.0, 129.3, 127.8. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3070, 1666, 1614, 1591, 1575, 1501, 1487, 1444, 1404, 1382, 
1325, 1307, 1290, 1247, 1239, 1222, 1173, 1167, 1156, 1135, 1103, 1070, 1052, 1024, 999, 982, 968, 
932, 902, 853, 821, 799, 756, 714, 700, 682, 653. 
MS (EI, 70 eV): m/z (%) = 254 (7), 252 [M+] (11), 106 (8), 105 (100), 77 (51), 44 (7). 
HRMS (EI) for C11H6Cl2N2O (251,9857): 251.9842 (M+). 
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Synthesis of (3,6-dichloropyridazin-4-yl)(phenyl)methanone (69b): 
 
(3,6-Dichloropyridazin-4-yl)zinc-pivalate (67d, 1.22 g, 0.74 mmol/g, 0.9 mmol) dissolved in 3 mL dry 
THF was cooled down to -20 °C. TMSCl (0.7 mL, 5.4 mmol) was added followed by 30 min stirring. 
Then CuCN·2LiCl (1 mL, 1 M, 1 mmol) and 2-furoylchloride (68b, 294 mg, 2.3 mmol) were added 
subsequently. The reaction mixture was stirred for 1.5 h at -20 °C and for 15 h at 0 °C. After quenching 
with aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted with ethylacetate (5 × 8 mL). 
The combined organic layers were dried over Na2SO4 and after filtration, the solvents were evaporated 
in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O = 1:1) afforded the product 
69b (189 mg, 87%) as a white solid. 
M.p. (°C): 131.4-132.6. 
1H-NMR (300 MHz, CDCl3): δ = 7.75 (dd, J = 1.7, 0.8 Hz, 1H), 7.57 (s, 1H), 7.33 (dd, J = 3.7, 0.7 Hz, 
1H), 6.69 (dd, J = 3.7, 1.7 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): δ = 175.7, 156.1, 151.8, 150.5, 149.5, 138.5, 127.9, 122.5, 113.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3114, 3044, 1658, 1558, 1505, 1462, 1392, 1354, 1319, 1283, 
1242, 1223, 1202, 1166, 1151, 1119, 1082, 1037, 981, 929, 911, 883, 861, 802, 791, 780, 768, 740, 709, 
697, 683, 658. 
MS (EI, 70 eV): m/z (%) = 242 [M+] (100), 96 (28), 84 (21), 67 (13), 43 (17). 
HRMS (EI) for C9H4Cl2N2O2 (241.9650): 241.9638 (M+). 
 
Synthesis of 3,6-dichloro-4-(cyclohex-2-en-1-yl)pyridazine (69c) 
 
5-(4,6-Dichloropyrimidinyl)zinc-pivalate (67d, 624 mg, 0.74 mmol/g, 0.5 mmol) dissolved in 1.5 mL 
dry THF was cooled down to -20 °C. CuCN·2LiCl (0.05 mL, 1 M, 0.05 mmol) and 3-bromocyclohexene 
(57a, 89 mg, 0.6 mmol) were added subsequently. The reaction mixture was stirred for 1 h at the same 
temperature. After quenching with a aqueous NH4Cl/NH3(conc.) (8:1) solution (4 mL) the mixture was 
extracted with ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after 
filtration, the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-
hexane / Et2O = 4:1) afforded the product 69c (95 mg, 90%) as a colorless liquid. 
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1H-NMR (600 MHz, CDCl3): δ / ppm = 7.37 (d, J = 0.6 Hz, 1H), 6.13 (dq, J = 9.9, 2.0 Hz, 1H), 5.56 
(dq, J = 10.0, 2.5 Hz, 1H), 3.70 – 3.77 (m, 1H), 2.17 – 2.10 (m, 3H), 1.71 – 1.47 (m, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 156.6, 156.1, 147.7, 132.60, 128.8, 124.8, 37.3, 28.3, 24.7, 
19.7. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3025, 2931, 2862, 2837, 1652, 1560, 1447, 1432, 1394, 1356, 
1342, 1313, 1293, 1276, 1252, 1192, 1128, 1101, 1059, 1048, 1038, 996, 922, 910, 881, 864, 852, 815, 
764, 754, 724, 686, 667. 
MS (EI, 70 eV): m/z (%) = 230 (67), 228 [M+] (100), 214 (27), 193 (47), 174 (41), 102 (22), 81 (48), 
77 (21), 67 (23), 54 (32), 41 (33). 
HRMS (EI) for C10H10Cl2N2 (228.0221): 228.0206 (M+). 
 
Synthesis of 3,6-dichloro-4-iodopyridazine (69d): 
 
To a solution of (3,6-dichloropyridazin-4-yl)zinc pivalate (67d, 1.35 g, 0.74 mmol/g, 1.0 mmol) in THF 
(3 mL) iodine (508 mg, 2 mmol) was added at 25 °C and the reaction mixture was stirred at 25 °C for 
1 h. After quenching with a saturated aqueous Na2S2O3 solution (4 mL) the mixture was extracted with 
ethyl acetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, the 
solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / DCM 
= 2:1) afforded the product 69d (252 mg, 92%) as a white solid 
M.p. (°C): 142.2-143.0. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.04 (s, 1H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 159.7, 153.9, 139.7, 105.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3093, 2247, 2191, 2156, 2024, 1965, 1794, 1490, 1464, 1381, 
1331, 1296, 1276, 1234, 1154, 1130, 1061, 1044, 994, 900, 812, 796, 730, 722, 698,659. 
MS (EI, 70 eV): m/z (%) = 276 (29), 274 [M+] (45), 121 (35), 119 (55), 84 (31), 61 (19), 43 (100). 
HRMS (EI) for C4HCl2IN2 (273.8561): 273.8561 (M+). 
 
Synthesis of (4,6-dichloropyrimidin-5-yl)(furan-2-yl)methanone (70a): 
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A solution of 5-(4,6-dichloropyrimidinyl)zinc pivalate (67a, 1.23 g, 1.0 mmol) in THF (3 mL) was 
cooled to -20 °C and CuCN·2LiCl (1.1 mmol, 1.1 mL, 1.0 m in THF) was added dropwise. After stirring 
at this temperature for 20 min, 2-furoyl chloride (68b, 392 mg, 3.0 mmol) was added and the mixture 
was left to reach 0 oC and stirred there for 3 h. Then, sat. aqueous NH4Cl solution (9 mL) and NH3 
(conc.) (1 mL) were used to quench the reaction, followed by extraction with diethyl ether (3×10 mL). 
The combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated 
in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 12:1) afforded 
the product 70a (233 mg, 96%) as brown solid. 
M.p. (°C): 143.6-145.4. 
1H-NMR (600 MHz, CDCl3):  / ppm = 8.87 (s, 1H), 7.69 (d, J = 0.9 Hz, 1H), 7.28 (br, s, 1H), 6.65 
(dd, J = 3.7, 1.7 Hz, 1H). 
13C-NMR (150 MHz, CDCl3):  / ppm = 175.6, 158.8, 158.4, 150.9, 149.0, 130.9, 121.4, 113.5. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3133, 2969, 2359, 2340, 1738, 1636, 1558, 1540, 1512, 1450, 
1403, 1375, 1361, 1297, 1230, 1216, 1168, 1123, 1083, 1032, 956, 904, 888, 878, 815, 789, 781, 746, 
738, 668, 626, 615, 609. 
MS (EI, 70 eV): m/z (%) = 242 [M+] (48), 167 (49), 95 (100), 58 (21), 43 (33). 
HRMS (EI) for C9H4Cl2N2O2 (241.9650): 241.9653 (M+). 
 
Synthesis of 4,6-dichloro-5-(4-(methylthio)phenyl)pyrimidine (70b): 
 
To a solution of 5-(4,6-dichloropyrimidinyl)zinc pivalate (67a, 1.23 g, 1.0 mmol) in THF (3 mL) 
Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and 4-iodothioanisole (68c, 200 mg, 0.8 mmol) 
were added subsequently at 25 °C. The reaction mixture was stirred at 25 °C for 2 h and then quenched 
with a sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether (3×10 mL). The 
combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated in 
vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 15:1) afforded the 
product 70b (197 mg, 91%) as white solid. 
 M.p. (°C): 88.7-90.4. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.76 (s, 1H), 7.36 (d, J = 8.2 Hz, 2H), 7.23 (d, J = 8.2 Hz, 2H), 
2.54 (s, 3H). 
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13C-NMR (75 MHz, CDCl3):  / ppm = 161.5, 156.6, 140.8, 133. 6, 129.5, 128.8, 125.9, 15.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = cm-1, 3050, 2992, 2925, 1916, 1713, 1652, 1594, 1552, 1539, 
1504, 1434, 1424, 1406, 1398, 1389, 1372, 1362, 1346, 1322, 1296, 1270, 1230, 1215, 1204, 1189, 
1163, 1114, 1093, 1020, 994, 969, 959, 951, 824, 801, 796, 780, 732, 721, 704. 
MS (EI, 70 eV): m/z (%) = 271 [M+] (32), 257 (20), 255 (30), 192 (16), 173 (15), 91 (16), 61 (20), 43 
(100). 
HRMS (EI) for C11H9Cl2N2S (270.9858): 270.9860 ([M+H]+). 
 
Synthesis of 5-allyl-4,6-dichloropyrimidine (70c): 
 
A solution of 5-(4,6-dichloropyrimidinyl)zinc pivalate (67a, 1.23 g, 1.0 mmol) in THF (3 mL) was 
cooled to -20 °C and CuCN·2LiCl (0.05 mmol, 0.05 mL, 1.0 m in THF) was added. After stirring for 
20 min the mixture was cooled further at -60 oC and allyl bromide (68d, 145 mg, 1.2 mmol) was added. 
The reaction mixture was allowed to warm to up to -30 °C over 1 h and then quenched with a sat. 
aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with ethyl acetate 
(3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 10:1) 
afforded the product 70c (166 mg, 88%) as colourless oil. 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.62 (s, 1H), 5.84 (ddd, J = 16.5, 11.1, 6.0 Hz, 1H), 5.27 – 
4.95 (m, 2H), 3.63 (dd, J = 6.2, 1.5 Hz, 2H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 162.0, 155.8, 130.9, 130.6, 118.1, 34.0. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2969, 2360, 1739, 1639, 1539, 1513, 1435, 1406, 1375, 1348, 
1313, 1290, 1200, 1162, 1129, 1090, 989, 929, 906, 839, 777, 687, 668, 627, 621, 616. 
MS (EI, 70 eV): m/z (%) = 188 [M+] (70), 125 (22), 117 (44), 90 (59), 64 (35), 49 (43), 41 (100). 
HRMS (EI) for C7H6Cl2N2 (187.9908): 187.9913 (M+). 
 
 
 
Synthesis of 2,6-difluoro-3',5'-dimethyl-3-nitro-1,1'-biphenyl (71a): 
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To a solution of (2,6-difluoro-3-nitrophenyl)zinc pivalate (65a, 1.23 g, 1.0 mmol) in THF (3 mL) 
Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and 1-iodo-3,5-dimethylbenzene (68e, 185 mg, 
0.8 mmol) were added subsequently at 25 °C. The reaction mixture was stirred at 25 °C over 3 h and 
then quenched with a sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether 
(3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 20:1) 
afforded the product 71a (206 mg, 98%) as off-white solid. 
M.p. (°C): 71.8-72.8 
1H-NMR (300 MHz, CDCl3):  / ppm = 8.09 (ddd, J = 9.26, 8.13, 5.61 Hz, 1H), 6.99 ‒ 7.20 (m, 4H), 
2.40 (s, 6H). 
13C-NMR (75 MHz, CDCl3):  / ppm = 162.8 (dd, J = 259, 6 Hz), 153.9 (dd, J = 259, 9 Hz), 138.2, 
134.7, 131.0, 127.7 (t, J = 2 Hz), 126.6, 125.7 (dd, J = 11, 2 Hz), 121.5 (dd, J = 21, 19 Hz), 111.9 (dd, 
J = 25, 4 Hz), 21.25. 
19F-NMR (254 MHz, CDCl3):  / ppm = -115.20 (dddt, 4JFF = 14.6, 4JHF = 8.0, 5JHF = 1.6, 5JHF = 1.4 Hz, 
1F, 2-F), -100.84 (dddt, 4JFF = 14.6, 3JHF = 8.1, 4JHF = 5.6, 5JHF = 1.4 Hz, 1F, 6-F). 
IR (Diamond-ATR, neat): ~  / cm-1 = 3098, 2949, 2916, 2863, 1863, 1618, 1602, 1586, 1526, 1479, 
1447, 1416, 1378, 1347, 1304, 1278, 1219, 1204, 1173, 1147, 1106, 1032, 996, 975, 941, 919, 908, 892, 
859, 830, 820, 766, 731, 699, 674. 
MS (EI, 70 eV): m/z (%) = 263 [M+] (55), 202 (20), 70 (10), 61 (14), 43 (100). 
HRMS (EI) for C14H11F2NO2 (263.0758): 263.0752 (M+). 
 
Synthesis of (2,6-difluoro-3-nitrophenyl)(phenyl)methanone (71b): 
 
A solution of (2,6-difluoro-3-nitrophenyl)zinc pivalate (65a, 1.23 g, 1.0 mmol) in THF (3 mL) was 
cooled to -20 °C and CuCN·2LiCl (1.1 mmol, 1.1 mL, 1.0 m in THF) was added dropwise. After stirring 
at this temperature for 20 min, benzoyl chloride (68a, 281 mg, 2.0 mmol) was added and the mixture 
was warmed up slowly to reach 25 oC and stirred there for 2 h. The reaction was quenched using sat. 
aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with diethyl ether 
(3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
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evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 10:1) 
afforded the product 71b (156 mg, 59%) as a colourless solid. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.28 (td, J = 8.77, 5.55 Hz, 1H), 7.87 (dd, J = 7.84, 0.60 Hz, 
2H), 7.64 - 7.75 (m, 1H), 7.48 - 7.61 (m, 2H), 7.11 - 7.23 (m, 1H). 
The physical and spectroscopical data of compound 71b were in perfect agreement with the one reported 
in the literature.60a 
 
Synthesis of 1,3-difluoro-2-iodo-4-nitrobenzene (71c): 
 
A solution of (2,6-difluoro-3-nitrophenyl)zinc pivalate (65a, 1.23 g, 1.0 mmol) in THF (3 mL) was 
cooled down to 0 °C and I2 (380 mg, 1.5 mmol) was added. The stirred reaction mixture was allowed to 
come to 25 °C (over 30 min) and then quenched with a sat. aqueous Na2S2O3 solution (9 mL) followed 
by extraction with diethyl ether (3×10 mL). The combined organic layers were dried over Na2SO4 and 
after filtration the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, 
iso-hexane / ethyl acetate = 12:1) afforded the product 71c (278 mg, 98%) as an off-white solid. 
1H-NMR (400 MHz, CDCl3):  / ppm = 8.16 (ddd, J = 9.24, 8.17, 5.61 Hz, 1H), 7.07 (ddd, J = 9.24, 
6.38, 1.88 Hz, 1H).  
The physical and spectroscopical data of compound 71c were in perfect agreement with the one reported 
in the literature. 60a 
 
Synthesis of 2-bromo-4-fluoro-3-(perfluorobenzoyl)benzonitrile (71d): 
 
(2-Bromo-3-cyano-6-fluorophenyl)-zinc-pivalate (65b, 1.17 g, 0.78 mmol/g, 0.9 mmol) dissolved in 
2 mL dry THF was cooled down to -20 °C. TMSCl (0.7 mL, 5.4 mmol) was added followed by 30 min 
stirring. After this CuCN·2LiCl (1 mL, 1 M, 1 mmol) and 2,3,4,5,6-pentafluorobenzoyl chloride (68f, 
524 mg, 231 g/mol, 2.3 mmol) were added subsequently. The reaction mixture was stirred for 30 min at 
-20 °C and for 15 h at 0 °C. After quenching with queous NH4Cl/NH3 (8:1) solution (4 mL) the mixture 
was extracted with ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and 
after filtration, the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, 
iso-hexane / Et2O = 4:1) afforded the product 71d (337 mg, 95%) as a off-white solid. 
M.p. (°C): 100.1-100.9. 
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1H-NMR (300 MHz, CDCl3): δ / ppm = 7.81 (dd, J = 8.8, 5.4 Hz, 1H), 7.31 (t, J = 8.5 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 180.4, 161.3 (d, J = 264 Hz), 145.8 (d, J = 250 Hz), 144.5 (d, 
J = 266 Hz), 137.8 (d, J = 260 Hz), 137.3 (d, J = 10 Hz), 135.5 (d, J = 10 Hz), 131.5 (d, J = 20 Hz) 
123.7, 116.6 (d, J = 23 Hz), 115.9 (d, J = 24 Hz), 113.9. 
19F-NMR (282 MHz, CDCl3): δ / ppm = -103.12 (ddt, J = 7.6, 5.3, 2.1 Hz, 1F), -139.48 – (-139.95) (m, 
2F), -144.16 (tt, J = 25, 6.2 Hz, 1F), -159.06 – (-159.27) (m, 2F). 
IR (Diamond-ATR, neat): ~  / cm-1 = 2239, 1693, 1653, 1575, 1523, 1497, 1456, 1409, 1393, 1365, 
1320, 1278, 1246, 1228, 1212, 1177, 1163, 1144, 1136, 1122, 1045, 1030, 984, 958, 911, 898, 852, 830, 
805, 781, 742, 711, 685, 667. 
MS (EI, 70 eV): m/z (%) = 395 (49), 393 [M+] (58), 228 (95), 226 (100), 200 (16), 198 (14), 195 (86), 
119 (25), 43 (12). 
HRMS (EI) for C14H2BrF6NO (392,9224): 392.9231 (M+). 
 
Synthesis of 2-bromo-3-(cyclobutanecarbonyl)-4-fluorobenzonitrile (71e): 
 
(2-Bromo-3-cyano-6-fluorophenyl)-zinc-pivalate (65b, 1.3 g, 0.78 mmol/g, 1.1 mmol) dissolved in 
2 mL dry THF was cooled down to -20 °C. TMSCl (0.8 mL, 6.3 mmol) was added followed by 30 min 
stirring. After this CuCN·2 LiCl (1.2 mL, 1 M, 1.2 mmol) and cyclobutanecarbonyl chloride (68g, 
311 mg, 2.6 mmol) were added subsequently. The reaction mixture was stirred for 30 min at -20 °C. 
After quenching with aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted with 
ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, the 
solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O 
= 4:1) afforded the product 71e (280 mg, 95%) as colourless liquid. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.69 (dd, J = 8.7, 5.4 Hz, 1H), 7.21 (dd, J = 8.7, 8.0 Hz, 1H), 
3.70 (quintt, J = 8.5, 1.2 Hz, 1H), 2.44 (quint, J = 9.2 Hz, 2H), 2.28 – 2.13 (m, 2H), 2.11 – 1.85 (m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 200.1, 184.6, 160.5 (d, J = 259 Hz), 140.0 (d, J = 10 Hz), 132.6 
(d, J = 24 Hz), 123.2 (d, J = 6.8 Hz), 116.2 (d, J = 24 Hz), 113.5 (d, J = 3.8 Hz), 46.3, 27.0, 17.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3087, 2949, 2871, 2237, 1701, 1576, 1483, 1457, 1414, 1388, 
1367, 1344, 1279, 1249, 1198, 1166, 1136, 1105, 1068, 984, 918, 885, 827, 798, 729, 692, 677. 
MS (EI, 70 eV): m/z (%) = 281 [M+] (3), 255 (10), 253 (10), 228 (98), 227 (11), 226 (100), 200 (11), 
198 (11), 119 (21). 
HRMS (EI) for C12H9BrFNO (280.9852): 280.9836 (M+). 
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Synthesis of 2-bromo-4-fluoro-3-iodobenzonitrile (71f): 
 
To a solution of (2-bromo-3-cyano-6-fluorophenyl)-zinc-pivalate (65b, 1.3 g, 0.78 mmol/g, 1.1 mmol) 
in 2 mL dry THF iodine (558 mg, 2.2 mmol) was added at 25 °C and the reaction mixture was stirred 
for 0.5 h at this temperature. After quenching with a saturated aqueous Na2S2O3 solution (4 mL) the 
mixture was extracted with ethylacetate (5 × 8 mL). The combined organic layers were dried over 
Na2SO4 and after filtration, the solvents were evaporated in vacuo. Purification by flash chromatography 
(silica gel, iso-hexane / Et2O = 9:1) afforded the product 71f (325 mg, 91%) as a white solid. 
M.p. (°C): 102.7-103.3. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.68 (dd, J = 8.6, 5.4 Hz, 1H), 7.12 (dd, J = 8.6, 6.8 Hz, 1H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 164.7 (d, J = 256 Hz), 135.4 (d, J = 9 Hz), 134.9 (d, J = 2 Hz), 
116.6 (d, J = 2 Hz), 114.7 (d, J = 26 Hz), 112.8 (d, J = 4 Hz), 92.9 (d, J = 29 Hz). 
IR (Diamond-ATR, neat): ~  / cm-1 = 3067, 2237, 1914, 1779, 1660, 1571, 1555, 1444, 1357, 1310, 
1292, 1258, 1248, 1223, 1213, 1138, 1076, 959, 920, 897, 826, 756, 741, 690, 661. 
MS (EI, 70 eV): m/z (%) = 327 (100), 325 [M+] (92), 200 (18), 198 (20), 119 (40), 43 (75). 
HRMS (EI) for C7H2BrFIN (324.8399): 324.8396 (M+). 
 
Synthesis of cyclobutyl(2,4,6-trichlorophenyl)methanone (71g): 
 
(2,4,6-Trichlorophenyl) zinc pivalate (65c, 1.53 g, 0.68 mmol/g, 1.0 mmol) dissolved in 2 mL dry THF 
was cooled to -20 °C. TMS-Cl (0.8 mL, 6.3 mmol) was added followed by 30 min stirring. After this 
CuCN·2 LiCl (1.1 mL, 1 M, 1.1 mmol) and cyclobutanecarbonyl chloride (68g, 307 mg, 2.5 mmol) 
were added subsequently. The reaction mixture was stirred for 30 min at -20 °C. After quenching with 
aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted with ethylacetate (5 × 8 mL). The 
combined organic layers were dried over Na2SO4 and after filtration, the solvents were evaporated in 
vacuo. Purification by flash chromatography (silica gel, iso-hexane) afforded the product 71g (250 mg, 
95%) as yellow liquid. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.32 (s, 2H), 3.71 (quintt, J = 8.5, 1.0 Hz, 1H), 2.56 – 2.37 (m, 
2H), 2.29 – 2.11 (m, 2H), 2.09 – 1.83 (m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 202.9, 138.0, 135.5, 131.4, 128.2, 46.2, 25.0, 18.0. 
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IR (Diamond-ATR, neat): ~  / cm-1 = cm-1, 3077, 2986, 2946, 2866, 1705, 1574, 1543, 1435, 1378, 
1365, 1344, 1260, 1246, 1204, 1183, 1155, 1105, 1086, 1050, 1016, 965, 919, 894, 853, 814, 797, 748, 
718, 691, 678. 
MS (EI, 70 eV): m/z (%) = 361 [M+] (2), 211 (31), 209 (94), 207 (100), 61 (14), 55 (26), 45 (12), 43 
(81). 
HRMS (EI) for C11H9Cl3O (261.9719): 261.9721 (M+). 
 
Synthesis of 1,3,5-trichloro-2-(2-methylallyl)benzene (71h): 
 
(2,4,6-Trichlorophenyl)zinc pivalate (65c, 1.44 g, 0.68 mmol/g, 0.9 mmol) dissolved in 2 mL dry THF 
was cooled down to -20 °C. After this CuCN·2LiCl (0.2 mL, 1 M, 0.2 mmol) and 3-bromo-2-
methylpropene (68h, 159 mg 1.2 mmol) were added. The reaction mixture was stirred for 45 min 
at -20 °C. After quenching with aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted 
with ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, 
the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane) 
afforded the product 71h (216 mg, 94%) as a colorless liquid. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.33 (s, 2H), 4.77 – 4.81 (m, 1H), 4.31 – 4.35 (m, 1H), 3.57 
(s, 2H), 1.81 – 1.84 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 140.9, 136.5, 134.6, 132.6, 128.0, 111.0, 38.2, 23.0. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3082, 2973, 2920, 2851, 1791, 1721, 1652, 1581, 1567, 1548, 
1442, 1424, 1390, 1373, 1330, 1283, 1265, 1229, 1208, 1164, 1133, 1098, 1071, 1038, 1020, 925, 915, 
890, 855, 812, 784, 766, 693, 673, 662. 
MS (EI, 70 eV): m/z (%) = 234 [M+] (8), 201 (7), 194 (6), 164 (5), 73 (5), 70 (12), 61 (15), 45 (14), 43 
(100), 42 (5), 41 (6). 
HRMS (EI) for C10H9Cl3 (233.9770): 233.9761 (M+). 
 
Synthesis of 5-bromo-2,4-dimethoxy-6-(4-(methylthio)phenyl)pyrimidine (72a): 
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To a solution of (5-bromo-2,6-dimethoxypyrimidin-4-yl)zinc pivalate (67b, 1.27 g, 1.0 mmol) in THF 
(3 mL) Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and 4-iodothioanisole (68c, 200 mg, 
0.8 mmol) were added subsequently at 25 °C. The reaction mixture was stirred at 25 °C over 12 h and 
then quenched with sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether (3 × 
10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O = 5:1) afforded 
the product 72a (276 mg, 81%) as white solid. 
M.p. (°C): 121.6-123.4. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.75 (d, J = 8.50 Hz, 2H), 7.31 (d, J = 8.43 Hz, 2H), 4.10 (s, 
3H), 4.02 (s, 3H), 2.53 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 168.1, 165.2, 163.4, 141.2, 134.0, 129.8, 125.2, 96.5, 55.3, 
55.2, 15.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3021, 2988, 2953, 2882, 2211, 1596, 1562, 1535, 1499, 1477, 
1448, 1420, 1401, 1383, 1350, 1324, 1301, 1240, 1196, 1151, 1111, 1092, 1034, 1020, 1011, 977, 964, 
949, 934, 900, 887, 863, 828, 814, 786, 736, 727, 681, 661. 
MS (EI, 70 eV): m/z (%) = 342 [81Br, M+] (100), 340 [79Br, M+] (92), 231 (29), 174 (11), 43 (14). 
HRMS (EI) for C13H1379BrN2O2S (339.9881): 339.9857. 
 
Synthesis of 5-bromo-4-(cyclohex-2-en-1-yl)-2,6-dimethoxypyrimidine (72b): 
 
A solution of (5-bromo-2,6-dimethoxypyrimidin-4-yl)zinc pivalate (67b, 1.27 g, 1.0 mmol) in THF 
(3 mL) was cooled to -20 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1 m in THF) and 3-bromocyclohexene 
(57a, 242 mg, 1.5 mmol) were added subsequently. The reaction mixture was allowed to warm up to 
25 °C over 12 h and then quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) 
followed by extraction with diethyl ether (3 × 10 mL). The combined organic layers were dried over 
Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash chromatography 
(silica gel, iso-hexane / Et2O = 10:1) afforded the product 72b (266 mg, 89%) as colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 5.82 – 5.93 (m, 1H), 5.57 – 7.70 (m, 1H), 4.04 (s, 3H), 3.95 – 
4.02 (m, 4H) 1.61 – 2.17 (m, 6H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 172.7, 167.1, 163.5, 128.5, 126.9, 97.6, 55.0, 54.9, 41.6, 27.3, 
24.6, 21.5.  
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IR (Diamond-ATR, neat): ~  / cm-1 = 3024, 2989, 2940, 2867, 2836, 1563, 1546, 1479, 1452, 1381, 
1352, 1299, 1285, 1258, 1239, 1200, 1156, 1138, 1109, 1084, 1069, 1042, 1026, 997, 956, 943, 926, 
896, 885, 864, 854, 791, 761, 743, 722, 700, 680, 658.  
MS (EI, 70 eV): m/z (%) = 298 [M+] (72), 271 (100), 259 (18), 234 (37), 219 (40), 72 (17), 43 (16). 
HRMS (EI) for C12H15BrN2O2 (298.0317): 298.0314. 
 
Synthesis of 2-chloro-3-(cyclohex-2-en-1-yl)pyrazine (72c): 
 
(3-Chloropyrazin-2-yl)zinc-pivalate (67c, 976 mg, 0.63 mmol/g, 0.62 mmol) dissolved in 1.2 mL dry 
THF was cooled down to -20 °C. After this CuCN·2LiCl (0.12 mL, 1 M, 0.12 mmol) and 3-
bromocyclohexene (57a, 119 mg, 161 g/mol, 0.7 mmol) were added. The reaction mixture was stirred 
for 15 h at -20 °C. After quenching with a aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was 
extracted with ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after 
filtration, the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-
hexane / Et2O = 9:1) afforded the product 72c (109 mg, 91%) as a colorless liquid. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.46 (d, J = 2.4 Hz, 1H), 8.20 (d, J = 2.4 Hz, 1H), 6.03 – 5.96 
(m, 1H), 5.75 – 5.69 (m, 1H), 4.09 – 4.00 (m, 1H), 2.18 – 2.09 (m, 3H), 1.91 – 1.79 (m, 1H), 1.78 – 1.61 
(m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 159.0, 148.7, 142.4, 141.3, 129.4, 126.8, 40.0, 28.2, 24.6, 21.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3266, 3027, 2934, 2861, 2836, 1681, 1552, 1519, 1446, 1433, 
1394, 1378, 1344, 1328, 1298, 1284, 1247, 1194, 1146, 1132, 1085, 1055, 1039, 987, 964, 934, 889, 
854, 809, 782, 753, 721, 661. 
MS (EI, 70 eV): m/z (%) = 194 [M+] (46), 193 (25), 179 (15), 167 (33), 166 (31), 165 (100), 159 (32), 
153 (14), 130 (16), 128 (40), 77 (11), 67 (21). 
HRMS (EI) for C10H11ClN2 (194.0611): 194.0590 (M+). 
 
Synthesis of 2-chloro-3-iodopyrazine (72d): 
 
To a solution of (3-Chloropyrazin-2-yl)zinc-pivalate (67c, 1.61 g, 1.0 mmol/g, 0.62 mmol) in 2 mL dry 
THF iodine (508 mg, 2.0 mmol) was added at 25 °C and the reaction mixture was stirred for 0.5 h at 
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this temperature. After quenching with sat. aqueous Na2S2O3 solution (4 mL) the mixture was extracted 
with ethyl acetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, 
the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / 
Et2O = 10:1) afforded the product 72d (223 mg, 93%) as a white solid. 
M.p. (°C): 141.0-142.2. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.29 (d, J = 1.4 Hz, 1H), 8.27 (d, J = 1.4 Hz, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 154.6, 142.6, 141.9, 119.5. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3060, 2963, 2925, 2854, 1932, 1821, 1723, 1531, 1494, 1423, 
1409, 1335, 1312, 1259, 1228, 1181, 1169, 1138, 1091, 1056, 1016, 858, 796, 778, 746, 702, 692. 
MS (EI, 70 eV): m/z (%) = 240 [M+] (28), 72 (39), 69 (38), 57 (79), 55 (60), 43 (57), 43 (100), 41 (42). 
HRMS (EI) for C4H2ClIN2 (239.8951): 239.8953 (M+). 
 
Synthesis of ethyl 3-(3-cyanophenyl)-5-nitrofuran-2-carboxylate (72e): 
 
To a solution of 3-(2-ethoxycarbonyl-5-nitrofuranyl)zinc pivalate (67e, 1.33 g, 1.0 mmol) in THF (3 mL) 
at 25 °C Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and 3-iodobenzonitrile (68i, 183 mg, 
0.8 mmol) were added subsequently. The reaction mixture was stirred for 6 h and then quenched with a 
sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether (3 × 10 mL). The 
combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated in 
vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 8:1) afforded the 
product 72e (189 mg, 66%) as off-white solid. 
M.p. (°C): 133.9-136.5 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.86 (td, J = 1.8, 0.6 Hz, 1H), 7.81 (ddd, J = 7.9, 1.8, 1.2 Hz, 
1H), 7.79 – 7.75 (m, 1H), 7.62 (td, J = 7.9, 0.6 Hz, 1H), 7.36 (s, 1H), 4.46 (q, J = 7.1 Hz, 2H), 1.42 (t, J 
= 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 156.7, 157.7, 143.6, 133.7, 133.3, 132.8, 129.8, 129.6, 125.3, 
120.4, 117.8, 113.2, 62.7, 14.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3098, 3066, 2997, 2910, 2238, 1746, 1612, 1591, 1532, 1509, 
1481, 1463, 1447, 1420, 1398, 1362, 1348, 1336, 1324, 1301, 1262, 1244, 1224, 1186, 1180, 1155, 
1123, 1111, 1096, 1011, 968, 934, 925, 891, 870, 848, 820, 799, 767, 744, 692, 680, 665. 
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MS (EI, 70 eV): m/z (%) = 286 [M+] (100), 241 (18), 213 (32), 200 (39), 172 (37), 139 (32), 130 (20), 
127 (59). 
HRMS (ESI) for C14H10N2O5 (286.0590): 286.0585 (M+). 
 
Synthesis of ethyl 3-(cyclohex-2-enyl)-5-nitrofuran-2-carboxylate (72f): 
 
A solution of 3-(2-ethoxycarbonyl-5-nitrofuranyl)zinc pivalate (67e, 1.33 g, 1.0 mmol) in THF (3 mL) 
was cooled to -20 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1 m in THF) and 3-bromocyclohexene (57a, 
242 mg, 1.5 mmol) were added subsequently. The reaction mixture was allowed to warm to 25 °C over 
12 h and then quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed 
by extraction with ethyl acetate (3 × 10 mL). The combined organic layers were dried over Na2SO4 and 
after filtration the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, 
iso-hexane / ethyl acetate = 10:1) afforded the product 72f (187 mg, 70%) as reddish oil. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.20 (d, J = 0.5 Hz, 1H), 5.97 (dtd, J = 9.8, 3.7, 2.2 Hz, 1H), 
5.64 – 5.54 (m, 1H), 4.41 (q, J = 7.1 Hz, 2H), 4.14 (ddd, J = 10.6, 5.5, 2.7 Hz, 1H), 2.17 – 1.99 (m, 3H), 
1.77 – 1.64 (m, 2H), 1.61 – 1.48 (m, 1H), 1.40 (t, J = 7.1 Hz, 3H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 157.2, 147.9, 143.0, 134.0, 130.5, 126.4, 119.9, 62.3, 32.3, 
29.1, 24.7, 20.6, 14.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3127, 3025, 2984, 2936, 2864, 2838, 1737, 1724, 1629, 1595, 
1532, 1502, 1475, 1465, 1447, 1433, 1402, 1390, 1367, 1337, 1286, 1251, 1226, 1197, 1156, 1140, 
1106, 1092, 1015, 981, 965, 932, 883, 851, 818, 764, 746, 725, 671. 
 MS (EI, 70 eV): m/z (%) = 265 [M+] (2), 248 (100), 231 (49), 220 (15), 146 (20), 91 (19), 77 (16). 
HRMS (ESI) for C13H15NO5 (265.0950): 265.0943 (M+). 
 
Synthesis of ethyl 4-(3-formyl-1-methyl-1H-indol-2-yl)benzoate (72g): 
 
To a solution of (3-formyl-1-methyl-1H-indol-2-yl)zinc pivalate (67f, 1.18 g, 1.0 mmol) in THF (3 mL) 
at 25 °C Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and ethyl 4-iodobenzoate (57d, 220 mg, 
0.8 mmol) were added subsequently. The reaction mixture was stirred at 25 °C over 3 h and then 
quenched with a sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether (3 × 
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10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O = 1:1) afforded 
the product 72g (281 mg, 91%) as off-white solid. 
M.p. (°C): 161.4-163.0. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.75 (s, 1H), 8.44 (d, J = 5.73 Hz, 1H), 8.18 – 8.30 (m, 2H), 
7.49 – 7.72 (m, 2H), 7.30 – 7.52 (m, 3H), 4.46 (q, J = 7.06 Hz, 2H), 3.69 (s, 3H), 1.45 (t, J = 7.17 Hz, 
3H).  
13C-NMR (75 MHz, CDCl3): δ / ppm = 186.0, 165.7, 149.7, 137.5, 133.0, 131.8, 130.9, 129.7, 125.1, 
124.3, 123.4, 122.2, 116.0, 109.8, 61.4, 31.1, 14.3.  
IR (Diamond-ATR, neat): ~  / cm-1 = 3034, 2988, 2978, 2886, 2803, 2770, 2730, 1712, 1649, 1608, 
1578, 1567, 1537, 1507, 1467, 1442, 1416, 1371, 1366, 1339, 1327, 1313, 1289, 1280, 1255, 1183, 
1155, 1128, 1107, 1082, 1072, 1049, 1028, 1018, 990, 977, 951, 901, 884, 874, 861, 848, 812, 760, 741, 
714, 700, 694, 682, 662. 
HRMS (ESI) for C19H18NO3 (308.1281): 308.1280 ([M+H]+). 
 
Synthesis of 2-(cyclohex-2-en-1-yl)-1-methyl-1H-indole-3-carbaldehyde (72h): 
 
A solution of (3-formyl-1-methyl-1H-indol-2-yl)zinc pivalate (67f, 1.18 g, 1.0 mmol) in THF (3 mL) 
was cooled to -20 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1 m in THF) and 3-bromocyclohexene (57a, 
242 mg, 1.5 mmol) were added subsequently. The reaction mixture was allowed to warm to 25 °C over 
12 h and then quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed 
by extraction with ethyl acetate (3 × 10 mL). The combined organic layers were dried over Na2SO4 and 
after filtration the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, 
iso-hexane / Et2O = 2:1) afforded the product 72h (234 mg, 98%) as orange resin. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 10.34 (s, 1H), 8.35 (s, 1H), 7.25 – 7.40 (m, 3H), 5.96 – 6.05 
(m, 1H), 5.80 – 5.88 (m, 1H), 4.22 – 4.37 (m, 1H), 3.80 (s, 3H), 2.11 – 2.26 (m, 3H), 1.74 – 2.04 (m, 
3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 185.2, 153.7, 137.2, 129.4, 127.5, 125.7, 123.3, 123.0, 121.6, 
114.3, 109.2, 34.0, 30.7, 27.0, 24.6, 22.2. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3054, 3024, 2932, 2862, 1713, 1641, 1612, 1580, 1513, 1468, 
1446, 1413, 1393, 1372, 1336, 1322, 1291, 1246, 1223, 1186, 1126, 1082, 1048, 1016, 980, 933, 890, 
859, 818, 801, 746, 729, 701, 683, 671.  
HRMS (ESI) for C16H18NO (240.1383): 240.1383 ([M+H]+). 
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Synthesis of 2-(cyclohex-2-en-1-yl)benzo[b]thiophene-3-carbaldehyde (72i): 
 
A solution of (3-formylbenzo[b]thiophen-2-yl)zinc pivalate (67g, 1.16 g, 1.0 mmol) in THF (2 mL) was 
cooled to -20 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1 m in THF) and 3-bromocyclohexene (57a, 242 mg, 
1.5 mmol) were added subsequently. The reaction mixture was allowed stirred at -20 °C for 12 h and 
then quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction 
with ethyl acetate (3 × 10 mL). The combined organic layers were dried over Na2SO4 and after filtration 
the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / 
Et2O = 10:1) afforded the product 72i (230 mg, 95%) as colorless oil. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 10.42 (s, 1H), 8.60 (dd, J = 8.1, 1.2 Hz, 1H), 7.78 (dd, J = 7.9, 
1.2 Hz, 1H), 7.46 (ddd, J = 8.0, 7.2, 1.3 Hz, 1H), 7.42 – 7.32 (m, 1H), 6.07 – 5.96 (m, 1H), 5.88 – 5.78 
(m, 1H), 4.44 – 4.58 (m, 1H), 2.32 – 2.09 (m, 3H), 1.96 – 1.65 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 184.2, 168.9, 137.6, 137.1, 130.5, 128.9, 128.0, 125.8, 125.0, 
124.0, 121.7, 35.5, 33.1, 24.7, 20.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3060, 3023, 2930, 2857, 2834, 2742, 1664, 1591, 1557, 1509, 
1461, 1444, 1433, 1398, 1356, 1326, 1294, 1275, 1260, 1224, 1176, 1155, 1146, 1080, 1052, 1020, 968, 
942, 900, 889, 863, 838, 817, 800, 754, 731, 698, 656. 
MS (EI, 70 eV): m/z (%) = 242 [M+] (100), 225 (27), 213 (41), 187 (21), 185 (25), 171 (15), 147 (16). 
HRMS (EI) for C15H14OS (242.0765): 242.076 (M+). 
 
Synthesis of 2-iodobenzo[b]thiophene-3-carbaldehyde (72j): 
 
To a solution of (3-formylbenzo[b]thiophen-2-yl)zinc pivalate (67g, 1.16 g, 1.0 mmol) in THF (2 mL) 
iodine (508 mg, 2.0 mmol) was added and the reaction mixture was allowed stirred at 25 °C for 30 min. 
After quenching with sat. aqueous Na2S2O3 solution (4 mL) the mixture was extracted with ethyl acetate 
(5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O = 10:1) afforded 
the product 72j (256 mg, 89%) as a white solid. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 9.99 (s, 1H), 8.88 – 8.60 (m, 1H), 7.84 – 7.64 (m, 1H), 7.54 – 
7.31 (m, 2H). 
The physical and spectroscopical data of compound 72j were in perfect agreement with the one reported 
in the literature.59a 
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Synthesis of (E)-6-nitro-2-(3-(triisopropylsilyloxy)prop-1-enyl)benzo[d]thiazole (72k): 
 
To a solution of (6-nitrobenzo[d]thiazol-2-yl)zinc pivalate (67h, 1.33 g, 1.0 mmol) in THF (3 mL) at 
25 °C Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and (E)-(3-iodoallyloxy)triisopropylsilane 
(68j, 272 mg, 0.8 mmol) were added subsequently. The reaction mixture was stirred for 2 h and then 
quenched with a sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether 
(3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 25:1) 
afforded the product 72k (298 mg, 95%) as orange crystals. 
M.p. (°C): 50.5-52.6. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.76 (dd, J = 2.3, 0.5 Hz, 1H), 8.32 (dd, J = 9.0, 2.3 Hz, 1H), 
8.04 (dd, J = 9.0, 0.4 Hz, 1H), 7.11 (dt, J = 15.6, 2.2 Hz, 1H), 6.96 (dt, J = 15.6, 3.4 Hz, 1H), 4.56 (dd, 
J = 3.4, 2.2 Hz, 2H), 1.24 – 1.13 (m, 3H), 1.13 – 1.07 (m, 18H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 172.6, 157.5, 144.8, 143.1, 134.7, 122.9, 122.1, 121.8, 118.0, 
62.7, 18.0, 11.9. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3112, 2957, 2942, 2890, 2864, 2839, 2718, 1646, 1601, 1567, 
1514, 1491, 1462, 1440, 1411, 1384, 1371, 1335, 1290, 1278, 1270, 1261, 1238, 1136, 1126, 1120, 
1096, 1073, 1046, 1016, 994, 964, 949, 919, 908, 882, 846, 824, 816, 793, 781, 764, 751, 716, 687, 663. 
MS (EI, 70 eV): m/z (%) = 392 [M+] (7), 349 (100), 173 (27), 103 (11), 75 (14), 43 (38). 
HRMS (ESI) for C19H28N2O3SSi (392.1590): 392.1584 (M+). 
 
Synthesis of 2-(2-methylallyl)-6-nitrobenzo[d]thiazole (72l): 
 
A solution of (6-nitrobenzo[d]thiazol-2-yl)zinc pivalate (67h, 1.33 g, 1.0 mmol) in THF (3 mL) was 
cooled to -40 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1 m in THF) and 3-bromo-2-methylpropene (68h, 
162 mg, 1.2 mmol) were added subsequently. The reaction mixture was stirred for 45 min at the same 
temperature and then quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) and 
allowed to warm up to 25 oC (prolonged reaction time or quenching at higher temperature led to partial 
migration of the double bond to conjugation) followed by extraction with ethyl acetate (3 × 10 mL). The 
combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated in 
vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 15:1) afforded the 
product 72l (205 mg, 88%) as orange solid. 
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M.p. (°C): 88.5-90.1. 
1H-NMR (600 MHz, CDCl3): δ / ppm = 8.78 (dd, J = 2.3, 0.4 Hz, 1H), 8.33 (dd, J = 9.0, 2.3 Hz, 1H), 
8.07 (dd, J = 9.0, 0.3 Hz, 1H), 5.07 – 5.04 (m, 1H), 5.04 – 5.02 (m, 1H), 3.88 (d, J = 1.0 Hz, 2H), 1.84 
(t, J = 1.1 Hz, 3H). 
13C-NMR (150 MHz, CDCl3): δ / ppm = 176.6, 157.1, 144.8, 140.8, 136.0, 123.0, 121.5, 118.1, 115.6, 
43.3, 22.1. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3094, 3063, 3002, 2980, 2933, 2906, 1944, 1833, 1812, 1738, 
1650, 1601, 1567, 1511, 1447, 1418, 1384, 1366, 1344, 1335, 1328, 1310, 1277, 1246, 1196, 1131, 
1113, 1047, 1022, 976, 914, 896, 845, 754, 743, 723, 681, 654. 
MS (EI, 70 eV): m/z (%) = 234 [M+] (23), 219 (29), 194 (15), 70 (15), 61 (18), 44 (17), 43 (100). 
HRMS (ESI) for C11H10N2O2S (234.0463): 234.0458 (M+). 
 
Synthesis of 8-(3,4-difluorobenzoyl)-1,3,7-trimethyl-3,7-dihydro-1H-purine-2,6-dione (72m): 
 
(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)zinc pivalate (67i, 1.30 g, 1.0 mmol) 
dissolved in 2 mL dry THF was cooled to -20 °C. TMSCl (0.75 mL, 6.0 mmol) was added followed by 
30 min stirring. After this CuCN·2 LiCl (1.1 mL, 1 M, 1.1 mmol) and 3,4-difluorobenzoyl chloride 
(68k, 441 mg, 2.5 mmol) were added subsequently. The reaction mixture was stirred for 18 h at -20 °C. 
After quenching with aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was extracted with 
ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after filtration, the 
solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / EtOAc 
= 4:1) afforded the product 72m (245 mg, 73%) as white solid. 
M.p. (°C): 176.9-178.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.29 (ddd, J = 11.1, 7.8, 2.1 Hz, 1H), 8.20 (dddd, J = 8.7, 4.4, 
2.1, 1.3 Hz, 1H), 7.30 (ddd, J = 9.6, 8.7, 7.6 Hz, 1H), 4.37 (s, 3H), 3.62 (s, 3H), 3.43 (s, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 180.8 (dd, J = 2.0, 1.0 Hz), 155.7, 154.1 (dd, J = 259, 13 Hz), 
151.4, 149.9 (dd, J = 250, 13 Hz), 146.4, 143.4, 133.0 (dd, J = 5.2, 3.5 Hz), 128.3 (dd, J = 7.5, 3.6 Hz), 
120.5 (dd, J = 19, 1.9 Hz), 117.3 (dd, J = 17.8, 0.5 Hz), 110.5, 35.1, 29.9, 28.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 2961, 1704, 1664, 1600, 1542, 1526, 1509, 1478, 1454, 1410, 
1388, 1372, 1342, 1286, 1264, 1241, 1229, 1216, 1182, 1128, 1102, 1044, 988, 972, 942, 900, 870, 850, 
831, 805, 779, 772, 764, 746, 738, 720, 689. 
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MS (EI, 70 eV): m/z (%) = 334 [M+] (100), 248 (11), 141 (33), 113 (23), 82 (14), 67 (33). 
HRMS (EI) for C15H12F2N4O3 (334.0877): 334.0870 (M+). 
 
Synthesis of 1,3,7-trimethyl-8-(2-methylallyl)-3,7-dihydro-1H-purine-2,6-dione (72n): 
 
(1,3,7-trimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-8-yl)zinc pivalate (67i, 1.30 g, 1.0 mmol) 
dissolved in 2 mL dry THF was cooled to -20 °C. CuCN·2 LiCl (0.1 mL, 1 M, 0.1 mmol) and 3-bromo-
2-methylpropene (68h, 162 mg, 1.2 mmol) were added subsequently. The reaction mixture was stirred 
for 1 h at -20 °C. After quenching with aqueous NH4Cl/NH3 (8:1) solution (4 mL) the mixture was 
extracted with ethylacetate (5 × 8 mL). The combined organic layers were dried over Na2SO4 and after 
filtration, the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-
hexane / EtOAc = 9:1) afforded the product 72n (248 mg, 94%) as white solid. 
M.p. (°C): 122.6-124.8. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 4.92 (quint, J = 1.3 Hz, 1H), 4.55 – 4.60 (m, 1H), 3.87 (s, 3H), 
3.56 (s, 3H), 3.47 – 3.50 (m, 2H), 3.38 (s, 3H), 1.76 – 1.79 (m, 3H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 155.3, 151.6, 151.4, 147.8, 139.6, 113.4, 107.7, 35.7, 31.9, 
29.7, 27.8, 22.4. 
IR (Diamond-ATR, neat): ~  / cm-1 = cm-1, 2973, 2940, 1698, 1694, 1659, 1606, 1544, 1494, 1450, 
1422, 1400, 1373, 1341, 1291, 1250, 1220, 1140, 1068, 1037, 976, 966, 951, 909, 795, 758, 741, 706, 
679. 
MS (EI, 70 eV): m/z (%) = 248 [M+] (81), 233 (32), 208 (35), 193 (19), 190 (10), 82 (19), 70 (11), 67 
(30), 61 (14), 45 (13), 43 (100). 
HRMS (EI) for C12H16N4O2 (248.1273): 248.1273 (M+). 
 
Synthesis of 3-(3-(trifluoromethyl)phenyl)-2H-chromen-2-one (72o): 
 
To a solution of (2-oxo-2H-chromen-3-yl)zinc pivalate (67j, 0.91 g, 1.0 mmol) in THF (3 mL) at 25 °C, 
Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 6 mol%) and 1-iodo-3-(trifluoromethyl)benzene (57c, 
217 mg, 0.8 mmol) were added successively. The reaction mixture was stirred at 25 °C for 1.5 h and 
then quenched with sat. aqueous NH4Cl solution (9 mL) followed by extraction with diethyl ether 
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(3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration the solvents were 
evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / Et2O = 5:1) afforded 
the product 72o (226 mg, 96%) as white solid. 
M.p. (°C): 122.9-124.4. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.90 – 8.01 (m, 2H), 7.89 (s, 1H), 7.64 – 7.73 (m, 1H), 7.58 (t, 
J = 7.36 Hz, 3H), 7.28 – 7.45 (m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 160.2, 153.7, 140.7, 135.4, 132.0, 131.9 (q, J = 1.3 Hz), 131.0 
(q, J = 32.5 Hz), 128.9, 128.1, 126.9, 125.5 (q, J = 3.8 Hz), 125.2 (q, J = 3.8 Hz), 124.7, 123.9 (q, J = 
272 Hz), 119.3, 116.6. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3038, 2979, 2889, 1710, 1658, 1608, 1567, 1508, 1492, 1458, 
1430, 1400, 1356, 1343, 1332, 1289, 1285, 1261, 1232, 1180, 1165, 1150, 1108, 1076, 1026, 1001, 986, 
968, 956, 940, 924, 904, 859, 808, 774, 758, 736, 691, 654. 
MS (EI, 70 eV): m/z (%) = 290 [M+] (100), 262 (88), 233 (9), 165 (29), 43 (10).. 
HRMS (EI) for C16H9F3O2 (290.0555): 290.0548 (M+). 
 
Synthesis of 3-allyl-2H-chromen-2-one (72p): 
 
A solution of (2-oxo-2H-chromen-3-yl)zinc pivalate (67j, 0.91 g, 1.0 mmol) in THF (3 mL) was cooled 
to -20 °C. CuCN·2LiCl (0.1 mmol, 0.1 mL, 1.0 M in THF) and allyl bromide (68d, 182 mg, 1.5 mmol) 
were added subsequently. The reaction mixture was allowed to warm to 25 °C over 12 h and was then 
quenched with a sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction 
with ethyl acetate (3×10 mL). The combined organic layers were dried over Na2SO4 and after filtration 
the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / 
Et2O = 4:1) afforded the product 72p (182 mg, 98%) as a white solid. 
M.p. (°C): 41.4-45.9. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 7.38 – 7.61 (m, 3H), 7.16 – 7.37 (m, 2H), 5.80 – 6.14 (m, 1H), 
5.04 – 5.43 (m, 2H), 3.32 (d, J = 6.77 Hz, 2H) 
13C-NMR (75 MHz, CDCl3): δ / ppm = 161.5, 153.1, 138.8, 133.7, 130.7, 128.0, 127.2, 124.2, 119.4, 
118.1, 116.4, 34.5.  
IR (Diamond-ATR, neat): ~  / cm-1 = 3068, 3016, 2976, 2905, 1707, 1633, 1608, 1578, 1568, 1508, 
1484, 1472, 1457, 1429, 1416, 1400, 1382, 1363, 1326, 1291, 1282, 1253, 1232, 1185, 1150, 1124, 
1082, 1050, 1026, 1006, 946, 932, 901, 864, 844, 787, 754, 744, 727, 712, 702, 682, 662. 
MS (EI, 70 eV): m/z (%) = 186 [M+] (49), 171 (20), 157 (24), 131 (23), 61 (19), 43 (100). 
C. Experimental Section 
 
 
156 
HRMS (ESI) for C12H10O2 (186.0681): 186.0674 (M+). 
 
Synthesis of 3-Iodo-2H-chromen-2-one (72q): 
 
A solution of oxo(2-oxo-2H-chromen-3-yl)zinc pivalate (67j, 0.91 g, 1.0 mmol) in THF (3 mL) was 
cooled down to 0 °C and I2 (380 mg, 1.5 mmol) was added. The stirred reaction mixture was allowed to 
come to 25 °C (over 30 min) and then quenched with a sat. aqueous Na2S2O3 solution (9 mL) followed 
by extraction with diethyl ether (3×10 mL). The combined organic layers were dried over Na2SO4 and 
after filtration the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, 
iso-hexane / Et2O = 4:1) afforded the product 72q (250 mg, 92%) as a white solid. 
M.p. (°C): 90.2-91.6. 
1H-NMR (300 MHz, CDCl3): δ / ppm = 8.36 (s, 1H), 7.52 – 7.63 (m, 1H), 7.44 (d, J = 7.67 Hz, 1H), 
7.27 – 7.37 (m, 2H). 
13C-NMR (75 MHz, CDCl3): δ / ppm = 157.4, 153.9, 152.1, 132.3, 126.8, 124.7, 120.1, 116.8, 86.2.  
R (Diamond-ATR, neat): ~  / cm-1 = 3069, 3047, 3027, 1720, 1706, 1687, 1669, 1602, 1564, 1553, 
1508, 1483, 1448, 1440, 1418, 1400, 1363, 1350, 1342, 1329, 1274, 1245, 1212, 1157, 1132, 1119, 
1083, 1049, 1026, 986, 958, 948, 934, 913, 860, 802, 782, 763, 750, 724, 700, 682. 
MS (EI, 70 eV): m/z (%) = 272 [M+] (100), 244 (29), 145 (44), 89 (61), 63 (28), 43 (18).  
HRMS (EI) for C9H5IO2 (271.9334): 271.9333 (M+). 
 
Synthesis of 2-(4-(tert-butyldimethylsilyloxy)phenyl)-4H-chromen-4-one (72r): 
 
According to TP6 chromone (66k, 146 mg, 1.0 mmol) in 2 mL THF reacted with BF3·OEt2 (156 mg, 
1.1 mmol) and TMPZnOPiv·LiCl (63, 1.3 mL, 0.85 M, 1.1 mmol) to give (4-oxo-4H-chromen-2-yl)zinc 
pivalate (67k) as a deep red solution. To this solution Pd(dba)2 (17 mg, 3 mol%), P(o-fur)3 (14 mg, 
6 mol%) and tert-butyl(4-iodophenoxy)dimethylsilane (68l, 267 mg, 0.8 mmol) were added 
subsequently at 25 °C. The reaction mixture was stirred for 2 h and then quenched with sat. aqueous 
NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) followed by extraction with diethyl ether (3 × 10 mL). 
The combined organic layers were dried over Na2SO4 and after filtration the solvents were evaporated 
in vacuo. Purification by flash chromatography (silica gel, iso-hexane / ethyl acetate = 25:1) afforded 
the product 72r (218 mg, 78%) as red-brown solid. 
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M.p. (°C): 94.7-96.3. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.23 (ddd, J = 7.9, 1.7, 0.4 Hz, 1H), 7.89 – 7.79 (m, 2H), 7.73 
– 7.65 (m, 1H), 7.55 (ddd, J = 8.4, 1.1, 0.4 Hz, 1H), 7.41 (ddd, J = 8.1, 7.1, 1.1 Hz, 1H), 7.00 – 6.92 (m, 
2H), 6.78 (s, 1H), 1.00 (s, 9H), 0.25 (s, 6H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 178.5, 163.6, 159.1, 156.2, 133.6, 128.0, 125.7, 125.1, 124.5, 
123.8, 120.6, 117.9, 106.2, 25.6, 18.3, -4.3. 
IR (Diamond-ATR, neat): ~  / cm-1 = 3060, 2955, 2928, 2857, 2769, 2703, 2641, 1642, 1632, 1620, 
1600, 1576, 1509, 1467, 1420, 1376, 1337, 1298, 1274, 1252, 1226, 1176, 1133, 1114, 1043, 1017, 
1009, 918, 908, 873, 836, 823, 806, 771, 752, 733, 726, 716, 673. 
MS (EI, 70 eV): m/z (%) = 253 [M+] (76), 297 (22), 296 (100), 295 (20), 175 (11), 121 (29). 
HRMS (ESI) for C21H24O3Si (352.1495): 352.1494 (M+). 
 
Synthesis of 2-(cyclohexanecarbonyl)-4H-chromen-4-one (72s): 
 
According to TP6 chromone (66k, 146 mg, 1.0 mmol) in 2 mL THF reacted with BF3·OEt2 (156 mg, 
1.1 mmol) and TMPZnOPiv·LiCl (63, 1.3 mL, 0.85 M, 1.1 mmol) to give (4-oxo-4H-chromen-2-yl)zinc 
pivalate (67k) as a deep red solution. This solution was cooled to -20 °C and CuCN·2LiCl (1.1 mmol, 
1.1 mL, 1 m in THF) was added. After stirring for 20 min at this temperature, cyclohexanecarbonyl 
chloride (68m, 292 mg, 2.0 mmol) were added dropwise and the reaction mixture was warmed to 25 oC 
and stirred there for 2 h. Then sat. aqueous NH4Cl solution (9 mL) and NH3 (conc.) (1 mL) were added 
followed by extraction with ethyl acetate (3 × 10 mL). The combined organic layers were washed with 
a 15% w/w aqueous solution K2CO3 (2×20 mL) and brine (1×20 mL) dried over Na2SO4. After filtration 
the solvents were evaporated in vacuo. Purification by flash chromatography (silica gel, iso-hexane / 
ethyl acetate = 15:1) afforded the product 72s (179 mg, 70%) as colourless crystals. 
M.p. (°C): 137.3-140.9. 
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.20 (ddd, J = 8.0, 1.7, 0.4 Hz, 1H), 7.75 (ddd, J = 8.8, 7.1, 
1.7 Hz, 1H), 7.58 (ddd, J = 8.5, 1.0, 0.4 Hz, 1H), 7.45 (ddd, J = 8.1, 7.2, 1.0 Hz, 1H), 6.97 (s, 1H), 3.27 
(tt, J = 11.2, 3.3 Hz, 1H), 1.95 (dd, J = 14.3, 1.3 Hz, 2H), 1.91 – 1.81 (m, 2H), 1.81 – 1.70 (m, 1H), 1.44 
(dtdd, J = 19.3, 16.0, 9.7, 3.3 Hz, 4H), 1.33 – 1.22 (m, 1H). 
13C-NMR (100 MHz, CDCl3): δ / ppm = 197.9, 178.6, 156.5, 155.56, 134.7, 125.9, 125.8, 124.5, 118.6, 
112.0, 45.6, 28.4, 25.7, 25.5. 
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IR (Diamond-ATR, neat): ~  / cm-1 = 3074, 2923, 2852, 1693, 1642, 1616, 1570, 1464, 1450, 1398, 
1367, 1352, 1331, 1315, 1294, 1272, 1254, 1240, 1224, 1190, 1169, 1148, 1136, 1114, 1103, 1084, 
1075, 1057, 1040, 1030, 1020, 996, 962, 924, 896, 878, 866, 839, 784, 771, 755, 744, 721, 676. 
MS (EI, 70 eV): m/z (%) = 256 [M+] (37), 83 (17), 70 (15), 61 (17), 55 (21), 43 (100). 
HRMS (ESI) for C16H16O3 (256.1099): 256.1085 (M+). 
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6. STRUCTURAL INSIGHTS ON ORGANOZINC PIVALATE REAGENTS 
Note: The experiments carried out in C6.1. and C6.2 were performed by the group of Prof. Mulvey and 
Prof. Hevia at the University of Strathclyde in Glasgow. 
6.1. Preparation of the Magnesium and Zinc Pivalate Complexes 
X-ray crystallographic studies: 
Single-crystal X-ray diffraction data were measured with Oxford Diffraction (now Agilent 
Technologies) Xcalibur or Gemini diffractometers using MoKα (λ = 0.71073) or Cu-Kα (λ = 1.54180) 
radiation. The structures were solved by direct methods and refined against all unique F2 values using 
programs from the SHELX suit.122 Refinement of CCDC-953398 
([{Mg(OPiv)2}5{Mg(OH)2}(MgO)∙4THF]), 953399 ([{Mg6(OPiv)12}(MgO2)]∙C7H8), 953400 
((TMEDA)ZnMe(p-C6H4)Cl) and 953401 ([(THF)2Li2(µ-Cl)2(µ-OPiv)2Zn] (24c)) contain the 
supplementary crystallographic data for this paper. These data can be obtained free of charge from The 
Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
Synthesis of [{Mg6(OPiv)12}(MgO2)]∙C7H8: 
MgBu2 (4 mL of a 1 M solution in heptane, 4 mmol) was added to a solution cooled at -30◦C of pivalic 
acid (0.817 g, 8 mmol) in THF (10 mL) and the resulting yellow pale solution was stirred at room 
temperature for 1 h. The solvent was then removed in vacuo and toluene (10 mL) was added affording 
a suspension. Gentle heating gave a clear solution which was left to slow cooling, resulted in the 
formation of colourless crystals (0.23 g, yield 32% based on MgBu2).  
1H-NMR (400 MHz, THF-d8): δ / ppm = 7.20 ‒ 7.08 (m, 5H, C6H5, Toluene), 2.30 (s, 3H, Me, Toluene), 
1.14 (s, 36H, CMe3,.Pivalate), 1.13 (s, 18H, CMe3,.Pivalate), 1.11(s, 54H, CMe3,.Pivalate). 
13C-NMR (100 MHz, THF-d8): δ / ppm = 193.3, 187.8, 186.9 (O2CCMe3, Pivalate), 138.6, 129.7, 
128.9, 126.0 (C6H4, Toluene), 40.0 (O2CCMe3, Pivalate), 28.5, 28.4, 28.1 (O2CCMe3, Pivalate), 21.5 
(Me, Toluene) 
 
6.2. Reaction of Zn(OPiv)2∙nLiCl (n=1, 2) with p-tolylMgX  
To a solution of Zn(Opiv)2∙nLiCl (2 mmol) in 10 mL of THF was added Me(p-C6H4)MgCl offering a 
colourless solution. After stirring the mixture at 25◦C for one hour, determination of the contents for the 
mixture by NMR spectroscopy was carried out. 
 
                                                     
122 G. M. Sheldrick, Acta Crystallogr. A64, 2008, 112 
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Table 13: NMR data in THF-d8 at 25◦C 
 1H/δppm 13C/ δ ppm 
Me(p-C6H4)MgCl∙LiCl 
7.46 (d, J = 7.4 Hz, 2H, Me(p-C6H4)), 
6.68 (d, J = 7.4 Hz, 2H, Me(p-C6H4)) 
2.06 (s, 3H, Me(p-C6H4)) 
165.1, 140.1, 130.8, 125.5 
Me(p-C6H4), 20.6 Me(p-C6H4) 
Me(p-C6H4)ZnCl∙LiCl 
7.37 (d, J = 7.4 Hz, 2H, Me(p-C6H4)), 
6.82 (d, J = 7.4 Hz, 2H, Me(p-C6H4)) 
2.14 (s, 3H, Me(p-C6H4)) 
153.0, 139.3, 134.0, 127.5 Me(p-
C6H4), 21.6 Me(p-C6H4) 
Me(p-C6H4)MgCl + 
Zn(OPiv)2∙LiCl  
7.39 (d, J = 7.6 Hz, 2H, Me(p-C6H4)), 
6.81 (d, J = 7.6 Hz, 2H Me(p-C6H4)) 2.14 
(s, 3 H, Me(p-C6H4)), 1.08 (s, 18 H, 
CO2CCH3) 
187.5 (CO2CCH3), 153.7, 139.4, 
133.8, 127.4 Me(p-C6H4), 39.7 
(CO2CCH3), 28.4 (CO2CCH3), 21.6 
Me(p-C6H4) 
Me(p-C6H4)MgCl + 
Zn(OPiv)2∙2LiCl 
7.57 (d, J = 7.6 Hz, 2H, Me(p-C6H4)), 
6.81 (d, J = 7.6 Hz, 2H, Me(p-C6H4)) 
2.15 (s, 3H, Me(p-C6H4)), 1.06 (s, 18H, 
CO2CCH3) 
Not detected (CO2CCH3), 156.8, 
140.1, 133.5, 127.2 Me(p-C6H4), 39.9 
(CO2CCH3), 28.4 (CO2CCH3), 21.6 
Me(p-C6H4) 
 
 
6.3.  Preparation of the p-tolylZnX reagents 76a-d 
Me(p-C6H4)MgCl·LiCl (75) and Me(p-C6H4)Li (77) were prepared according to literature procedures.
123
 
The reagents Me(p-C6H4)ZnX 76a-d were generated by adding 1.1 equivalents of ZnCl2 (as 1 M solution 
in THF) and Zn(OPiv)2 (as a neat solid), respectively, to solutions of Me(p-C6H4)MgCl·LiCl (75) and 
Me(p-C6H4)Li (77) in THF at room temperature. These mixtures were stirred for further 15 min at this 
temperature until a clear solution formed. The concentration of the active zinc species was determined 
by titration against a stoichiometric amount of iodine (100 mg) in THF (2 mL). To get comparable 
reactivities all zinc reagents were then diluted to a concentration of ca. 0.35 mol/L. 
 
6.4. Reaction conditions for the Negishi cross-coupling 
When the reactions were performed under argon the reaction flasks were flame dried in vacuum prior 
to use, while the reactions in air were carried out in non-dried glassware. The EtOAc used in the cross-
coupling reactions was purchased from Fluka in analytical grade (99.9%) and was stored in air and used 
without further drying. 
 
                                                     
123 a) M. P. R. Spee, J. Boersma, M. D. Meijer, M. Q. Slagt, G. van Koten, J. W. Geus, J. Org. Chem. 2001, 66, 1647; b) A. K. 
Steib, T. Thaler, K. Komeyama, P. Mayer, P. Knochel, Angew. Chem., Int. Ed. 2011, 50, 3303. 
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Cross-coupling with ethyl 4-iodobenzoate (78)  
 
To a solution of Me(p-C6H4)ZnX (2.86 mL, 1 mmol, 0.35 M in THF) 17.3 mg Pd(dba)2 (0.03 mmol), 
14.0 mg P(o-furyl)3 (0.06 mmol) and 221 mg ethyl 4-iodobenzoate (0.8 mmol) were added subsequently 
ad 25 °C. The reaction was stirred for 30 min at this temperature and then quenched with a sat. aqueous 
NH4Cl solution (10 mL) followed by extraction with diethyl ether (3×10 mL). The combined organic 
layers were dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification 
by flash chromatography (silica gel, iso-hexane / Et2O = 20:1) afforded the product 79 as a white solid.  
1H-NMR (400 MHz, CDCl3): δ / ppm = 8.11 (d, J = 8.5 Hz, 2H), 7.41 (d, J = 8.5 Hz, 2H), 7.17 – 7.34 
(m, 4H), 4.42 (q, J = 7.1 Hz, 2H), 2.28 (s, 3H), 1.43 (t, J = 7.1 Hz, 3H). 
The analytical data were in accordance with the literature data.
124
 
 
Cross-coupling with 4-bromoanisole (81) in THF 
 
To a solution of Me(p-C6H4)ZnX (2.86 mL, 1 mmol, 0.35 M in THF) 6.74 mg Pd(OAc)2 (0.03 mmol), 
23.6 mg DavePhos (0.06 mmol) and 150 mg 4-bromoanisole (0.8 mmol) were added subsequently ad 
25 °C. The reaction was stirred for 1.5 h at 50 °C and then quenched with a sat. aqueous NH4Cl solution 
(10 mL) followed by extraction with diethyl ether (3×10 mL). The combined organic layers were dried 
over Na2SO4 and after filtration the solvents were evaporated in vacuo. Purification by flash 
chromatography (silica gel, iso-hexane / Et2O = 100:1) afforded the product 81 as a white solid.  
1H-NMR (400 MHz, CDCl3): δ / ppm = 7.41 – 7.58 (m, 4H), 7.24 (d, J = 7.8 Hz, 2H), 6.98 (d, J = 
8.8 Hz, 2H), 3.86 (s, 3H), 2.40 (s, 3H). 
The analytical data were in accordance with the literature data.124 
 
Cross-coupling with 4-bromoanisole (81) in EtOAc 
 
The corresponding solutions of Me(p-C6H4)ZnX (2.86 mL, 1 mmol, 0.35 M in THF) were dried in high 
vacuum (<0.1 mbar) to give the THF-free zinc reagents 76a and 76c as yellowish slurry and the reagents 
76b and 76d as off white solids. The reagents were then dissolved in EtOAc (2.5 mL) and 6.74 mg 
                                                     
124 N. Liu, L. Wang, Z.-X. Wang, Chem. Commun. 2011, 47, 1598. 
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Pd(OAc)2 (0.03 mmol), 23.6 mg DavePhos (0.06 mmol) and 150 mg 4-bromoanisole (0.8 mmol) were 
added subsequently ad 25 °C. The reaction was stirred for 1.5 h at 50 °C and then quenched with a sat. 
aqueous NH4Cl solution (10 mL) followed by extraction with diethyl ether (3×10 mL). The combined 
organic layers were dried over Na2SO4 and after filtration the solvents were evaporated in vacuo. 
Purification by flash chromatography (silica gel, iso-hexane / Et2O = 100:1) afforded the product 81 as 
a white solid.  
 
6.5. Synthesis and Stability Studies of (3-(trifluoromethyl)-
phenyl)ZnCl·Mg(OPiv)2·nLiCl (n=0, 1, 2) 
The stability studies of the reagents 83a and 83b were carried out as described in C5.1. The 
determination of the active zinc reagent was determined by titration against iodine.67,68 
Synthesis of (3-(trifluoromethyl)phenyl)ZnCl·Mg(OPiv)2·nLiCl (n=0, 1, 2): 
 
To a suspension of anhydrous LiCl (0, 2.4, 4.8 mmol) in THF (4 mL) was added Zn(OPiv)2 (24b, 
642 mg, 2.4 mmol) at room temperature. The mixture was stirred at this temperature for 30 min before 
1-bromo-3-(trifluoromethyl)benzene (84, 450 mg, 2.0 mmol) and Mg turnings (122 mg, 5.0 mmol) were 
added subsequently. After stirring the reaction mixture for 2 h at 25 °C the THF was removed in vacuo 
to give the reagents (3-(trifluoromethyl)phenyl)ZnCl·Mg(OPiv)2·2LiCl (83a, 1.49 g) and (3-
(trifluoromethyl)phenyl)ZnCl·Mg(OPiv)2·LiCl (83b, 1.50 g) as white solids. The content of active zinc 
species was determined by titration of the reagents with a stock solution of iodine (0.25 M in THF). A 
concentration of 1.13 mmol/g was obtained for 83a which corresponds to a yield of 84%. For 83b a 
concentration of 1.19 mmol/g was obtained which corresponds to a yield of 89%. The LiCl-free reagent 
83c did not furnish a homogeneous solid, but a sticky and inhomogeneous slurry and was therefore not 
titrated. 
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1. NMR-SPECTRA BF3 COMPLEXES AND METALATED INTERMEDIATES 
1.1. Metalated intermediate 47a 
 
1H-NMR expansions of intermediate 47a of the aromatic region (left) and the CH2 signal region (right). 
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13C-NMR expansions of the intermediate 47a of the aromatic region (120-230 ppm, left) and the 
alliphatic region (0-70 ppm) right). 
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1.2. (3-(ethoxycarbonyl)pyridin-1-ium-1-yl)trifluoroborate (49) 
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1.3. Trifluoro(2,2,6,6-tetramethylpiperidin-1-ium-1-yl)borate (50) 
 
 
 ( M i l l i o n s )
0
1 . 0
2 . 0
3 . 0
X  :  p a r t s  p e r  M i l l i o n  :  1 H
7 . 0 6 . 0 5 . 0 4 . 0 3 . 0 2 . 0 1 . 0 0
   4 . 8 3 9   4 . 8 2 1   4 . 8 0 4   4 . 5 9 5    3 . 5 6 6   3 . 5 4 0   3 . 5 2 2   3 . 4 0 6   3 . 3 8 6   3 . 3 6 8   3 . 3 5 1   3 . 3 3 3   3 . 2 1 1   3 . 1 9 2   3 . 1 7 5    1 . 7 1 7   1 . 6 0 2   1 . 5 9 4   1 . 5 8 3   1 . 5 7 0   1 . 5 6 2   1 . 5 4 6   1 . 5 3 6   1 . 5 0 0   1 . 4 9 0   1 . 3 9 9   1 . 3 7 7   1 . 2 6 5   1 . 1 1 7   1 . 1 0 0   1 . 0 8 2   1 . 0 3 4    0 . 0 8 8   0 . 0 4 8
1 . 0 1
0 . 7 9
0 . 7 9
0 . 5 8
0 . 5 3
0 . 2 9
0 . 1 3
8 0 . 0 4 m
6 8 . 6 0 m 5 0 . 2 7 m
4 5 S O M 1 - 4 . j d f  
S o p h i a ,  S O M 3 7 1 ,  - 2 0  G r a d  C ,  d 8 - T H F ,  1 H - N M R
 ( M i l l i o n s )
0
1 . 0
2 . 0
3 . 0
4 . 0
5 . 0
6 . 0
7 . 0
X  :  p a r t s  p e r  M i l l i o n  :  1 9 F
- 1 2 9 . 0 - 1 3 1 . 0 - 1 3 3 . 0 - 1 3 5 . 0 - 1 3 7 . 0 - 1 3 9 . 0 - 1 4 1 . 0 - 1 4 3 . 0 - 1 4 5 . 0 - 1 4 7 . 0 - 1 4 9 . 0 - 1 5 1 . 0 - 1 5 3 . 0 - 1 5 5 . 0 - 1 5 7 . 0 - 1 5 9 . 0 - 1 6 1 . 0
- 1 3 2 . 3 2 7- 1 3 2 . 3 8 1- 1 3 2 . 4 3 6- 1 3 2 . 4 9 0 - 1 4 8 . 0 4 1- 1 4 8 . 0 9 5 - 1 5 6 . 5 9 7- 1 5 6 . 6 6 2
6 7 0 . 7 6 M
3 2 3 . 3 5 M
1 4 6 . 5 8 M
7 2 . 7 8 M
4 5 S O M 2 - 4 . j d f  
S o p h i a ,  S O M 3 7 1 ,  - 2 0  G r a d  C ,  d 8 - T H F ,  1 9 F - N M R
1H-NMR 
19F-NMR of 50 
D. Appendix 
 
 
171 
 ( M i l l i o n s )
0
1 . 0
2 . 0
3 . 0
4 . 0
5 . 0
6 . 0
7 . 0
8 . 0
9 . 0
1 0 . 0
X  :  p a r t s  p e r  M i l l i o n  :  1 1 B
1 . 1 1 . 0 0 . 9 0 . 8 0 . 7 0 . 6 0 . 5 0 . 4 0 . 3 0 . 2 0 . 1 0 - 0 . 1 - 0 . 2 - 0 . 3 - 0 . 4 - 0 . 5 - 0 . 6 - 0 . 7 - 0 . 8 - 0 . 9 - 1 . 0 - 1 . 1 - 1 . 2 - 1 . 3 - 1 . 4 - 1 . 5 - 1 . 6 - 1 . 7 - 1 . 8 - 1 . 9 - 2 . 0 - 2 . 1 - 2 . 2 - 2 . 3 - 2 . 4 - 2 . 5 - 2 . 6 - 2 . 7 - 2 . 8 - 2 . 9 - 3 . 0 - 3 . 1 - 3 . 2
  - 0 . 2 2 0   - 0 . 3 8 1  - 0 . 4 6 3  - 0 . 5 4 1   - 0 . 7 0 7   - 1 . 0 0 0   - 2 . 0 0 5
0 . 6 8
0 . 3 7
0 . 1 2
4 5 S O M 3 - 6 . j d f  
S o p h i a ,  S O M 3 7 1 ,  - 2 0  G r a d  C ,  d 8 - T H F ,  1 1 B - N M R
 ( M i l l i o n s )
0
1 . 0
2 . 0
3 . 0
X  :  p a r t s  p e r  M i l l i o n  :  1 3 C
7 0 . 0 6 0 . 0 5 0 . 0 4 0 . 0 3 0 . 0 2 0 . 0 1 0 . 0 0
  6 6 . 9 7 6  6 6 . 7 5 6  6 . 6 6 5  6 . 5 3 8  6 6 . 3 8 7  6 6 . 3 1 8  6 6 . 0 9 9  6 5 . 5 7 1   5 8 . 1 1 2   4 9 . 1 8 1   4 1 . 0 8 6  4 0 . 5 8 5  3 8 . 1 8 8  3 6 . 2 9 9  3 4 . 5 8 3  3 1 . 4 9 0  3 1 . 4 4 6  3 1 . 3 3 1  2 4 . 8 2 5  2 4 . 6 2 6  2 4 . 4 2 5  2 4 . 2 2 7  2 4 . 0 2 7  2 2 . 2 0 5  2 2 . 1 7 3   1 8 . 4 2 2  1 6 . 5 0 6  1 4 . 9 2 3
   0 . 5 4 3
4 5 S O M 4 - 5 . j d f  
S o p h i a ,  S O M 3 7 1 ,  - 2 0  G r a d  C ,  d 8 - T H F ,  1 3 C - N M R
11B-NMR of 50 
13C-NMR of 50 
D. Appendix 
 
 
172 
 
 
 ( M i l l i o n s )
0
0 . 1
0 . 2
0 . 3
0 . 4
0 . 5
0 . 6
0 . 7
0 . 8
0 . 9
1 . 0
1 . 1
1 . 2
X  :  p a r t s  p e r  M i l l i o n  :  1 3 C
3 2 . 0 3 1 . 0 3 0 . 0 2 9 . 0 2 8 . 0 2 7 . 0 2 6 . 0 2 5 . 0 2 4 . 0 2 3 . 0 2 2 . 0
  3 1 . 5 3 5  3 1 . 4 9 0  3 1 . 4 4 6  3 1 . 4 0 2  3 1 . 3 3 1   2 6 . 5 5 1   2 4 . 9 6 0  2 4 . 8 2 5  2 4 . 7 5 7  2 4 . 6 2 6  2 4 . 5 5 5  2 4 . 4 2 5  2 4 . 2 2 7  2 4 . 0 2 7   2 2 . 2 3 7  2 2 . 2 0 5  2 2 . 1 7 3  2 2 . 1 4 1
4 5 S O M 4 - 5 . j d f  
S o p h i a ,  S O M 3 7 1 ,  - 2 0  G r a d  C ,  d 8 - T H F ,  1 3 C - N M R
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1.4. (5-(neopenthyl)pyrimidin-1-ium-1-yl)trifluoroborate (61) 
 
 
1H-NMR of 61 
11B-NMR of 61 
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19F-NMR of 61 
13C-NMR of 61 
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1.5. Zinc Intermediate 62 
 
 
 
1H-NMR of 62 
11B-NMR of 61 
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13C-NMR of 62 
19F-NMR of 62 
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2. TRANSMETALATION STUDIES OF RMGX AND ZN(OPIV)2·NLICL 
2.1. Transmetallation study of the mixture of the arylester reagent EtO2C(p-
C6H4)MgCl·LiCl and Zn(OPiv)2 
1H NMR in THF-d8 at 25°C: 
 
COSY NMR in THF-d8 at 25°C: 
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1H DOSY NMR in THF-d8 at 25°C 
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2.2. Transmetallation study of the mixture of the arylester reagent p-
TolylMgCl·LiCl and Zn(OPiv)2 
 
Figure 10: 1H NMR spectrum of a) Me(p-C6H4)MgCl∙LiCl; b) Me(p-C6H4)ZnCl∙LiCl; c) Zn(OPiv)2∙LiCl and 
Me(p-C6H4)MgCl; d) Zn(OPiv)2∙2LiCl and Me(p-C6H4)MgCl in THF-d8 at 25°C. 
 
Figure 11: 13C NMR spectrum of a) Me(p-C6H4)MgCl∙LiCl; b) Me(p-C6H4)ZnCl∙LiCl; c) Zn(OPiv)2∙LiCl and 
Me(p-C6H4)MgCl; d) Zn(OPiv)2∙2LiCl and Me(p-C6H4)MgCl in THF-d8 at 25°C. 
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Figure 12: 1H DOSY NMR spectrum of Zn(OPiv)2∙LiCl and Me(p-C6H4)MgCl in THF-d8 at 25°C 
 
 
Figure 13: 1H DOSY NMR spectrum of Zn(OPiv)2∙2LiCl and Me(p-C6H4)MgCl in [D8]THF at 25°C. 
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2.3.  Crystal Structures of the Mg and Zn Pivalate Complexes 
Molecular structure of (TMEDA)ZnMe(p-C6H4)Cl:  
 
Molecular structure of [(THF)2Li2(µ-Cl)2(µ-OPiv)2Zn] (24c) with H atoms omitted for clarity: 
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X-ray crystallographic structure of [{Mg6(OPiv)12}(MgO)2]∙C7H8 with hydrogen atoms, 
solvent molecule, tert-butyl substituent and disorder omitted for clarity: 
 
 
Crystallographically derived structure of the [{Mg(OPiv)2}5{Mg(OH)2}(MgO)∙4THF] core with 
hydrogen atoms, solvent molecule, tert-butyl substituent and disorder omitted for clarity (this Mg7 
species cocrystallizes with the isostructural Mg6Zn species in a 4:1 ratio): 
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Table 14: Selected crystallographic data for compounds:  
 
(TMEDA)ZnMe 
(p-C6H4)Cl 
[(THF)2Li2(µ-
Cl)2(µ-OPiv)2Zn] 
(24c) 
[{Mg6(OPiv)12} 
(MgO)2]∙C7H8 
[{Mg(OPiv)2}5{Mg(OH)2
}(MgO)∙4THF] 
Empirical 
formula 
C13H23Cl1N2Zn1 C18H34Cl2Li2O6Zn1 C74H124Mg8O26 
C68.64H129.28Mg6.75O27.66Z
n0.25 
Molecular 
Weight 
308.17 496.6 1624.21 1577.76 
Temperature (K) 123(2) 123(2) 123(2) 123(2) 
Wavelenght (Å) 0.71073 0.71073 1.54180 0.71073 
Crystal system,  Monoclinic Orthorhombic Monoclinic Orthorhombic  
Space group P21/c Pbca P21/c C2cb 
a (Å) 9.9500(3) 14.9325(3) 13.1072(2) 19.2990(6) 
b (Å) 11.8823(3) 17.9451(5) 15.5468(3) 24.0340(7) 
c (Å) 12.6338(4) 18.2119(4) 23.2630(4) 18.7974(6) 
(°) 90 90 90 90 
(°) 95.329(3) 90 105.827(2) 90 
(°) 90 90 105.827(2) 90 
Cell volume (Å3) 1487.22(8) 4880.2(2) 90 8718.8(5) 
Z 4 8 2 4 
calc (g.cm-3) 1.376 1.352 1.183 1.204 
 (mm-1) 1.813 1.253 1.207 0.200 
 max(°) 60.50 58.00 147.02 58.00 
Index ranges 
-14≤h≤14 
-16≤k≤16 
-16≤l≤17 
-19≤h≤18 
-23≤k≤20 
-24≤l≤14 
-16≤h≤15 
-19≤k≤19 
-26≤l≤28 
-16≤h≤26 
-32≤k≤32 
-25≤l≤18 
Reflections 
collected 
14826 29165 36435 21834 
Reflections 
unique 
4064 6343 9049 8210 
Reflections obs. 3349 4693 6967 6661 
Rint 0.0400 0.0401 0.0597 0.0378 
No. Parameters 159 268 508  533 
Goodnes-of-fit-
on F2 (GOF) 
1.032 1.098 1.053 1.063 
Final R indices 
[>2()] 
0.0329  0.0399 0.0636  0.0582 
R indices (all 
data) 
0.081 0.0911 0.193 0.1557 
Largest diff. peak 
and hole (e Å-3) 
0.629 and -0.456 0.628 and -0.353 1.021 and -0.620 0.796 and -0.276 
 
